<SEC-DOCUMENT>0001493152-23-016736.txt : 20230512
<SEC-HEADER>0001493152-23-016736.hdr.sgml : 20230512
<ACCEPTANCE-DATETIME>20230512171247
ACCESSION NUMBER:		0001493152-23-016736
CONFORMED SUBMISSION TYPE:	F-3
PUBLIC DOCUMENT COUNT:		11
FILED AS OF DATE:		20230512
DATE AS OF CHANGE:		20230512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Genenta Science S.p.A.
		CENTRAL INDEX KEY:			0001838716
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L6

	FILING VALUES:
		FORM TYPE:		F-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271901
		FILM NUMBER:		23916987

	BUSINESS ADDRESS:	
		STREET 1:		OLGETTINA, NO. 58
		CITY:			MILAN
		STATE:			L6
		ZIP:			20132
		BUSINESS PHONE:		39-02-2643-6639

	MAIL ADDRESS:	
		STREET 1:		OLGETTINA, NO. 58
		CITY:			MILAN
		STATE:			L6
		ZIP:			20132

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genenta Science S.r.l.
		DATE OF NAME CHANGE:	20210104
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3
<SEQUENCE>1
<FILENAME>formf-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on May 12, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
F-3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>GENENTA
SCIENCE S.P.A.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of Registrant as specified in its charter)</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Republic
    of Italy </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
    Applicable</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or other jurisdiction of</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation
    or organization)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
    Employer</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
    Number)</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pierluigi
Paracchi</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Via
Olgettina No. 58</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20132
Milan, Italy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tel:
+39-02-2643-4681</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
and telephone number of Registrant&rsquo;s principal executive offices)</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cogency
Global Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>122
East 42nd Street, 18th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, New York 10168</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tel:
+1.800.221.0102</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
address, and telephone number of agent for service)</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
B. Chilstrom, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fenwick
&amp; West LLP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>902
Broadway</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, New York 10010</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
430-2600</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public:</B> From time to time after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the
following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&dagger; provided
pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards
    Board to its Accounting Standards Codification after April 5, 2012. </FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective
on such date as the Securities and Exchange Commission acting pursuant to said Section 8(a) may determine.</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPLANATORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
registration statement contains two prospectuses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    base prospectus (the &ldquo;Base Prospectus&rdquo;), which covers the offering, issuance and sale by Genenta Science S.p.A. (the
    &ldquo;Company&rdquo;) of up to a maximum aggregate offering price of $100,000,000 of the Company&rsquo;s ordinary shares; ordinary
    shares represented by American depositary shares (&ldquo;ADSs&rdquo;), each representing one of our ordinary shares; rights exercisable
    for ordinary shares and/or ordinary shares represented by ADSs (&ldquo;rights&rdquo;); or any combination thereof as described in
    the Base Prospectus; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    sales agreement prospectus (the &ldquo;Sales Agreement Prospectus&rdquo;) covering the offering, issuance and sale by the Company
    of up to a maximum aggregate offering price of $30,000,000 of its ordinary shares represented by ADSs (the &ldquo;Sales Agreement
    Securities&rdquo;) that may be issued and sold under a Controlled Equity Offering<SUP>SM</SUP> Sales Agreement, dated May 12, 2023
    (the &ldquo;Sales Agreement&rdquo;), between the Company and Cantor Fitzgerald &amp; Co. (&ldquo;Cantor&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Base Prospectus immediately follows this Explanatory Note. The specific terms of any securities to be offered pursuant to the Base Prospectus,
other than the shares to be issued and sold under the Sales Agreement, will be specified in a prospectus supplement to the Base Prospectus.
The specific terms of the securities to be issued and sold under the Sales Agreement are specified in the Sales Agreement Prospectus
immediately following the Base Prospectus. The $30,000,000 of the Sales Agreement Securities that may be offered, issued and sold under
the Sales Agreement Prospectus are included in the $100,000,000 of securities that may be offered, issued and sold by the Company under
the Base Prospectus. Upon termination of the Sales Agreement with Cantor, any portion of the $30,000,000 included in the Sales Agreement
Prospectus that is not sold pursuant to the Sales Agreement will be available for sale in other offerings pursuant to the Base Prospectus
and a corresponding prospectus supplement, and if no Sales Agreement Securities are sold under the Sales Agreement, the full $100,000,000
of securities may be sold in other offerings by the Company pursuant to the Base Prospectus and a corresponding prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subject
to completion, dated May 12, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>$100,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Ordinary
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Ordinary
Shares Represented by American Depositary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formf-3_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Genenta
Science S.p.A.</B></FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt 0pt 0pt auto; width: 100%"><DIV STYLE="margin-right: 0pt; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
this prospectus, we may offer and sell from time to time, in one or more offerings, together or separately, ordinary shares; ordinary
shares represented by American depositary shares (&ldquo;ADSs&rdquo;), each ADS representing one of our ordinary shares; rights exercisable
for ordinary shares and/or ordinary shares represented by ADSs (&ldquo;rights&rdquo;); or any combination thereof as described in this
prospectus. The total amount of these securities will have an initial aggregate offering price of up to $100,000,000. You should carefully
read this prospectus, any prospectus supplement and any free writing prospectus, as well as any documents incorporated in any of the
foregoing by reference, before you invest in our securities. This prospectus may not be used to sell our securities unless accompanied
by a prospectus supplement. A prospectus supplement or any related free writing prospectus may also add to, update, supplement or clarify
information contained in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs are listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;GNTA.&rdquo; The last reported sale price
of the ADSs on the Nasdaq on May 11, 2023 was $5.95 per ADS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer and sell our securities to or through one or more agents, underwriters, dealers or other third parties or directly to one or
more purchasers on a continuous or delayed basis. If agents, underwriters or dealers are used to sell our securities, we will name them
and describe their compensation in a prospectus supplement. The price to the public of our securities and the net proceeds we expect
to receive from the sale of such securities will also be set forth in a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are an &ldquo;emerging growth company&rdquo; as defined in Section 2(a) of the Securities Act of 1933, as amended, and, as such, have
elected to comply with certain reduced disclosure and regulatory requirements. Investing in our securities involves a high degree of
risk. Before buying any of our securities, you should carefully read the discussion of material risks of investing in our securities.
Please read the section entitled &ldquo;<A HREF="#toc1_003">Risk Factors</A>&rdquo; beginning on page 3 of this prospectus, as well as the section entitled &ldquo;Item
3. Key Information&mdash;D. Risk Factors&rdquo; beginning on page 3 of our Annual Report on Form 20-F for the year ended December 31,
2022, which report is incorporated by reference in this prospectus, before investing in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_001">About this Prospectus</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_002">Prospectus Summary</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_003">Risk Factors</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_004">Special Note Regarding Forward-Looking Statements</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_005">Use of Proceeds</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_006">Description of Share Capital and Governing Documents</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_007">Description of Securities</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_008">Plan of Distribution</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_009">Legal Matters</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_010">Experts</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>15</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_011">Expenses</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>15</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_012">Enforcement of Civil Liabilities</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>16</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_013">Where You Can Find More Information</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>17</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc1_014">Incorporation of Information by Reference</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>18</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are responsible for the information contained and incorporated by reference in this prospectus, in any accompanying prospectus supplement,
and in any related free writing prospectus we prepare or authorize. We have not authorized anyone to give you any other information,
and we take no responsibility for any other information that others may give you. If you are in a jurisdiction where offers to sell,
or solicitations of offers to purchase, the securities offered by this documentation are unlawful, or if you are a person to whom it
is unlawful to direct these types of activities, then the offer presented in this document does not extend to you. The information contained
in this document speaks only as of the date of this document, unless the information specifically indicates that another date applies.
Our business, financial condition, results of operations and prospects may have changed since those dates.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a shelf registration statement that we have filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
this shelf registration, we may offer our ordinary shares, ordinary shares represented by ADSs, rights or any combination thereof, from
time to time in one or more offerings. The total amount of these securities will have an initial aggregate offering price of up to $100,000,000.
This prospectus only provides you with a general description of the securities that we may offer. Each time we offer a type of securities
under this prospectus, we will provide a prospectus supplement that will contain more specific information about the specific terms of
the offering. If any such securities are to be listed or quoted on a securities exchange or quotation system, the applicable prospectus
supplement will say so. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information
relating to these offerings. This prospectus may not be used to sell our securities unless accompanied by a prospectus supplement. Each
such prospectus supplement and any free writing prospectus that we may authorize to be provided to you may also add, update or change
information contained in this prospectus or in documents incorporated by reference into this prospectus. We urge you to carefully read
this prospectus, any applicable prospectus supplement and any related free writing prospectus, together with the information incorporated
herein by reference as described under the headings &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Information
by Reference&rdquo; before you invest in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized anyone to provide you with additional information or information different from that contained in or incorporated
by reference in this prospectus, any applicable prospectus supplement and any related free writing prospectus filed with the SEC. We
take no responsibility for, and can provide no assurances as to the reliability of, any information not contained in this prospectus,
any applicable prospectus supplement or any related free writing prospectus that we may authorize to be provided to you. This prospectus
is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where offers and sales of the
securities are legally permitted. The information contained in this prospectus, any applicable prospectus supplement or any related free
writing prospectus we file is accurate only as of the date on the front of the document and that any information incorporated by reference
is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, any
applicable prospectus supplement or any related free writing prospectus, or any sale of a security. Our business, financial condition,
results of operations and prospects may have changed since that date. We will update this prospectus to the extent required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &ldquo;Where
You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration
statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreement rather than establishing matters of fact. The information in the
exhibits should not be read alone and instead should be read in conjunction with the information in this prospectus and other filings
that we make with the SEC. Moreover, such representations, warranties or covenants were accurate only as of the date they were made.
Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our
affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this prospectus to &ldquo;U.S. dollars&rdquo; or &ldquo;$&rdquo; are to the legal currency of the United States and all
references to &ldquo;&euro;&rdquo; or &ldquo;euro&rdquo; are to the currency introduced at the start of the third stage of the European
economic and monetary union pursuant to the treaty establishing the European Community, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
figures included in this prospectus have been rounded for ease of presentation. Percentage figures included in this prospectus have not
in all cases been calculated on the basis of such rounded figures but on the basis of such amounts prior to rounding. For this reason,
percentage amounts in this prospectus may vary slightly from those obtained by performing the same calculations using the figures in
our consolidated financial statements. Certain other amounts that appear in this prospectus may similarly not sum due to rounding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise mentioned or unless the context requires otherwise, throughout this prospectus, any applicable prospectus supplement and any
related free writing prospectus, the words &ldquo;Genenta,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the Company,&rdquo;
&ldquo;our company&rdquo; or similar references refer to Genenta Science S.p.A. and its subsidiaries; and the term &ldquo;securities&rdquo;
refers collectively to our ordinary shares, ordinary shares represented by ADSs, rights, or any combination of the foregoing securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-right: 0pt; padding: 0.1in; border: Black 1.5pt solid">

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_002"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained in other parts of this prospectus or incorporated by reference in this prospectus from our Annual
Report on Form 20-F for the year ended December 31, 2022, and our other filings with the SEC listed below under the heading &ldquo;Incorporation
of Information by Reference.&rdquo; This summary may not contain all the information that you should consider before investing in our
securities. You should read the entire prospectus, any applicable prospectus supplement and the information incorporated by reference
in this prospectus and any applicable prospectus supplement carefully, including &ldquo;Risk Factors&rdquo; and the financial data and
related notes and other information incorporated by reference, before making an investment decision. See &ldquo;Special Note Regarding
Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of
solid tumors. We have developed a novel biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate into autologous
hematopoietic stem/progenitor cells (&ldquo;HSPCs&rdquo;) to deliver immunomodulatory molecules directly to the tumor by infiltrating
monocytes/macrophages (Tie2 Expressing Monocytes &ndash; &ldquo;TEMs&rdquo;). Our technology is designed to turn TEMs, which normally
have an affinity for and travel to tumors, into a &ldquo;Trojan Horse&rdquo; to counteract cancer progression and to prevent tumor relapse.
Our technology is not target dependent, and therefore we believe it can be used as a treatment for a broad variety of cancers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead product candidate, Temferon, was developed using our platform and carries an interferon-alpha (&ldquo;IFN-&alpha;&rdquo;) payload.
IFN-&alpha; is a well-known therapeutic that was previously administered intravenously for treatment of various cancers, but it is currently
rarely used because of its systemic toxicity. The Temferon-modified TEMs express the transgene payload, IFN-&alpha;, in the tumor microenvironment
resulting in the breakdown of tumor induced immune-tolerance. As a result, the immune system can recognize the tumor, respond, and inhibit
tumor growth. Because Temferon is designed to deliver the IFN-&alpha; payload directly to the tumor, we believe it will demonstrate clinical
activity without the side effect profile of systemic delivery of IFN-&alpha;. In preclinical mouse cancer models treated with Temferon,
both direct (anti-angiogenic, pro-apoptotic) and indirect (immune response) effects were observed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
was formed as an Italian limited liability company (<I>societ&agrave; a responsabilit&agrave; limitata</I>) in 2014. In May 2021, we
changed the legal form of our company under Italian law to a joint stock company (<I>societ&agrave; per azioni</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at Via Olgettina No. 58, 20132 Milan, Italy. Our telephone number in Italy is +39.02.2643.6639.
Our website address is www.genenta.com. The information contained on, or that can be accessed through, our website is not part of, and
is not incorporated by reference into, this prospectus. We have included our website address in this prospectus solely as an inactive
textual reference. Investors should not rely on any such information in deciding whether to purchase our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs, each representing one ordinary share of the Company, have been listed on the Nasdaq Capital Market under the symbol &ldquo;GNTA&rdquo;
since December 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Securities We May Offer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
this prospectus, we may offer ordinary shares, ordinary shares represented by ADSs, rights or any combination thereof. The aggregate
offering price of securities that we may offer with this prospectus will not exceed $100,000,000. Each time we offer securities with
this prospectus, we will provide offerees with a prospectus supplement that will contain the specific terms of the securities being offered.
The following is a summary of the securities we may offer with this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ordinary
Shares</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer ordinary shares with no par value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ordinary
Shares Represented by ADSs</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer ADSs, each representing one ordinary share of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer rights exercisable for ordinary shares and/or ordinary shares represented by ADSs. We may issue rights independently or together
with other securities, the rights may be attached to or separate from these securities and the rights may or may not be transferable
by the shareholder receiving the rights in the rights offering. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_003"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our securities involves a high degree of risk. You should carefully consider the risks described in &ldquo;Item 3. Key Information&mdash;D.
Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2022, which is incorporated herein by reference,
and other documents we file with the SEC that are incorporated by reference in this prospectus and any applicable prospectus supplement,
before making an investment decision. Each of the risks described could materially adversely affect our business, financial condition
or results of operations, or the trading price of our securities. In such case, you could lose all or a portion of your original investment.
See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_004"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains many statements that are &ldquo;forward-looking&rdquo; within the meaning of Section 27A of the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and uses forward-looking terminology such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;future,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;ought to,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo;
&ldquo;potentially,&rdquo; &ldquo;predicts,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo;
negatives of such terms or other similar statements. You should not place undue reliance on any forward-looking statement due to its
inherent risk and uncertainties, both general and specific. Although we believe the assumptions on which the forward-looking statements
are based are reasonable and within the bounds of our knowledge of our business and operations as of the date of this prospectus, any
or all of those assumptions could prove to be inaccurate. As a result, the forward-looking statements based on those assumptions could
also be incorrect. The forward-looking statements in this prospectus include, without limitation, statements relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    goals and strategies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    future business development, results of operations and financial condition;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect our intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected
    revenues, profits, earnings and other estimated financial information;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain strong relationships with our customers and suppliers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    planned use of proceeds; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">governmental
    policies regarding our industry; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risk factors as set forth under the &ldquo;Risk Factors&rdquo; section of this prospectus and under &ldquo;Item 3. Key Information&mdash;D.
    Risk Factors.&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2022, which report is incorporated by reference
    in this prospectus.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate. These statements are only current predictions
and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry&rsquo;s actual results,
levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements.
We discuss many of these risks in this prospectus in greater detail under the heading &ldquo;Risk Factors&rdquo; and elsewhere in this
prospectus. You should not rely upon forward-looking statements as predictions of future events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether as a result of new information, future events or otherwise, after the date of this prospectus. Comparisons of results
for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed
as such, and should only be viewed as historical data. You should, however, review the factors and risks we describe in the reports we
will file from time to time with the SEC after the date of this prospectus. See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should also read carefully the factors described in the &ldquo;Risk Factors&rdquo; section of this prospectus, in &ldquo;Item 3. Key
Information&mdash;D. Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2022 and in the other documents
that we file with the SEC after the date of this prospectus that are incorporated by reference into this prospectus to better understand
the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these factors, we
cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking
statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking
statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our
objectives and plans in any specified timeframe, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_005"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described in any prospectus supplement or in any related free writing prospectus that we may authorize to be provided to you, the
net proceeds received by us from our sale of the securities described in this prospectus will be used for our general corporate purposes,
w<FONT STYLE="background-color: white">hich may include funding research and development, increasing our working capital, reducing indebtedness,
acquisitions or investments in businesses, products or technologies that are complementary to our own and capital expenditures</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_006"></A>DESCRIPTION
OF SHARE CAPITAL AND GOVERNING DOCUMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
share capital is composed of ordinary shares with no par value. As of December 31, 2022, our issued share capital consisted of 18,216,858
ordinary shares. All issued shares are fully paid, non-assessable and in registered form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
preference shares are designated, issued or outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain information concerning our ordinary shares and bylaws (<I>Statuto</I>), as well as Italian law provisions
applicable to companies like ours whose shares are not listed in a &ldquo;regulated market&rdquo; within the European Union, as in effect
at the date of this prospectus. The summary contains such information as we consider material regarding the ordinary shares but does
not purport to be complete and is qualified in its entirety by reference to our bylaws or Italian law, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Italian law, most of the procedures regulating our Company, including certain rights of shareholders, are contained in our bylaws. Amendments
to our bylaws must be approved at an extraordinary meeting of shareholders, as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Form
and transfer of shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are not represented by share certificates (<I>certificati azionari) </I>as they are dematerialised <I>(azioni dematerializzate</I>).
The ownership of the shares, their transfer, the related rights and restrictions on the shares (if any) results from the electronical
register managed by an intermediary (banks and other financial institutions). The entitlement to exercise the rights attached to the
shares is then proven by the exhibition of certifications or communications to the issuer made by the intermediary, pursuant to its own
accounting records, in favor of the subject entitled to the right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations on the right to own or vote our ordinary shares, which applies to non-Italian residents and foreign residents except
for &ldquo;Golden Power&rdquo; regulations and Italian Antitrust laws (see &ldquo;Notification of acquisition of shares&rdquo; below).
There are no provisions in our articles of association or bylaws that would have the effect of delaying, deferring or preventing a change
of control of our Company and that would operate only with respect to a merger, acquisition or corporate restructuring involving our
Company. There are no provisions in our bylaws governing the ownership threshold where shareholder ownership must be disclosed. There
are no provisions discriminating against any existing or prospective holder of our ordinary shares as a result of such shareholder owning
a substantial number of our shares. There are no sinking fund provisions or provisions providing for liability for further capital calls
by our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividend
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
by the Company of any annual dividend is proposed by the board of directors and is subject to the approval of the shareholders at the
annual shareholders&rsquo; meeting. Before dividends may be paid out of the Company&rsquo;s unconsolidated net income in any year, an
amount at least equal to 5% of such net income must be allocated to the Company&rsquo;s legal reserve until such reserve is at least
equal to one-fifth of the Company&rsquo;s issued share capital. If the Company&rsquo;s share capital is reduced as a result of accumulated
losses, no dividends may be paid until the capital is reconstituted or reduced by the amount of such losses. The Company may pay dividends
out of available retained earnings from prior years, provided that, after such payment, the Company will have a legal reserve at least
equal to the legally required minimum. No interim dividends may be approved or paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
will be paid in the manner and on the date specified in the shareholders&rsquo; resolution approving their payment. Dividends that are
not collected within five years of the date on which they become payable are forfeited to the benefit of the Company. Holders of ADSs
will be entitled to receive payments in respect of dividends on the underlying shares through The Bank of New York Mellon, as Depositary,
in accordance with the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
holders of the Company&rsquo;s ordinary shares are entitled to one vote per ordinary share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a registered shareholder of the ordinary shares underlying the ADSs, the Depositary (or its nominee) will be entitled to vote the ordinary
shares underlying the ADSs with respect to voting instructions received from ADS holders in accordance with the terms and conditions
of the Deposit Agreement. Neither Italian law nor the Company&rsquo;s bylaws limit the right of non-resident or foreign owners of the
Company&rsquo;s ordinary shares to hold or vote shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preemptive
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Italian law, holders of outstanding ordinary shares and convertible debentures are entitled to subscribe for newly issued ordinary
shares or convertible debentures in proportion to their holdings at the time that the shareholders authorize the capital increase for
those issuances, unless those issuances are for non-cash consideration. Those who exercise their preemptive rights, provided they make
such request simultaneously, have a preemptive right on the purchase of shares and debentures convertible into shares that have not been
subscribed. Preemptive rights may be excluded or limited by resolution of the shareholders at an extraordinary shareholders&rsquo; meeting,
or by the board of directors if the bylaws delegate such power to the board of directors (including the power to exclude or limit the
preemptive right), and provided that such exclusion or limitation is in the interest of the Company, or if the shares are to be paid
by means of contributions in kind. According to Italian law proposals to increase share capital with exclusion or limitation of preemptive
rights must be accompanied by a report of the board of directors setting forth the reasons for the exclusion or limitation of preemptive
rights, or, if the exclusion derives from a contribution in kind, the reasons for such contribution in kind, and the report must in all
cases set forth the criteria adopted for determining the issue price. The report must be communicated by the board of directors to the
board of statutory auditors and to the external auditor at least 30 days prior to the date set for the shareholders&rsquo; meeting. Within
15 days, the board of statutory auditors must express its opinion on the fairness of the issue price of the shares. The opinion of the
board of statutory auditors and, only in the case of contributions in kind, the sworn report of an expert appointed by a competent court
or documentation provided by Italian law, must remain deposited at the Company&rsquo;s registered office during the 15 days prior to
the shareholders&rsquo; meeting and until the latter has passed a resolution. The resolution shall determine the issue price of the shares
on the basis of shareholders&rsquo; equity, taking into account, in the case of shares listed on regulated markets, also the trend in
prices over the last six months. The foregoing procedure shall apply also in case of capital increase delegated to the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preference
shares; other securities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law permits us to issue preference shares with limited voting rights, other classes of equity securities with different economic and
voting rights, shares with economic rights related to the results of the corporate activity in a specific sector, &ldquo;participation
instruments&rdquo; with limited economic and voting rights against the contribution, by shareholders or third-parties, of work or services,
as well as &ldquo;participation instruments&rdquo; in favor of employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws allow us to issue shares without voting rights, with voting rights limited to particular subjects, with voting rights subject
to the occurrence of particular conditions not merely arbitrary or with multiple voting rights (each multiple voting right share may
have a maximum of three votes). According to Italian law, the total value of such shares may not exceed half of the share capital. Our
bylaws also provides that, in relation to the quantity of shares held by the same party, the voting right may be limited to a maximum
extent or may be staggered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Participation
instruments&rdquo; may include convertible equity and/or &ldquo;hybrid&rdquo; instruments that confer on the holder the right to vote
on specific matters and/or grants economic rights, to be determined at the time of the issuance of such instruments, or management rights,
such as the right to appoint, in accordance with the procedures established by the bylaws, an independent member of the board of directors
or a statutory auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws currently allow us to issue these securities. We may also issue convertible and non-convertible debt securities. In order to issue
convertible debt securities, our board of directors would need to recommend to our shareholders that they approve the issuance of particular
securities in connection with a capital increase, and the shareholders would need to vote to approve such an issuance and capital increase
at an extraordinary meeting. The board of directors would also need to recommend, and the shareholders would need to approve by vote
at the extraordinary meeting, specific terms of the securities. The shareholders may vote at the extraordinary shareholders&rsquo; meeting
to delegate authority to the board of directors to issue those securities from time to time, but not for more than five years from the
date of the extraordinary shareholders&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Debt-equity
ratio</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law provides that we may not issue debt securities for an amount exceeding twice the value of the sum of our equity capital, our legal
reserve and any other disposable reserves appearing on the latest balance sheet approved by our shareholders. The board of statutory
auditors must certify compliance with such limitation. This limitation may be exceeded if the debt securities issued in excess are intended
for subscription by professional investors subject to prudential supervision pursuant to special laws. In the event of subsequent circulation
of the debt security, whoever transfers them is liable for the solvency of the company vis-&agrave;-vis buyers who are not professional
investors. The rules indicated above do not apply in case we intend to issue debt securities to be listed on regulated markets or multilateral
trading systems or which have attached the right to purchase or subscribe shares. The legal reserve is a reserve to which we are required
to allocate 5% of our Italian GAAP net income each year until it equals at least 20% of our equity capital. One of the other reserves
that we maintain on our balance sheet is a &ldquo;share premium reserve&rdquo;, meaning amounts paid for our ordinary shares in excess
of the amount of such ordinary shares that is allocated to stated capital (<I>valore nominale</I>). Until our outstanding debt securities
are repaid in full, we may not voluntarily reduce our equity capital or distribute our reserves (such as by declaring dividends) in the
event the aggregate of the capital plus reserves, after giving effect to such reduction, is less than half of the outstanding amount
of the debt securities. If our equity capital is reduced by losses or otherwise such that the amount of the outstanding debt securities
is more than twice the amount of our equity capital, we cannot distribute profits to our shareholders until the ratio between the amount
of our debt securities and our equity capital plus reserves is restored. If our equity capital is reduced, we could recapitalize by means
of issuing new shares or having our current shareholders contribute additional capital to our company, although there can be no assurance
that we would be able to find purchasers for new shares or that any of our current shareholders would be willing to contribute additional
capital. The legal requirements regarding the ratio of debt securities to equity capital plus reserves do not apply to issuances of debt
securities to professional investors (as defined by Italian law). However, in such a case, should the professional investors transfer
such debt securities to third parties not qualified as professional investors, the former remains liable for the payment of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Reduction
of equity by losses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law requires us to reduce our shareholders&rsquo; equity in certain situations. Our shareholders&rsquo; equity has three main components:
capital, legal reserves and other shareholders&rsquo; equity (such as share premium and retained earnings). We first apply our losses
from operations against our shareholders&rsquo; equity other than legal reserves and capital. If additional losses remain and, after
the legal reserves, our corporate capital is reduced by more than one-third, our board of directors must call a shareholders&rsquo; meeting
as soon as possible. The shareholders should take appropriate measures, which may include, among others, either reducing the legal reserves
and capital by the amount of the remaining losses, or carrying the losses forward for up to one year. If the shareholders vote to elect
to carry the losses forward for up to one year, and the losses are still more than one-third of the amount of the capital at the end
of the year, then we must reduce our capital by the amount of the losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no present intention to enter into any such transaction and no such transaction is currently in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidation
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Italian law and subject to the satisfaction of the claims of all creditors, our shareholders are entitled to a distribution in liquidation
that is equal to an amount resulting from the division of the positive liquidation balance by the number of shares (to the extent available
out of our net assets). Preferred shareholders and holders of &ldquo;participating certificates&rdquo; typically do not participate in
the distribution of assets of a dissolved corporation beyond their established contractual preferences. Once the rights of preferred
shareholders and holders of participating certificates and the claims of all creditors have been fully satisfied, holders of ordinary
shares are entitled to the distribution of any remaining assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purchase
of shares by us (Treasury shares)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are permitted to purchase our outstanding shares, subject to certain conditions and limitations provided for by Italian law. We may only
purchase the shares out of profits available for dividends or out of distributable reserves, in each case as appearing on the latest
shareholder-approved financial statements; if we do not have such available profits or reserves, the shares in excess must be cancelled
and the corporate capital must be reduced accordingly. Further, we may only repurchase fully paid-in shares. Such purchases and the conditions
thereto must be authorized by our shareholders by vote at an ordinary shareholders&rsquo; meeting and the authorization may be issued
for a period not exceeding the term of eighteen (18) months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
corresponding reserve equal to the purchase price of such shares must be created in the balance sheet, and such reserve is not available
for distribution, unless such shares are sold or cancelled. Shares purchased and held by us may be resold only pursuant to a resolution
of our shareholders adopted at an ordinary shareholders&rsquo; meeting. The voting rights attaching to the shares held by us or our subsidiaries
cannot be exercised, but the shares can be counted for quorum purposes in shareholders&rsquo; meetings. Dividends and other rights, including
preemptive rights, attaching to such shares will accrue to the benefit of other shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing limitations do not apply in case we purchase our shares: (i) by giving execution to a shareholders&rsquo; meeting resolution
authorizing capital reduction through repurchase or cancellation; (ii) for free, to the extent they are fully paid-in; (iii) as a consequence
of universal succession, merger or demerger; or (iv) on occasion of foreclosures authorized to satisfy a creditor of our company, to
the extent they are fully paid-in.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as such shares remain the property of the company, the right to profits and the right of option are attributed proportionally to
the other shares. The right to vote is suspended, but such shares are nevertheless taken into account for the purposes of calculating
the majority and the quorum required for the constitution and for the resolutions of the shareholders&rsquo; meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not hold any of its shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Notification
of the acquisition of shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Italian antitrust laws, the Italian Antitrust Authority could prohibit, if certain threshold requirements are met, the
acquisition of control in a company which would thereby create or strengthen a dominant position in the domestic market or a significant
part thereof and which would result in the elimination or substantial reduction, on a lasting basis, of competition, provided that certain
turnover thresholds are exceeded. However, if the turnover of the acquiring party and the company to be acquired exceed certain other
monetary thresholds, the antitrust review of the acquisition falls within the exclusive jurisdiction of the European Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we fall under the scope of the Law Decree No. 21 of March 15, 2012 (the so-called Italian &ldquo;Golden Power&rdquo; regulations),
as subsequently amended and supplemented, (i) certain resolutions of the Company and, if specific thresholds requirements are met, and
(ii) certain third-party investors&rsquo; purchases of our shares may be subject to <I>ad hoc </I>notifications to the Italian Government
which may object to the transaction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, in such cases the Government would have, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    power to veto or to impose specific conditions with respect to the acquisition of certain shareholdings by any foreign entity outside
    the European Union with respect to companies having assets and business in sectors of strategic importance; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    power to veto or impose specific conditions with regard to the adoption of specific corporate resolutions, acts or transactions by
    the same companies.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Minority
shareholders&rsquo; rights; withdrawal rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
resolutions which are not adopted in conformity with applicable law or our bylaws may be challenged (with certain limitations and exceptions)
within 90 days of such resolution (or, if such resolution is subject to registration or filing with the Italian Company Register, within
ninety days of its registration or filing) by absent, dissenting or abstaining shareholders representing individually or in the aggregate
at least 5% of our share capital (as well as by our board of directors or our board of statutory auditors). Shareholders not reaching
this threshold or shareholders not entitled to vote at our meetings may only claim damages arising from the challenged resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting
or absent shareholders may withdraw from the company as a result of shareholders&rsquo; resolutions approving, among other things, material
modifications of our corporate purpose or of the voting rights of our ordinary shares, our transformation from a share corporation into
a different legal entity or the transfer of our registered seat outside Italy. In such a case, our other shareholders would have a preemptive
right to purchase the shares of the withdrawing shareholder. Should no shareholder exercise that preemptive right, the shares must be
offered to third parties or, in the absence of any third party wishing to buy them, they will be purchased by us by using the available
reserves. In the event that no reserve is available, our equity capital must be reduced accordingly. Any repurchase of such shares by
us must be on terms authorized by our board of directors, upon consultation with our board of statutory auditors and our external auditor,
having regard to our net asset value, our prospective earnings and the market value of our ordinary shares, if any. Under Italian law,
we may set forth different criteria in our bylaws for the consideration to be paid to withdrawing shareholders. We have not done so as
of the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
shareholder may bring to the attention of the board of statutory auditors facts or acts which such shareholder deems wrongful. If such
shareholders represent at least 5% of our share capital, or in case we are considered an Open Company (as described below) 2% of the
same, our board of statutory auditors must investigate without delay and report its findings and recommendations at our shareholders&rsquo;
meeting. Shareholders representing more than 10% of our share capital, or, in case we are considered an Open Company one-twentieth, have
the right to report to the competent court serious breaches of the duties of the directors which may be prejudicial to us or to our subsidiaries.
In addition, shareholders representing at least 20% of our share capital may commence derivative suits before the competent court against
our directors, statutory auditors and general managers. We may waive or settle the suit unless shareholders holding at least 20% of the
shares vote against such waiver or settlement. We will reimburse the legal costs of such action in the event that the claim of such shareholder
is successful and the court does not award such costs against the relevant directors, statutory auditors or general managers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Applicable
Laws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is governed by the corporate laws of Italy, and is legally considered and treated, according to the Italian Civil Code, as a
private company because our shares are not listed on a regulated market in Italy or within the European Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
should be noted that under Italian corporate law, while joint-stock companies are all the same type of legal entity, there is a distinction
between those companies that do not have access to the capital markets (<I>Private Companies</I>) and companies that have such access.
This latter category comprises both companies listed on European regulated markets (<I>Public Companies</I>) and companies whose securities
are not listed on such markets, insofar as they have completed a significant distribution of their securities among the public (so-called
&ldquo;<I>emittenti aventi strumenti finanziari diffusi tra il pubblico in maniera rilevante</I>&rdquo;), according to the relevant provisions
set forth in Italian Financials&rsquo; Consolidated Act and its implementing provisions (<I>Open Companies</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 2-bis of the Issuer&rsquo;s Regulation implemented by Consob (<I>Regolamento emittenti</I>), Open Companies must meet the
following requirements:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    at least 500 shareholders in addition to the majority shareholders who hold at least 5% of the outstanding share capital; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exceeding
    at least two out of the following three thresholds:</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    assets side of &euro;4.4 million;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    revenues of &euro;8.8 million; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    average of 50 employees during the year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we issue financial instruments widely distributed among the public, the regulation relating to Open Companies could apply to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Exchange Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are listed on The Nasdaq Capital Market represented by ADSs under the symbol &ldquo;GNTA.&rdquo; Neither the Company&rsquo;s
ordinary shares nor its ADSs are listed on a securities exchange outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrar
of Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
share register is currently kept by Spafid S.p.A., which acts as registrar. The share register reflects only record owners of our ordinary
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_007"></A>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer ordinary shares, ordinary shares represented by ADSs, rights or any combination thereof from time to time in one or more offerings
under this prospectus at prices and on terms to be determined at the time of any offering. This prospectus provides you with a general
description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide
a prospectus supplement and/or free writing prospectus that will describe the specific amounts, prices and other important terms of the
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of our ordinary shares, please refer to the Description of Securities, filed as Exhibit 2.4 to our Annual Report on Form
20-F for the year ended December 31, 2022, which is incorporated herein by reference. Because that description is a summary, it may not
contain all of the information important to you. Accordingly, that description is qualified entirely by reference to our bylaws (<I>statuto</I>),
a copy of which has been filed as an exhibit to the registration statement of which this prospectus forms a part. See &ldquo;Where You
Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>American
Depositary Shares Representing Our Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of the ADSs, please refer to the Description of Securities, filed as Exhibit 2.4 to our Annual Report on Form 20-F for
the year ended December 31, 2022, which is incorporated herein by reference. Because that description is a summary, it may not contain
all of the information important to you. Accordingly, that description is qualified entirely by reference to the Deposit Agreement and
the form of American Depositary Receipt, which are filed as exhibits to the registration statement of which this prospectus forms a part.
See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue rights for the purchase of our ordinary shares and/or ordinary shares represented by ADSs. We may issue rights independently
or together with other securities, the rights may be attached to or separate from these securities and the rights may or may not be transferable
by the shareholder receiving the rights in the rights offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may evidence rights by rights certificates that we will issue. Rights may be issued under an applicable rights agreement that we enter
into with a rights agent. We will indicate the name and address of the rights agent, if applicable, in the prospectus supplement relating
to the rights being offered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
urge you to read the applicable prospectus supplement and any free writing prospectus that we may authorize to be provided to you related
to the rights being offered, as well as the complete rights agreements and/or rights certificates that contain the terms of the rights.
Forms of the rights agreements and/or forms of rights certificates containing the terms of the rights being offered will be filed as
exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file
with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_008"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell our securities from time to time in one or more transactions. We may sell our securities to or through agents, underwriters,
dealers, remarketing firms or other third parties or directly to one or more purchasers or through a combination of any of these methods.
In some cases, we or dealers acting with us or on our behalf may also purchase our securities and reoffer them to the public. We may
also offer and sell, or agree to deliver, securities pursuant to, or in connection with, any option agreement or other contractual arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents
whom we designate may solicit offers to purchase our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will name any agent involved in offering or selling our securities, and disclose any commissions that we will pay to the agent, in
    the applicable prospectus supplement. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    we indicate otherwise in the applicable prospectus supplement, agents will act on a best efforts basis for the period of their appointment.
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents
    may be deemed to be underwriters under the Securities Act of any of our securities that they offer or sell. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may use an underwriter or underwriters in the offer or sale of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we use an underwriter or underwriters, we will execute an underwriting agreement with the underwriter or underwriters at the time
    that we reach an agreement for the sale of our securities. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will include the names of the specific managing underwriter or underwriters, as well as the names of any other underwriters, and
    the terms of the transactions, including the compensation the underwriters and dealers will receive, in the applicable prospectus
    supplement. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriters will use the applicable prospectus supplement, together with the prospectus, to sell our securities. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we offer our ordinary shares (including those represented by ADSs) in a subscription rights offering to our existing shareholders, we
may enter into a standby underwriting agreement with dealers acting as standby underwriters. We may pay the standby underwriters a commitment
fee for the securities they commit to purchase on a standby basis. If we do not enter into a standby underwriting arrangement, we may
retain a dealer-manager to manage a subscription rights offering for us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may use a dealer to sell our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we use a dealer, we will sell our securities to the dealer, as principal. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dealer will then sell our securities to the public at varying prices that the dealer will determine at the time it sells our securities.
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will include the name of the dealer and the terms of the transactions with the dealer in the applicable prospectus supplement. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
or more firms, referred to as &ldquo;remarketing firms,&rdquo; may also offer or sell the securities, if a prospectus supplement so indicates,
in connection with a remarketing arrangement upon their purchase. Remarketing firms will act as principals for their own accounts or
as our agents. These remarketing firms will offer or sell the securities in accordance with the terms of the securities. Each prospectus
supplement will identify and describe any remarketing firm and the terms of its agreement, if any, with us and will describe the remarketing
firm&rsquo;s compensation. Remarketing firms may be deemed to be underwriters in connection with the securities they remarket. Remarketing
firms may be entitled under agreements that may be entered into with us to indemnification by us against certain civil liabilities, including
liabilities under the Securities Act, and may be customers of, engage in transactions with or perform services for us in the ordinary
course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may solicit directly offers to purchase our securities, and we may directly sell our securities to institutional or other investors.
We will describe the terms of direct sales in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may engage in at-the-market offerings into an existing trading market in accordance with Rule 415(a)(4) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may enter into derivative or hedging transactions with third parties or sell securities not covered by this prospectus to third parties
in privately negotiated transactions. In connection with such a transaction, the third parties may sell securities covered by and pursuant
to this prospectus and any accompanying prospectus supplement. If so, the third party may use securities borrowed from us or others to
settle such sales and may use securities received from us to close out any related short positions. We may also loan or pledge securities
covered by this prospectus and any accompanying prospectus supplement to third parties, who may sell the loaned securities or, in an
event of default in the case of a pledge, sell the pledged securities pursuant to this prospectus and any accompanying prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents,
underwriters and dealers participating in the distribution of the securities may be deemed to be underwriters within the meaning of the
Securities Act, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be
deemed to be underwriting discounts and commissions. We may indemnify agents, underwriters and dealers against certain liabilities, including
liabilities under the Securities Act. Agents, underwriters and dealers, or their affiliates, may be customers of, engage in transactions
with or perform services for us or our respective affiliates, in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may authorize agents and underwriters to solicit offers by certain institutions to purchase our securities at the public offering price
under delayed delivery contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we use delayed delivery contracts, we will disclose that we are using them in the applicable prospectus supplement and will tell
    you when we will demand payment and when delivery of our securities will be made under the delayed delivery contracts. </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    delayed delivery contracts will be subject only to the conditions that we describe in the applicable prospectus supplement. </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will describe in the applicable prospectus supplement the commission that underwriters and agents soliciting purchases of our securities
    under delayed delivery contracts will be entitled to receive. </FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified in connection with a particular underwritten offering of our securities, the underwriters will not be obligated to
purchase offered securities unless specified conditions are satisfied, and if the underwriters do purchase any offered securities, they
will purchase all offered securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
underwriters may use this prospectus and any accompanying prospectus supplement for offers and sales related to market-making transactions
in the securities. These underwriters may act as principal or agent in these transactions, and the sales will be made at prices related
to prevailing market prices at the time of sale. Any underwriters involved in the sale of the securities may qualify as &ldquo;underwriters&rdquo;
within the meaning of Section 2(a)(11) of the Securities Act. In addition, the underwriters&rsquo; commissions, discounts or concessions
may qualify as underwriters&rsquo; compensation under the Securities Act and the rules of the Financial Industry Regulatory Authority,
Inc. (&ldquo;FINRA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to facilitate the offering of the securities, certain persons participating in the offering may engage in transactions that stabilize,
maintain or otherwise affect the price of the securities. This may include over-allotments or short sales of the securities, which involve
the sale by persons participating in the offering of more securities than we sold to them. In these circumstances, these persons would
cover such over-allotments or short positions by making purchases in the open market or by exercising their over-allotment option. In
addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing the applicable security in
the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed
if the securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be
to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These
transactions may be discontinued at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters, dealers and agents may engage in other transactions with us, or perform other services for us, in the ordinary course of
their business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may effect sales of securities in connection with forward sale, option or other types of agreements with third parties. Any distribution
of securities pursuant to any forward sale agreement may be effected from time to time in one or more transactions that may take place
through a stock exchange, including block trades or ordinary broker&rsquo;s transactions, or through broker-dealers acting either as
principal or agent, or through privately-negotiated transactions, or through an underwritten public offering, or through a combination
of any such methods of sale, at market prices prevailing at the time of sale, prices relating to such prevailing market prices or at
negotiated or fixed prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
specific terms of the lock-up provisions, if any, with respect to any given offering will be described in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expenses of any offering of our securities will be detailed in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will identify the specific plan of distribution, including any agents, underwriters, dealers, remarketing firms or other third parties
and their compensation in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_009"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated in the applicable prospectus supplement, the validity of the securities offered by this prospectus will be passed
upon for us by Giovannelli e Associati, Studio Legale, Italy. Any underwriters, dealers or agents will be advised by their own legal
counsel concerning issues relating to any offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_010"></A>EXPERTS<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Genenta as of December 31, 2022 and for its fiscal year ended December 31, 2022, included in the Company&rsquo;s
Annual Report on Form 20-F for the year ended December 31, 2022, incorporated by reference herein has been audited by Dannible and
McKee, LLP, independent registered public accounting firm, as set forth in their report thereon. Such financial statements are incorporated
by reference in this prospectus in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
The address of Dannible &amp; McKee, LLP is 221 S. Warren Street #500, Syracuse, New York, United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Genenta as of December 31, 2021, and for each of its fiscal years in the two-year period
ended December 31, 2021, included in the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2022, incorporated
by reference herein has been audited by Mayer Hoffman McCann P.C., independent registered public accounting firm, as set forth in their
report thereon. Such financial statements are incorporated by reference in this prospectus in reliance upon such report given on the
authority of such firm as experts in accounting and auditing. The address of Mayer Hoffman McCann P.C. is 13500 Evening Creek Drive North
#450, San Diego, California, United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_011"></A>EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the SEC registration fee and the FINRA filing fee, the following are the estimated expenses related to the filing of the registration
statement of which this prospectus forms a part, all of which will be paid by us. In addition, we anticipate incurring additional expenses
in the future in connection with the offering of our securities pursuant to this prospectus. Any such additional expenses will be disclosed
in a prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">SEC registration fee</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">11,020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">FINRA filing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,500</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Printing and engraving expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Miscellaneous costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    fees and expenses depend on the securities offered and the number of issuances, and accordingly cannot be estimated at this time
    and will be reflected in the applicable prospectus supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_012"></A>ENFORCEMENT
OF CIVIL LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the laws of Italy and our registered office and domicile is located in Milan, Italy. Moreover, a majority of our
directors and executive officers are not residents of the United States, and all or a substantial portion of our assets are located outside
the United States. As a result, it may not be possible for investors to effect service of process within the United States upon us or
upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil
liability provisions of the federal securities laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have been advised by our Italian counsel that the recognition and enforcement of foreign judgements in Italy is regulated either by (i)
treaties or conventions, bilateral or multilateral, between Italy and the foreign country, whose court issued the judgement, or (ii)
Italian Law no. 218 of May 31, 1995 (the &ldquo;International Private Law Act&rdquo;). In this regard, the provisions of the applicable
treaties and conventions, if any, prevail on the provisions of the International Private Law Act. Indeed, Section 2 of the International
Private Law Act states that the provisions of the International Private Law Act are &ldquo;<I>without prejudice to the application of
the international conventions binding on Italy</I>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
said, Italian counsels advise us that there exist no treaties or other conventions in existence between the Republic of Italy and the
United States, or between the Republic of Italy and the U.S. laws, relating to the recognition and enforcement of civil judgments. There
follows that a civil judgment of a court of New York or of a United States federal court applying New York law will be recognized in
Italy under the general provisions of the International Private Law Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
64 of the International Private Law Act provides that a judgment issued in a foreign country is recognized in Italy, without any proceedings
(<I>i.e., </I>without a rehearing on the merits) being necessary, if all of the following conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
the judge who issued the judgment had the power to decide the case pursuant to the principles on jurisdiction provided by Italian law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
the writ of summons (or equivalent pleading) was duly served upon the defendant in compliance with the applicable provisions of the <I>lex
fori </I>(i.e., the application of the rules of the legal system to which the judge belongs);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
the parties entered an appearance, or their default was duly declared in compliance with the applicable provisions of the <I>lex fori</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
the judgment to be recognized is a final judgment subject to no further appeal;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
the judgment to be recognized does not contrast with a final judgment issued by an Italian court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
there are no pending proceedings between the same parties and in relation to the same matter, which proceedings were commenced prior
to the commencement of the foreign proceedings; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
the judgment to be recognized does not conflict with Italian public order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the foreign civil judgment must be enforced in Italy, the above-mentioned conditions must be verified by the Italian Court of Appeal
based in the area where the judgment must be executed, as indicated in Article 67 of the International Private Law Act. The subsequent
decision of the competent Court of Appeal constitutes the title to enforce the foreign decision. Whether these requirements are met in
respect of a judgment based upon the civil liability provisions of the United States securities laws, including whether the award of
monetary damages under such laws would constitute a penalty, is an issue for the court making such decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing, investors may be able to enforce in Italy judgments in civil and commercial matters that have been obtained from U.S.
federal or state courts. Nevertheless, we cannot assure you that those judgments will be recognized or enforceable in Italy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_013"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual reports on Form 20-F and other information with the SEC and furnish reports on Form 6-K to the SEC. We are not required to
disclose certain other information that is required from U.S. domestic issuers. Also, as a foreign private issuer, we are exempt from
the rules of the Exchange Act prescribing the furnishing of proxy statements to shareholders and our directors, senior management and
principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC.
Our filings with the SEC are also available to the public through the SEC&rsquo;s website at www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are also exempt from the requirements of Regulation FD (Fair Disclosure) which, generally, are meant to
ensure that select groups of investors are not privy to specific information about an issuer before other investors. We are, however,
still subject to the anti-fraud and anti-manipulation rules of the SEC, such as Rule 10b-5. Since many of the disclosure obligations
required of us as a foreign private issuer are different than those required by other U.S. domestic reporting companies, our shareholders,
potential shareholders and the investing public in general should not expect to receive information about us in the same amount and at
the same time as information is received from, or provided by, other U.S. domestic reporting companies. We are liable for violations
of the rules and regulations of the SEC which do apply to us as a foreign private issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a corporate website at www.genenta.com. Information contained on, or that can be accessed through, our website does not constitute
a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc1_014"></A>INCORPORATION
OF INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to
you by referring you to another document that we have filed separately with the SEC. You should read the information incorporated by
reference because it is an important part of this prospectus. We incorporate by reference the following information or documents that
we have filed with the SEC:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Reports on Form 6-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223003331/form6-k.htm" STYLE="-sec-extract: exhibit">February 1, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223014964/form6-k.htm" STYLE="-sec-extract: exhibit">May
    1, 2023</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223016155/form6-k.htm" STYLE="-sec-extract: exhibit">May 10, 2023</A>; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001838716/000149315223013272/form20-f.htm" STYLE="-sec-extract: exhibit">Form 20-F</A> for the year ended December 31, 2022 filed with the SEC on April 21, 2023; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    descriptions of our ordinary shares and ADSs contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315222011671/ex2-4.htm" STYLE="-sec-extract: exhibit">Exhibit 2.4</A> to our Annual Report on Form 20-F for the year ended December
    31, 2022 filed by us with the SEC on April 21, 2023, including any amendment or report filed to update such description and any subsequent
    amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
annual reports on Form 20-F and any amendment thereto and any report on Form 6-K (or portion thereof) that expressly indicates it is
being incorporated by reference in this prospectus, in each case, that we file with or furnish to the SEC prior to the termination or
completion of the offering under this prospectus (including all such reports or documents we may file with or furnish to the SEC on or
after the date on which the registration statement of which this prospectus is a part is first filed with the SEC and prior to the effectiveness
of the registration statement), will also be incorporated by reference into this prospectus and deemed to be part of this prospectus
from the date of the filing or furnishing of such reports and documents. Unless expressly incorporated by reference, nothing in this
prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in any document incorporated by reference herein shall be deemed to be modified or superseded for purposes of this
prospectus to the extent that a statement contained in this prospectus or any prospectus supplement modifies or supersedes such statement.
Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the documents that are incorporated by reference are available at the website maintained by the SEC at http://www.sec.gov. In addition,
copies of all documents incorporated by reference in this prospectus, other than exhibits to those documents unless such exhibits are
specifically incorporated by reference in this prospectus, will be provided at no cost to each person, including any beneficial owner,
to whom a copy of this prospectus is delivered on the written or oral request of that person made to: Genenta Science S.p.A., Via Olgettina
No. 58, 20132, Milan, Italy, Attention: Pierluigi Paracchi.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>Subject
to completion, dated May 12, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formf-3_001.jpg" ALT="" ></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Up
to $30,000,000</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>American
Depositary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Representing
Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into a Controlled Equity Offering<SUP>SM</SUP> Sales Agreement (the &ldquo;Sales Agreement&rdquo;), with Cantor
Fitzgerald &amp; Co. (&ldquo;Cantor&rdquo;), dated May 12, 2023, relating to the sale of American depositary shares
(&ldquo;ADSs&rdquo;), each representing one of our ordinary shares, no par value, offered by this prospectus. In accordance with the
terms of the Sales Agreement, under this prospectus, we may offer and sell ADSs having an aggregate offering price of up to
$30,000,000 from time to time through or to Cantor, acting as our sales agent or principal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of ADSs, if any, under this prospectus, may be made by any method that is deemed to be an &ldquo;at the market offering&rdquo; as defined
in Rule 415(a)(4) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Cantor is not required to sell any
specific number or dollar amount of ADSs, but will act as our sales agent and use commercially reasonable efforts consistent with its
normal trading and sales practices, on mutually agreed terms between Cantor and us. There is no arrangement for funds to be received
in any escrow, trust or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
will receive from us a commission of 3.0% of the gross proceeds of any ADSs sold through it under the Sales Agreement. In connection
with the sale of ADSs on our behalf, Cantor will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act
and the compensation of Cantor may be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification
and contribution to Cantor with respect to certain liabilities, including liabilities under the Securities Act. For additional information,
see &ldquo;Plan of Distribution&rdquo; beginning on page 21 of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs are listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;GNTA.&rdquo; The last reported sale price
of the ADSs on the Nasdaq on May 11, 2023 was $5.95 per ADS. The trading price of the ADSs has fluctuated, and is likely to continue
to fluctuate due to a variety of factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are an &ldquo;emerging growth company&rdquo; as defined in Section 2(a) of the Securities Act of 1933, as amended, and, as such, have
elected to comply with certain reduced disclosure and regulatory requirements. Investing in our securities involves a high degree of
risk. Before buying any of our securities, you should carefully read the discussion of material risks of investing in our securities.
Please read the section entitled &ldquo;<A HREF="#toc2_104">Risk Factors</A>&rdquo; beginning on page 4 of this prospectus, as well as the section entitled &ldquo;Item
3. Key Information&mdash;D. Risk Factors&rdquo; beginning on page 3 of our Annual Report on Form 20-F for the year ended December 31,
2022, which report is incorporated by reference in this prospectus, before investing in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formf-3_002.jpg" ALT="" ></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 7%"><B>Page</B></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_101">About this Prospectus</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">1</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_102">Prospectus Summary</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">2</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_103">The Offering</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">3</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_104">Risk Factors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">4</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_105">Special Note Regarding Forward-Looking Statements</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">7</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_106">Use of Proceeds</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">8</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_107">Dividend Policy</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">9</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_108">Dilution</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">10</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_109">Description of Share Capital and Governing Documents</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">11</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_110">Description of Securities</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">16</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_111">Taxation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom">17</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_112">Plan of Distribution</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">21</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_113">Legal Matters</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_114">Experts</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_115">Expenses of the Offering</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_116">Enforcement of Civil Liabilities</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">23</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_117">Where You Can Find More Information</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">24</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_118">Incorporation of Information by Reference</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">25</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are responsible for the information contained and incorporated by reference in this prospectus, and in any related free writing prospectus
we prepare or authorize. We have not authorized anyone to give you any other information, and we take no responsibility for any other
information that others may give you. If you are in a jurisdiction where offers to sell, or solicitations of offers to purchase, the
securities offered by this documentation are unlawful, or if you are a person to whom it is unlawful to direct these types of activities,
then the offer presented in this document does not extend to you. The information contained in this document speaks only as of the date
of this document, unless the information specifically indicates that another date applies. Our business, financial condition, results
of operations and prospects may have changed since those dates.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_101"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) using
a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we may sell any combination of the securities described
in our base prospectus included in the shelf registration statement from time to time in one or more offerings up to a total aggregate
offering price of $100,000,000. Under this prospectus, we may from time to time sell ADSs having an aggregate offering price of up to
$30,000,000, at prices and on terms to be determined by market conditions at the time of the offering. The $30,000,000 of ADSs that may
be sold under this prospectus are included in the $100,000,000 of securities that may be sold under the shelf registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus describes the specific terms of this offering of ADSs and also adds to and updates information contained in the documents
incorporated by reference into this prospectus. To the extent there is a conflict between the information contained in this prospectus,
on the one hand, and the information contained in any document incorporated by reference into this prospectus that was filed with the
SEC before the date of this prospectus, on the other hand, you should rely on the information in this prospectus. If any statement in
one of these documents is inconsistent with a statement in another document having a later date&mdash;for example, a document incorporated
by reference into this prospectus&mdash;the statement in the document having the later date modifies or supersedes the earlier statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
buying any of the ADSs that we are offering, we urge you to carefully read this prospectus, and any free writing prospectus that we have
authorized for use in connection with this offering, and the information incorporated by reference as described under the headings &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Incorporation of Information by Reference&rdquo; in this prospectus. These documents
contain important information that you should consider when making your investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor Cantor has authorized anyone to provide you with any information other than that contained or incorporated by reference in this
prospectus or any related free writing prospectus to which we have referred you. Neither we nor Cantor takes any responsibility for,
and can provide no assurance as to the reliability of, any other information others may give you. Neither we nor Cantor is making an
offer to sell these securities in any jurisdiction where the offer or sale is not permitted or in which the person making that offer
or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. You should assume that
the information appearing in this prospectus, the documents incorporated by reference herein and any free writing prospectus that we
have authorized for use in connection with this offering, is accurate only as of the date of those respective documents. Our business,
financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus, the documents
incorporated by reference herein and any free writing prospectus that we have authorized for use in connection with this offering, in
their entirety before making an investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering to sell, and seeking offers to buy, ADSs only in jurisdictions where offers and sales are permitted. The distribution of
this prospectus and the offering of ADSs in certain jurisdictions may be restricted by law. Persons outside the United States who come
into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of ADSs and the
distribution of this prospectus outside the United States. This prospectus does not constitute, and may not be used in connection with,
an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus by any person in any jurisdiction in
which it is unlawful for such person to make such an offer or solicitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this prospectus to &ldquo;U.S. dollars&rdquo; or &ldquo;$&rdquo; are to the legal currency of the United States and all
references to &ldquo;&euro;&rdquo; or &ldquo;euro&rdquo; are to the currency introduced at the start of the third stage of the European
economic and monetary union pursuant to the treaty establishing the European Community, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
figures included in this prospectus have been rounded for ease of presentation. Percentage figures included in this prospectus have not
in all cases been calculated on the basis of such rounded figures but on the basis of such amounts prior to rounding. For this reason,
percentage amounts in this prospectus may vary slightly from those obtained by performing the same calculations using the figures in
our consolidated financial statements. Certain other amounts that appear in this prospectus may similarly not sum due to rounding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise mentioned or unless the context requires otherwise, throughout this prospectus and any related free writing prospectus, the
words &ldquo;Genenta,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;the Company,&rdquo; &ldquo;our company&rdquo;
or similar references refer to Genenta Science S.p.A. and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-right: 0pt; padding: 0.1in; border: Black 1.5pt solid">

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_102"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained in other parts of this prospectus or incorporated by reference in this prospectus from our Annual
Report on Form 20-F for the year ended December 31, 2022, and our other filings with the SEC listed below under the heading &ldquo;Incorporation
of Information by Reference.&rdquo; This summary may not contain all the information that you should consider before investing in the
ADSs. You should read the entire prospectus and the information incorporated by reference in this prospectus carefully, including &ldquo;Risk
Factors&rdquo; and the financial data and related notes and other information incorporated by reference, before making an investment
decision. See &ldquo;Special Note Regarding Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of
solid tumors. We have developed a novel biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate into autologous
hematopoietic stem/progenitor cells (&ldquo;HSPCs&rdquo;) to deliver immunomodulatory molecules directly to the tumor by infiltrating
monocytes/macrophages (Tie2 Expressing Monocytes &ndash; &ldquo;TEMs&rdquo;). Our technology is designed to turn TEMs, which normally
have an affinity for and travel to tumors, into a &ldquo;Trojan Horse&rdquo; to counteract cancer progression and to prevent tumor relapse.
Our technology is not target dependent, and therefore we believe it can be used as a treatment for a broad variety of cancers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead product candidate, Temferon, was developed using our platform and carries an interferon-alpha (&ldquo;IFN-&alpha;&rdquo;) payload.
IFN-&alpha; is a well-known therapeutic that was previously administered intravenously for treatment of various cancers, but it is currently
rarely used because of its systemic toxicity. The Temferon-modified TEMs express the transgene payload, IFN-&alpha;, in the tumor microenvironment
resulting in the breakdown of tumor induced immune-tolerance. As a result, the immune system can recognize the tumor, respond, and inhibit
tumor growth. Because Temferon is designed to deliver the IFN-&alpha; payload directly to the tumor, we believe it will demonstrate clinical
activity without the side effect profile of systemic delivery of IFN-&alpha;. In preclinical mouse cancer models treated with Temferon,
both direct (anti-angiogenic, pro-apoptotic) and indirect (immune response) effects were observed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
was formed as an Italian limited liability company (<I>societ&agrave; a responsabilit&agrave; limitata</I>) in 2014. In May 2021, we
changed the legal form of our company under Italian law to a joint stock company (<I>societ&agrave; per azioni</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at Via Olgettina No. 58, 20132 Milan, Italy. Our telephone number in Italy is +39.02.2643.6639.
Our website address is www.genenta.com. The information contained on, or that can be accessed through, our website is not part of, and
is not incorporated by reference into, this prospectus. We have included our website address in this prospectus solely as an inactive
textual reference. Investors should not rely on any such information in deciding whether to purchase our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ADSs, each representing one ordinary share of the Company, have been listed on the Nasdaq Capital Market under the symbol &ldquo;GNTA&rdquo;
since December 2021.</FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<DIV STYLE="padding: 0.1in; border: Black 1.5pt solid">

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="toc2_103"></A>The
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs
    offered by us</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 63%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs
    having an aggregate offering price of up to $30,000,000.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    shares to be outstanding immediately after this offering</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 23,258,875 shares (as more fully described in the notes following this table), assuming sales of 5,042,017 ADSs
    in this offering at an offering price of $5.95 per ADS, which was the last reported sale price of the ADSs on the Nasdaq on
    May 11, 2023. The actual number of ADSs issued will vary depending on the number of ADSs that are sold and the sales price under
    this offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ADSs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    ADS represents one of our ordinary shares, with no par value. The ADSs may be evidenced by American Depositary Receipts (&ldquo;ADRs&rdquo;).
    The depositary will hold in custody the ordinary shares underlying the ADSs and you will have the rights of an ADS holder as provided
    in the Deposit Agreement among us, the depositary and owners and holders of ADSs from time to time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
    of Distribution</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;At
    the market offering&rdquo; that may be made from time to time through or to Cantor as our sales agent or principal. See &ldquo;Plan
    of Distribution&rdquo; on page 21.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Proceeds</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to use the net proceeds, if any, from the sale of the ADSs under this prospectus for our pipeline development, general corporate
    purposes and working capital<SUP></SUP>. See &ldquo;Use of Proceeds.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depositary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Bank of New York Mellon.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Custodian</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Bank of New York Mellon, as custodian, acting through an office located in the United Kingdom.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in the ADSs involves significant risks. See the disclosure under the heading &ldquo;Risk Factors&rdquo; on page 4 in this prospectus
    and under similar headings in other documents incorporated by reference into this prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nasdaq Capital Market symbol</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;GNTA&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of our ordinary shares to be outstanding after this offering as shown above is based on 18,216,858 of our ordinary shares
outstanding as of December 31, 2022, and excludes<SUP></SUP>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">540,523
                                            ordinary shares issuable upon exercise of stock options outstanding as of December 31, 2022
                                            with a weighted-average exercise price of $5.32 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,502
                                            ordinary shares represented by ADSs issuable upon exercise of warrants outstanding as of
                                            December 31, 2022 with an exercise price of $14.375 per ADS; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">up
                                            to </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,281,162
                                            <FONT STYLE="background-color: white">ordinary shares reserved for future issuance </FONT>under
                                            our 2021 &ndash; 2025 Stock Option Plan (the &ldquo;Stock Option Plan&rdquo;) as of December
                                            31, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated, all information in this prospectus does not assume or give effect to the grant of any stock options or the exercise
of outstanding stock options or warrants after December 31, 2022.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_104"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investment
in the ADSs sold in this offering involves risks. You should carefully consider the risk factors described below and in our Annual Report
on Form 20-F for the year ended December 31, 2022, incorporated by reference in this prospectus, any amendment or update thereto reflected
in subsequent filings with the SEC, and all other information contained or incorporated by reference in this prospectus, as updated by
our subsequent filings with the SEC. The occurrence of any of these risks might cause you to lose all or part of your investment in the
ADSs offered under this prospectus. The risks and uncertainties previously described and discussed below are not the only ones we face.
Additional risks and uncertainties not presently known to us, or that we currently see as immaterial, may also harm our business. If
any of these risks actually occurs, our business, financial condition, results of operation or cash flow could be adversely affected.
This could cause the trading price of the ADSs to decline, resulting in a loss of all or part of your investment. Please also read carefully
the section below titled &ldquo;Special Note Regarding Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you purchase the ADSs sold in this offering, you may experience immediate and substantial dilution in the net tangible book value of
the ADSs. In addition, we may issue additional equity or convertible debt securities in the future, which may result in additional dilution
to you.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price per ADS of the ADSs being offered pursuant to this prospectus may be higher than the net tangible book value per ADS prior to this
offering. Assuming an aggregate gross amount of $30.0 million of ADSs will be sold in this offering at an assumed offering price of $5.95
per ADS, the last reported sale price of the ADSs on the Nasdaq on May 11, 2023, and after deducting commissions and estimated offering
expenses payable by us, new investors in this offering will incur immediate dilution of $3.29 per ADS. For a more detailed discussion
of the foregoing, see the section entitled &ldquo;Dilution&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent outstanding stock options or warrants are exercised, there will be further dilution to new investors. In addition, to the
extent we need to raise additional capital in the future and we issue additional ordinary shares, ordinary shares represented by ADSs
or securities convertible or exchangeable for our ordinary shares and/or ordinary shares represented by ADSs, our then existing shareholders
may experience dilution and the new securities may have rights senior to those of the ADSs offered in this offering. The price per share
or ADS at which we sell additional ordinary shares or ADSs, as applicable, or securities convertible or exchangeable into ordinary shares
and/or ADSs, in any future transactions may be higher or lower than the price per ADS paid by investors in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have broad discretion in the use of the net proceeds from this offering and may not use them effectively.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described
in the section entitled &ldquo;Use of Proceeds,&rdquo; and you will not have the opportunity as part of your investment decision to assess
whether the net proceeds are being used appropriately. Because of the number and variability of factors that will determine our use of
the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. Our management might
not apply our net proceeds in ways that ultimately increase the value of your investment. We expect to use the net proceeds from this
offering for our pipeline development, general corporate purposes and working capital. The failure by our management to apply these
funds effectively could harm our business. Pending their use, we plan to invest the net proceeds from this offering in a variety of capital
preservation investments, including short-term, investment grade, and interest-bearing instruments and government securities. These investments
may not yield a favorable return to our investors. If we do not invest or apply the net proceeds from this offering in ways that enhance
value for investors, we may fail to achieve expected financial results, which could cause the price of the ADSs to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
actual number of ADSs that are sold under the Sales Agreement, at any one time or in total, is uncertain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations in the Sales Agreement and in compliance with applicable laws and regulations, we have the discretion to deliver
a placement notice to Cantor at any time throughout the term of the Sales Agreement. The number of ADSs that are sold, if any, by Cantor
after we deliver a placement notice will fluctuate based on the market price of the ADSs during the sales period and limits we set with
Cantor. Because the price per ADS sold will fluctuate based on the market price of the ADSs during the sales period, it is not possible
at this stage to predict the number of ADSs that will be ultimately issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
ADSs offered hereby will be sold in &ldquo;at the market offerings,&rdquo; and investors who buy shares at different times will likely
pay different prices.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
who purchase ADSs in this offering at different times will likely pay different prices, and so may experience different outcomes in their
investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of ADSs sold, and there
is no minimum or maximum sales price. Investors may experience a decline in the value of their ADSs as a result of ADS sales made at
prices lower than the prices they paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have not paid, and do not intend to pay, dividends on our ordinary shares and, therefore, unless the ADSs appreciate in value, our investors
may not benefit from holding the ADSs.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our ordinary shares. We do not anticipate paying any cash dividends on our ordinary shares
in the foreseeable future. Consequently, investors may need to rely on sales of their ADSs after price appreciation, which may never
occur, as the only way to realize any future gains on their investment. Investors seeking cash dividends should not purchase the ADSs.
Moreover, Italian law imposes certain restrictions on our ability to declare and pay dividends. In particular, Italian law prohibits
distributing dividends other than from net income or distributable reserves set forth in a company&rsquo;s statutory accounts approved
by a meeting of shareholders and after the establishment of certain compulsory reserves. In addition, if losses from previous fiscal
years have reduced a company&rsquo;s capital, dividends may not be paid until the capital is reconstituted or its stated amount is reduced
by the amount of such losses. The application of these restrictions limits our ability to make distributions to holders of our shares
See &ldquo;Dividend Policy&rdquo; for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
trading price of the ADSs is likely to be highly volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of the ADSs has fluctuated, ranging from a closing price low of $3.93 to a closing price high of $11.40 during the year
ended December 31, 2022, and is likely to continue to be highly volatile. The following factors, in addition to other risk factors described
in this section, may have a significant impact on the market price of the ADSs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    results or delays in pre- and non-clinical studies or clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reports
    of adverse events in other gene therapy products or clinical studies of such products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to obtain additional funding;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to obtain the approvals necessary to commence clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unsatisfactory
    results of clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of regulatory approval or the failure to obtain it, or specific label indications or patient populations for its use, or changes
    or delays in the regulatory review process;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of therapeutic innovations or new products by us or our competitors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    actions taken by regulatory authorities with respect to our clinical trials, manufacturing supply chain or sales and marketing activities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    or developments in laws or regulations applicable to the treatment of cancer tumors, or any other indication that we may seek to
    develop;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    adverse changes to our relationship with manufacturers or suppliers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    intellectual property infringement actions in which we may become involved;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    concerning our competitors or the biotechnology and pharmaceutical industries in general;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">achievement
    of expected product sales and profitability or our failure to meet expectations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    commencement of, or involvement in, litigation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    major changes in our board of directors or management;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to recruit and retain qualified regulatory, research and development personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">legislation
    in the United States relating to the sale or pricing of biotechnology or gene therapy products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    depth of the trading market in the ADSs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
    downturns, recessions, inflation, increasing interest rates, supply chain shortages, rising fuel prices, or political instability
    in global, U.S. or particular foreign economies and markets;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">instability
    in the global or U.S. banking systems or the banking systems of foreign countries;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
    interruptions resulting from a local or worldwide pandemic, such as COVID-19, geopolitical actions, including war and terrorism (including
    the ongoing war in Ukraine), or natural disasters;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    granting or exercise of employee stock options or other equity awards;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
    or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection
    for our technologies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key scientific or management personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    lawsuits, including patent or shareholder litigation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in investors&rsquo; and securities analysts&rsquo; perception of the business risks and conditions of our business.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market in general, and the Nasdaq Stock Market in particular, have experienced extreme price and volume fluctuations
that have often been unrelated or disproportionate to the operating performance of small companies. Broad market and industry factors
may negatively affect the market price of the ADSs, regardless of our actual operating performance. Further, a systemic decline in the
financial markets and related factors beyond our control may cause the ADS price to decline rapidly and unexpectedly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is a substantial risk that we are or will become classified as a passive foreign investment company. If we are or become classified as
a passive foreign investment company, our U.S. shareholders may suffer adverse tax consequences as a result.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, we will be treated as a passive foreign investment company (a &ldquo;PFIC&rdquo;) for U.S. federal income tax purposes in any
taxable year in which either (1) at least 75% of our gross income is &ldquo;passive income&rdquo; or (2) on average at least 50% of our
assets by value produce passive income or are held for the production of passive income. Passive income for this purpose generally includes,
among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the
sale or exchange of property that gives rise to passive income. Passive income also includes interest income earned by reason of the
temporary investment of funds, including those raised in a public offering, and the excess of certain foreign currency gains over certain
foreign currency losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
status as a PFIC will depend on the nature and composition of our income and the nature, composition and value of our assets. Our status
may also depend, in part, on how quickly we utilize the cash proceeds from this offering in our business. We have not made the formal
analysis necessary to determine whether or not we are currently a PFIC or whether we have ever been a PFIC. Based on preliminary analysis
done in connection with this offering, however, we believe that we were likely classified as a PFIC in 2022, and we may be classified
as a PFIC for 2023 and future years. In particular, so long as we do not generate revenue from operations for any taxable year and do
not receive any research and development grants, or even if we receive a research and development grant, if such grant does not constitute
gross income for United States federal income tax purposes, we likely will be classified as a PFIC in any taxable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC in any taxable year during which a U.S. taxpayer holds the ADSs, such U.S. taxpayer would be subject to certain adverse
U.S. federal income tax rules. In particular, if the U.S. taxpayer did not make an election to treat us as a &ldquo;qualified electing
fund&rdquo; (&ldquo;QEF&rdquo;) or make a &ldquo;mark-to- market&rdquo; election, then &ldquo;excess distributions&rdquo; to the U.S.
taxpayer, and any gain realized on the sale or other disposition of the ADSs by the U.S. taxpayer: (1) would be allocated ratably over
the U.S. taxpayer&rsquo;s holding period for the ADSs; (2) the amount allocated to the current taxable year and any period prior to the
first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of
the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year,
and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other
taxable year. In addition, if the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;) determines that we are a PFIC for a year with
respect to which we have determined that we were not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark-to-market
election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
taxpayers that have held the ADSs during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be
a PFIC in subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark-to-market election. At this time, we
do not expect to provide U.S. shareholders with the information necessary for a U.S. shareholder to make a QEF election. Prospective
investors should assume that a QEF election will not be available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
taxpayers that hold the ADSs are strongly urged to consult their tax advisors about the PFIC rules, including tax return filing requirements
and the eligibility, manner, and consequences to them of making a QEF or mark-to-market election with respect to the ADSs in the event
that we are a PFIC. See &ldquo;Taxation&mdash;U.S. Federal Income Taxation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_105"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains many statements that are &ldquo;forward-looking&rdquo; within the meaning of Section 27A of the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and uses forward-looking terminology such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;future,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;ought to,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo;
&ldquo;potentially,&rdquo; &ldquo;predicts,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo;
negatives of such terms or other similar statements. You should not place undue reliance on any forward-looking statement due to its
inherent risk and uncertainties, both general and specific. Although we believe the assumptions on which the forward-looking statements
are based are reasonable and within the bounds of our knowledge of our business and operations as of the date of this prospectus, any
or all of those assumptions could prove to be inaccurate. As a result, the forward-looking statements based on those assumptions could
also be incorrect. The forward-looking statements in this prospectus include, without limitation, statements relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expected application of the net proceeds from this offering;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    goals and strategies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    future business development, results of operations and financial condition;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect our intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected
    revenues, profits, earnings and other estimated financial information;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain strong relationships with our customers and suppliers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    planned use of proceeds; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">governmental
    policies regarding our industry; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    risk factors as set forth under the &ldquo;Risk Factors&rdquo; section of this prospectus and under &ldquo;Item 3. Key Information&mdash;D.
    Risk Factors.&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2022, which report is incorporated by reference
    in this prospectus.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate. These statements are only current predictions
and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry&rsquo;s actual results,
levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements.
We discuss many of these risks in this prospectus in greater detail under the heading &ldquo;Risk Factors&rdquo; and elsewhere in this
prospectus. You should not rely upon forward-looking statements as predictions of future events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether as a result of new information, future events or otherwise, after the date of this prospectus. Comparisons of results
for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed
as such, and should only be viewed as historical data. You should, however, review the factors and risks we describe in the reports we
will file from time to time with the SEC after the date of this prospectus. See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should also read carefully the factors described in the &ldquo;Risk Factors&rdquo; section of this prospectus, in &ldquo;Item 3. Key
Information&mdash;D. Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2022 and in the other documents
that we file with the SEC after the date of this prospectus that are incorporated by reference into this prospectus to better understand
the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these factors, we
cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking
statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking
statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our
objectives and plans in any specified timeframe, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_106"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue and sell ADSs having aggregate sales proceeds of up to $30,000,000 from time to time. Because there is no minimum offering
amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any,
are not determinable at this time. There can be no assurance that we will sell any ADSs under or fully utilize the Sales Agreement as
a source of financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to use the net proceeds from this offering, if any, for our pipeline development, general corporate purposes and working
capital. We have not determined the amount of net proceeds to be used specifically for the foregoing purposes. As a result, our management
will have broad discretion in the allocation of the net proceeds from this offering. Pending use of the net proceeds, we currently intend
to invest any proceeds in a variety of capital preservation instruments, including short-term, investment grade, and interest-bearing
instruments and government securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_107"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our ordinary shares and do not anticipate paying any cash dividends in the foreseeable
future. Payment of cash dividends, if any, in the future will be at the discretion of our shareholders, upon proposal by our board of
directors, and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions,
capital requirements, business prospects and other factors our board of directors may deem relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Italian law, Italian companies are required to furnish certain information to the Italian tax authorities regarding the identity of non-resident
shareholders in connection with the payment of dividends. Shareholders are required to provide their Italian tax identification number,
if any, or alternatively, in the case of legal entities, their name, country of establishment and address, or in the case of individuals,
their name, address and place and date of birth, or in the case of partnerships, the information required for individuals with respect
to one of their representatives. Payment of dividends may be subject to Italian withholding taxes. However, beneficial U.S. holders are
entitled to a reduction of the withholding taxes applicable to dividends paid to them under the income tax convention for the avoidance
of double taxation between the United States and Italy, which was signed on August 25, 1999 and went into effect on December 16, 2009
(the &ldquo;Income Tax Convention&rdquo;); provided, however, that conditions set out in the Income Tax Convention are met and subject
to the applicable anti-avoidance provisions contained therein. In order for you to benefit from that reduction, we are required to furnish
certain information about you to the Italian tax authorities and, therefore, any claim by you for those benefits would need to be accompanied
by the required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_108"></A>DILUTION<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in the ADSs in this offering, your interest will be diluted to the extent of the difference between the price per ADS you
pay in this offering and the net tangible book value per ADS immediately after this offering. The net tangible book value of our ordinary
shares as of December 31, 2022 was approximately $33.2 million, or approximately $1.82 per ordinary share, based upon 18,216,858
ordinary shares outstanding as of December 31, 2022. Net tangible book value per ordinary share is equal to our total tangible assets,
less our total liabilities, divided by the total number of ordinary shares outstanding as of December 31, 2022. For purposes of illustration,
the following discussion assumes that all of our outstanding ordinary shares both before and after this offering are represented by ADSs,
each representing one ordinary share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the sale of the ADSs in the aggregate amount of $30.0 million at an assumed offering price of $5.95 per ADS,
the last reported sale price of the ADSs on the Nasdaq on May 11, 2023, and after deducting commissions and estimated offering expenses
payable by us, our as adjusted net tangible book value as of December 31, 2022 would have been $61.9 million, or $2.66
per ADS. This represents an immediate increase in net tangible book value of $0.84 per ADS to our existing shareholders and an
immediate dilution in net tangible book value of $3.29 per ADS to new investors in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table illustrates this calculation on a per ADS basis. The as-adjusted information is illustrative only and will adjust based
on the actual price to the public, the actual number of ADSs sold and other terms of the offering determined at the time ADSs are sold
pursuant to this prospectus. The as-adjusted information assumes that all of the ADSs in the aggregate amount of $30.0 million will be
sold at the assumed offering price of $5.95 per ADS, the last reported sale price of the ADSs on the Nasdaq on May 11, 2023. The
ADSs sold in this offering, if any, will be sold from time to time at various prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    public offering price per ADS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.95</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    tangible book value per ADS as of December 31, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.82</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in net tangible book value per ADS attributable to the offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.84</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted net tangible book value per ADS after giving effect to the offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.66</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    per ADS to new investors participating in the offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing table excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">540,523
    ordinary shares issuable upon exercise of stock options outstanding as of December 31, 2022 with a weighted-average exercise price
    of $5.32 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,502
    ordinary shares represented by ADSs issuable upon exercise of warrants outstanding as of December 31, 2022 with an exercise price
    of $14.375 per ADS; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">up
    to </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,281,162 <FONT STYLE="background-color: white">ordinary
    shares reserved for future issuance </FONT>under the Stock Option Plan as of December 31, 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing table does not assume or give effect to the grant of any stock options or the exercise of outstanding stock options or warrants
after December 31, 2022. To the extent stock options are exercised, there may be further dilution to new investors.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_109"></A>DESCRIPTION
OF SHARE CAPITAL AND GOVERNING DOCUMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
share capital is composed of ordinary shares with no par value. As of December 31, 2022, our issued share capital consisted of 18,216,858
ordinary shares. All issued shares are fully paid, non-assessable and in registered form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
preference shares are designated, issued or outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain information concerning our ordinary shares and bylaws (<I>Statuto</I>), as well as Italian law provisions
applicable to companies like ours whose shares are not listed in a &ldquo;regulated market&rdquo; within the European Union, as in effect
at the date of this prospectus. The summary contains such information as we consider material regarding the ordinary shares but does
not purport to be complete and is qualified in its entirety by reference to our bylaws or Italian law, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Italian law, most of the procedures regulating our Company, including certain rights of shareholders, are contained in our bylaws. Amendments
to our bylaws must be approved at an extraordinary meeting of shareholders, as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Form
and transfer of shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are not represented by share certificates (<I>certificati azionari) </I>as they are dematerialised <I>(azioni dematerializzate</I>).
The ownership of the shares, their transfer, the related rights and restrictions on the shares (if any) results from the electronical
register managed by an intermediary (banks and other financial institutions). The entitlement to exercise the rights attached to the
shares is then proven by the exhibition of certifications or communications to the issuer made by the intermediary, pursuant to its own
accounting records, in favor of the subject entitled to the right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations on the right to own or vote our ordinary shares, which applies to non-Italian residents and foreign residents except
for &ldquo;Golden Power&rdquo; regulations and Italian Antitrust laws (see &ldquo;Notification of acquisition of shares&rdquo; below).
There are no provisions in our articles of association or bylaws that would have the effect of delaying, deferring or preventing a change
of control of our Company and that would operate only with respect to a merger, acquisition or corporate restructuring involving our
Company. There are no provisions in our bylaws governing the ownership threshold where shareholder ownership must be disclosed. There
are no provisions discriminating against any existing or prospective holder of our ordinary shares as a result of such shareholder owning
a substantial number of our shares. There are no sinking fund provisions or provisions providing for liability for further capital calls
by our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividend
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
by the Company of any annual dividend is proposed by the board of directors and is subject to the approval of the shareholders at the
annual shareholders&rsquo; meeting. Before dividends may be paid out of the Company&rsquo;s unconsolidated net income in any year, an
amount at least equal to 5% of such net income must be allocated to the Company&rsquo;s legal reserve until such reserve is at least
equal to one-fifth of the Company&rsquo;s issued share capital. If the Company&rsquo;s share capital is reduced as a result of accumulated
losses, no dividends may be paid until the capital is reconstituted or reduced by the amount of such losses. The Company may pay dividends
out of available retained earnings from prior years, provided that, after such payment, the Company will have a legal reserve at least
equal to the legally required minimum. No interim dividends may be approved or paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
will be paid in the manner and on the date specified in the shareholders&rsquo; resolution approving their payment. Dividends that are
not collected within five years of the date on which they become payable are forfeited to the benefit of the Company. Holders of ADSs
will be entitled to receive payments in respect of dividends on the underlying shares through The Bank of New York Mellon, as Depositary,
in accordance with the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Voting
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
holders of the Company&rsquo;s ordinary shares are entitled to one vote per ordinary share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a registered shareholder, the Depositary (or its nominee) will be entitled to vote the ordinary shares underlying the ADSs with respect
to voting instructions received from ADS holders in accordance with the terms and conditions of the Deposit Agreement. Neither Italian
law nor the Company&rsquo;s bylaws limit the right of non-resident or foreign owners of the Company&rsquo;s ordinary shares to hold or
vote shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preemptive
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Italian law, holders of outstanding ordinary shares and convertible debentures are entitled to subscribe for newly issued ordinary
shares or convertible debentures in proportion to their holdings at the time that the shareholders authorize the capital increase for
those issuances, unless those issuances are for non-cash consideration. Those who exercise their preemptive rights, provided they make
such request simultaneously, have a preemptive right on the purchase of shares and debentures convertible into shares that have not been
subscribed. Preemptive rights may be excluded or limited by resolution of the shareholders at an extraordinary shareholders&rsquo; meeting,
or by the board of directors if the bylaws delegate such power to the board of directors (including the power to exclude or limit the
preemptive right), and provided that such exclusion or limitation is in the interest of the Company, or if the shares are to be paid
by means of contributions in kind. According to Italian law proposals to increase share capital with exclusion or limitation of preemptive
rights must be accompanied by a report of the board of directors setting forth the reasons for the exclusion or limitation of preemptive
rights, or, if the exclusion derives from a contribution in kind, the reasons for such contribution in kind, and the report must in all
cases set forth the criteria adopted for determining the issue price. The report must be communicated by the board of directors to the
board of statutory auditors and to the external auditor at least 30 days prior to the date set for the shareholders&rsquo; meeting. Within
15 days, the board of statutory auditors must express its opinion on the fairness of the issue price of the shares. The opinion of the
board of statutory auditors and, only in the case of contributions in kind, the sworn report of an expert appointed by a competent court
or documentation provided by Italian law, must remain deposited at the Company&rsquo;s registered office during the 15 days prior to
the shareholders&rsquo; meeting and until the latter has passed a resolution. The resolution shall determine the issue price of the shares
on the basis of shareholders&rsquo; equity, taking into account, in the case of shares listed on regulated markets, also the trend in
prices over the last six months. The foregoing procedure shall apply also in case of capital increase delegated to the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preference
shares; other securities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law permits us to issue preference shares with limited voting rights, other classes of equity securities with different economic and
voting rights, shares with economic rights related to the results of the corporate activity in a specific sector, &ldquo;participation
instruments&rdquo; with limited economic and voting rights against the contribution, by shareholders or third-parties, of work or services,
as well as &ldquo;participation instruments&rdquo; in favor of employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws allow us to issue shares without voting rights, with voting rights limited to particular subjects, with voting rights subject
to the occurrence of particular conditions not merely arbitrary or with multiple voting rights (each multiple voting right share may
have a maximum of three votes). According to Italian law, the total value of such shares may not exceed half of the share capital. Our
bylaws also provides that, in relation to the quantity of shares held by the same party, the voting right may be limited to a maximum
extent or may be staggered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Participation
instruments&rdquo; may include convertible equity and/or &ldquo;hybrid&rdquo; instruments that confer on the holder the right to vote
on specific matters and/or grants economic rights, to be determined at the time of the issuance of such instruments, or management rights,
such as the right to appoint, in accordance with the procedures established by the bylaws, an independent member of the board of directors
or a statutory auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws currently allow us to issue these securities. We may also issue convertible and non-convertible debt securities. In order to issue
convertible debt securities, our board of directors would need to recommend to our shareholders that they approve the issuance of particular
securities in connection with a capital increase, and the shareholders would need to vote to approve such an issuance and capital increase
at an extraordinary meeting. The board of directors would also need to recommend, and the shareholders would need to approve by vote
at the extraordinary meeting, specific terms of the securities. The shareholders may vote at the extraordinary shareholders&rsquo; meeting
to delegate authority to the board of directors to issue those securities from time to time, but not for more than five years from the
date of the extraordinary shareholders&rsquo; meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Debt-equity
ratio</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law provides that we may not issue debt securities for an amount exceeding twice the value of the sum of our equity capital, our legal
reserve and any other disposable reserves appearing on the latest balance sheet approved by our shareholders. The board of statutory
auditors must certify compliance with such limitation. This limitation may be exceeded if the debt securities issued in excess are intended
for subscription by professional investors subject to prudential supervision pursuant to special laws. In the event of subsequent circulation
of the debt security, whoever transfers them is liable for the solvency of the company vis-&agrave;-vis buyers who are not professional
investors. The rules indicated above do not apply in case we intend to issue debt securities to be listed on regulated markets or multilateral
trading systems or which have attached the right to purchase or subscribe shares. The legal reserve is a reserve to which we are required
to allocate 5% of our Italian GAAP net income each year until it equals at least 20% of our equity capital. One of the other reserves
that we maintain on our balance sheet is a &ldquo;share premium reserve&rdquo;, meaning amounts paid for our ordinary shares in excess
of the amount of such ordinary shares that is allocated to stated capital (<I>valore nominale</I>). Until our outstanding debt securities
are repaid in full, we may not voluntarily reduce our equity capital or distribute our reserves (such as by declaring dividends) in the
event the aggregate of the capital plus reserves, after giving effect to such reduction, is less than half of the outstanding amount
of the debt securities. If our equity capital is reduced by losses or otherwise such that the amount of the outstanding debt securities
is more than twice the amount of our equity capital, we cannot distribute profits to our shareholders until the ratio between the amount
of our debt securities and our equity capital plus reserves is restored. If our equity capital is reduced, we could recapitalize by means
of issuing new shares or having our current shareholders contribute additional capital to our company, although there can be no assurance
that we would be able to find purchasers for new shares or that any of our current shareholders would be willing to contribute additional
capital. The legal requirements regarding the ratio of debt securities to equity capital plus reserves do not apply to issuances of debt
securities to professional investors (as defined by Italian law). However, in such a case, should the professional investors transfer
such debt securities to third parties not qualified as professional investors, the former remains liable for the payment of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Reduction
of equity by losses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law requires us to reduce our shareholders&rsquo; equity in certain situations. Our shareholders&rsquo; equity has three main components:
capital, legal reserves and other shareholders&rsquo; equity (such as share premium and retained earnings). We first apply our losses
from operations against our shareholders&rsquo; equity other than legal reserves and capital. If additional losses remain and, after
the legal reserves, our corporate capital is reduced by more than one-third, our board of directors must call a shareholders&rsquo; meeting
as soon as possible. The shareholders should take appropriate measures, which may include, among others, either reducing the legal reserves
and capital by the amount of the remaining losses, or carrying the losses forward for up to one year. If the shareholders vote to elect
to carry the losses forward for up to one year, and the losses are still more than one-third of the amount of the capital at the end
of the year, then we must reduce our capital by the amount of the losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no present intention to enter into any such transaction and no such transaction is currently in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidation
rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Italian law and subject to the satisfaction of the claims of all creditors, our shareholders are entitled to a distribution in liquidation
that is equal to an amount resulting from the division of the positive liquidation balance by the number of shares (to the extent available
out of our net assets). Preferred shareholders and holders of &ldquo;participating certificates&rdquo; typically do not participate in
the distribution of assets of a dissolved corporation beyond their established contractual preferences. Once the rights of preferred
shareholders and holders of participating certificates and the claims of all creditors have been fully satisfied, holders of ordinary
shares are entitled to the distribution of any remaining assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purchase
of shares by us (Treasury shares)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are permitted to purchase our outstanding shares, subject to certain conditions and limitations provided for by Italian law. We may only
purchase the shares out of profits available for dividends or out of distributable reserves, in each case as appearing on the latest
shareholder-approved financial statements; if we do not have such available profits or reserves, the shares in excess must be cancelled
and the corporate capital must be reduced accordingly. Further, we may only repurchase fully paid-in shares. Such purchases and the conditions
thereto must be authorized by our shareholders by vote at an ordinary shareholders&rsquo; meeting and the authorization may be issued
for a period not exceeding the term of eighteen (18) months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
corresponding reserve equal to the purchase price of such shares must be created in the balance sheet, and such reserve is not available
for distribution, unless such shares are sold or cancelled. Shares purchased and held by us may be resold only pursuant to a resolution
of our shareholders adopted at an ordinary shareholders&rsquo; meeting. The voting rights attaching to the shares held by us or our subsidiaries
cannot be exercised, but the shares can be counted for quorum purposes in shareholders&rsquo; meetings. Dividends and other rights, including
preemptive rights, attaching to such shares will accrue to the benefit of other shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing limitations do not apply in case we purchase our shares: (i) by giving execution to a shareholders&rsquo; meeting resolution
authorizing capital reduction through repurchase or cancellation; (ii) for free, to the extent they are fully paid-in; (iii) as a consequence
of universal succession, merger or demerger; or (iv) on occasion of foreclosures authorized to satisfy a creditor of our company, to
the extent they are fully paid-in.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as such shares remain the property of the company, the right to profits and the right of option are attributed proportionally to
the other shares. The right to vote is suspended, but such shares are nevertheless taken into account for the purposes of calculating
the majority and the quorum required for the constitution and for the resolutions of the shareholders&rsquo; meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not hold any of its shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Notification
of the acquisition of shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Italian antitrust laws, the Italian Antitrust Authority could prohibit, if certain threshold requirements are met, the
acquisition of control in a company which would thereby create or strengthen a dominant position in the domestic market or a significant
part thereof and which would result in the elimination or substantial reduction, on a lasting basis, of competition, provided that certain
turnover thresholds are exceeded. However, if the turnover of the acquiring party and the company to be acquired exceed certain other
monetary thresholds, the antitrust review of the acquisition falls within the exclusive jurisdiction of the European Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we fall under the scope of the Law Decree No. 21 of March 15, 2012 (the so-called Italian &ldquo;Golden Power&rdquo; regulations),
as subsequently amended and supplemented, (i) certain resolutions of the Company and, if specific thresholds requirements are met, and
(ii) certain third-party investors&rsquo; purchases of our shares may be subject to <I>ad hoc </I>notifications to the Italian Government
which may object to the transaction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, in such cases the Government would have, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    power to veto or to impose specific conditions with respect to the acquisition of certain shareholdings by any foreign entity outside
    the European Union with respect to companies having assets and business in sectors of strategic importance; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    power to veto or impose specific conditions with regard to the adoption of specific corporate resolutions, acts or transactions by
    the same companies.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Minority
shareholders&rsquo; rights; withdrawal rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
resolutions which are not adopted in conformity with applicable law or our bylaws may be challenged (with certain limitations and exceptions)
within 90 days of such resolution (or, if such resolution is subject to registration or filing with the Italian Company Register, within
ninety days of its registration or filing) by absent, dissenting or abstaining shareholders representing individually or in the aggregate
at least 5% of our share capital (as well as by our board of directors or our board of statutory auditors). Shareholders not reaching
this threshold or shareholders not entitled to vote at our meetings may only claim damages arising from the challenged resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenting
or absent shareholders may withdraw from the company as a result of shareholders&rsquo; resolutions approving, among other things, material
modifications of our corporate purpose or of the voting rights of our ordinary shares, our transformation from a share corporation into
a different legal entity or the transfer of our registered seat outside Italy. In such a case, our other shareholders would have a preemptive
right to purchase the shares of the withdrawing shareholder. Should no shareholder exercise that preemptive right, the shares must be
offered to third parties or, in the absence of any third party wishing to buy them, they will be purchased by us by using the available
reserves. In the event that no reserve is available, our equity capital must be reduced accordingly. Any repurchase of such shares by
us must be on terms authorized by our board of directors, upon consultation with our board of statutory auditors and our external auditor,
having regard to our net asset value, our prospective earnings and the market value of our ordinary shares, if any. Under Italian law,
we may set forth different criteria in our bylaws for the consideration to be paid to withdrawing shareholders. We have not done so as
of the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
shareholder may bring to the attention of the board of statutory auditors facts or acts which such shareholder deems wrongful. If such
shareholders represent at least 5% of our share capital, or in case we are considered an Open Company (as described below) 2% of the
same, our board of statutory auditors must investigate without delay and report its findings and recommendations at our shareholders&rsquo;
meeting. Shareholders representing more than 10% of our share capital, or, in case we are considered an Open Company one-twentieth, have
the right to report to the competent court serious breaches of the duties of the directors which may be prejudicial to us or to our subsidiaries.
In addition, shareholders representing at least 20% of our share capital may commence derivative suits before the competent court against
our directors, statutory auditors and general managers. We may waive or settle the suit unless shareholders holding at least 20% of the
shares vote against such waiver or settlement. We will reimburse the legal costs of such action in the event that the claim of such shareholder
is successful and the court does not award such costs against the relevant directors, statutory auditors or general managers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Applicable
Laws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is governed by the corporate laws of Italy, and is legally considered and treated, according to the Italian Civil Code, as a
private company because our shares are not listed on a regulated market in Italy or within the European Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
should be noted that under Italian corporate law, while joint-stock companies are all the same type of legal entity, there is a distinction
between those companies that do not have access to the capital markets (<I>Private Companies</I>) and companies that have such access.
This latter category comprises both companies listed on European regulated markets (<I>Public Companies</I>) and companies whose securities
are not listed on such markets, insofar as they have completed a significant distribution of their securities among the public (so-called
&ldquo;<I>emittenti aventi strumenti finanziari diffusi tra il pubblico in maniera rilevante</I>&rdquo;), according to the relevant provisions
set forth in Italian Financials&rsquo; Consolidated Act and its implementing provisions (<I>Open Companies</I>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 2-bis of the Issuer&rsquo;s Regulation implemented by Consob (<I>Regolamento emittenti</I>), Open Companies must meet the
following requirements:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    at least 500 shareholders in addition to the majority shareholders who hold at least 5% of the outstanding share capital; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exceeding
    at least two out of the following three thresholds:</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    assets side of &euro;4.4 million;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">total
    revenues of &euro;8.8 million; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    average of 50 employees during the year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we issue financial instruments widely distributed among the public, the regulation relating to Open Companies could apply to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Exchange Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are listed on The Nasdaq Capital Market represented by ADSs under the symbol &ldquo;GNTA.&rdquo; Neither the Company&rsquo;s
ordinary shares nor its ADSs are listed on a securities exchange outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registrar
of Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
share register is currently kept by Spafid S.p.A., which acts as registrar. The share register reflects only record owners of our ordinary
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_110"></A>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
descriptions of our ordinary shares and the ADSs, please refer to the Description of Securities, filed as Exhibit 2.4 to our Annual Report
on Form 20-F for the year ended December 31, 2022, which is incorporated herein by reference. Because those descriptions are summaries,
they may not contain all of the information important to you. Accordingly, those descriptions are qualified entirely by reference to
our bylaws (statuto), the Deposit Agreement and the form of ADR, as applicable, copies of which have been filed as exhibits to the registration
statement of which this prospectus forms a part. See &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_111"></A>TAXATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Italian
Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should refer to <FONT STYLE="background-color: white">&ldquo;Item 10. Additional Information&mdash;E. Taxation&mdash;Italian Tax Consequences&rdquo;
in our Annual Report on Form 20-F for the year ended December 31, 2022, which is incorporated herein by reference, for a summary
of </FONT>material tax consequences under Italian law relating to the purchase, ownership and disposition of the ADSs to be offered and
sold under this prospectus. Such summary is not intended to constitute a complete analysis of all tax consequences relating to
the acquisition, ownership, and disposition of the ADSs. You should consult your own tax advisor concerning the tax consequences of your
particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
Federal Income Taxation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR
TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES
OF THE PURCHASE, OWNERSHIP AND SALE OF ADSS, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE
CHANGES IN THE TAX LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the limitations described in the next paragraph, the following discussion summarizes the material U.S. federal income tax consequences
to a &ldquo;U.S. Holder&rdquo; arising from the purchase, ownership and sale of the ADSs. For this purpose, a &ldquo;U.S. Holder&rdquo;
is a holder of ADSs that is: (1) an individual citizen or resident of the United States, including an alien individual who is a lawful
permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws; (2) a corporation
(or entity treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership that is not treated
as a U.S. person under any applicable U.S. Treasury regulations) created or organized under the laws of the United States or the District
of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income for U.S. federal income
tax purposes regardless of source; (4) a trust if a court within the United States is able to exercise primary supervision over the administration
of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust; or (5) a trust that has a
valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is for general information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income
tax considerations that may be relevant to a decision to invest in or dispose of the ADSs. This summary generally considers only U.S.
Holders that will own the ADSs as capital assets and who will not hold the ADSs as part of a permanent establishment in Italy. This summary
does not consider the U.S. federal tax consequences to a person that is not a U.S. Holder, nor does it describe the rules applicable
to determine a taxpayer&rsquo;s status as a U.S. Holder. This summary is based on the provisions of the Internal Revenue Code of 1986,
as amended, or the Code, final, temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative and judicial
interpretations thereof, and the U.S./Italy Income Tax Treaty, all as in effect as of the date hereof and all of which are subject to
change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will not seek a ruling from the IRS
with regard to the U.S. federal income tax treatment of an investment in the ADSs by U.S. Holders and, therefore, can provide no assurances
that the IRS will agree with the conclusions set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not address all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. holder based
on such holder&rsquo;s particular circumstances and in particular does not discuss any estate, gift, generation-skipping, transfer, state,
local, excise or foreign tax considerations. In addition, this discussion does not address the U.S. federal income tax treatment of a
U.S. Holder who is: (1) a bank, life insurance company, regulated investment company, or other financial institution or &ldquo;financial
services entity;&rdquo; (2) a broker or dealer in securities or foreign currency; (3) a person who acquired our securities in connection
with employment or other performance of services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder
that holds our securities as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction
transaction for U.S. federal income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) an
expatriate or a former long-term resident of the United States; or (9) a U.S. Holder having a functional currency other than the U.S.
dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns, directly or constructively,
at any time, securities representing 10% or more of the voting power or value of our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the U.S. federal income tax treatment of partnerships (or other pass-through entities) or persons who hold securities through a partnership
or other pass-through entity are not addressed. If a partnership (including any entity treated as a partnership for U.S. federal income
tax purposes) holds ADSs, the U.S. federal income tax consequences to the partners of such partnership will depend on the activities
of the partnership and the status of the partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing, holding or
disposing of our securities, including the effects of applicable state, local, foreign or other tax laws and possible changes in the
tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Taxation
of Dividends Paid on Ordinary Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to pay dividends in the foreseeable future. In the event that we do pay dividends, and subject to the discussion under
the heading &ldquo;Passive Foreign Investment Companies&rdquo; below and the discussion of &ldquo;qualified dividend income&rdquo; below,
a U.S. Holder, other than certain U.S. Holders that are U.S. corporations, will be required to include in gross income as ordinary income
the U.S. dollar amount of any distribution paid on ordinary shares (including the amount of any Italy tax withheld on the date of the
distribution), to the extent that such distribution does not exceed our current and accumulated earnings and profits, as determined for
U.S. federal income tax purposes. The amount of a distribution which exceeds our earnings and profits will be treated first as a non-taxable
return of capital, reducing the U.S. Holder&rsquo;s tax basis for the ordinary shares to the extent thereof, and then as capital gain.
We do not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders
should expect that the entire amount of any distribution generally will be reported as dividend income. Any dividends we pay with respect
to the ADSs or ordinary shares are expected to constitute foreign source income for foreign tax credit purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, preferential tax rates for &ldquo;qualified dividend income&rdquo; and long-term capital gains are applicable for U.S. Holders
that are individuals, estates or trusts. For this purpose, &ldquo;qualified dividend income&rdquo; means, inter alia, dividends received
from a &ldquo;qualified foreign corporation.&rdquo; A &ldquo;qualified foreign corporation&rdquo; is a corporation that is entitled to
the benefits of a comprehensive tax treaty with the United States which includes an exchange of information program. The IRS has stated
that the Italy/U.S. Tax Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our dividends will be qualified dividend income if our ordinary shares are readily tradable on Nasdaq or another established
securities market in the United States. Dividends will not qualify for the preferential rates if we are treated, in the year the dividend
is paid or in the prior year, as a PFIC, as described below under &ldquo;Passive Foreign Investment Companies.&rdquo; A U.S. Holder will
not be entitled to the preferential rate: (1) if the U.S. Holder has not held our ordinary shares for at least 61 days of the 121-day
period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under an obligation
to make related payments on substantially similar property. Any days during which the U.S. Holder has diminished its risk of loss on
our ordinary shares are not counted towards meeting the 61-day holding period. Finally, U.S. Holders who elect to treat the dividend
income as &ldquo;investment income&rdquo; pursuant to Code section 163(d)(4) will not be eligible for the preferential rate of taxation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of a distribution with respect to our ordinary shares will be measured by the amount of the fair market value of any property
distributed, and for U.S. federal income tax purposes, the amount of any Italian taxes withheld therefrom. Cash distributions paid by
us in Euros will be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on
the date the dividend is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such Euros for U.S. federal
income tax purposes equal to such U.S. dollar value. If the U.S. Holder subsequently converts the Euros into U.S. dollars or otherwise
disposes of it, any subsequent gain or loss in respect of such Euros arising from exchange rate fluctuations will be U.S. source ordinary
exchange gain or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations, Italian withholding tax, if any, paid in connection with any distribution with respect to ADSs may be claimed
as a credit against a U.S. Holder&rsquo;s U.S. federal income tax liability if the U.S. Holder elects not to take a deduction for any
non-U.S. income taxes for that taxable year; otherwise, such Italian withholding tax may be taken as a deduction. If a U.S. Holder is
eligible for benefits under the Treaty or is otherwise entitled to a refund for the taxes withheld, the U.S. Holder will not be entitled
to a foreign tax credit or deduction for the amount of any Italian taxes withheld in excess of the maximum rate under the Treaty or for
the taxes with respect to which the U.S. Holder can obtain a refund from the Italian taxing authorities. As the relevant rules are very
complex, U.S. Holders should consult their own tax advisors concerning the availability and utilization of the foreign tax credit or
deductions for non-U.S. taxes in their particular circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Taxation
of the Disposition of Ordinary Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided under the PFIC rules described below under &ldquo;Passive Foreign Investment Companies,&rdquo; upon the sale, exchange or
other disposition of our ordinary shares, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between
such U.S. Holder&rsquo;s tax basis for the ordinary shares in U.S. dollars and the amount realized on the disposition in U.S. dollar
(or its U.S. dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized
is denominated in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of ordinary shares will be
long-term capital gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals
who recognize long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject
to various limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Passive
Foreign Investment Companies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
U.S. federal income tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for
U.S. federal income tax purposes for any taxable year that either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%
    or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25%
    or more of the shares by value), in a taxable year is passive; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share
    of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of,
    or produce, passive income.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
this purpose, passive income generally consists of dividends, interest, rents, royalties, annuities, the excess of certain foreign currency
gains over certain currency losses, and income from certain commodities transactions and from notional principal contracts. Cash is treated
as generating passive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
status as a PFIC will depend on the nature and composition of our income and the nature, composition and value of our assets. Our status
may also depend, in part, on how quickly we utilize the cash proceeds from this offering in our business. We have not made the formal
analysis necessary to determine whether or not we are currently a PFIC or whether we have ever been a PFIC. Based on preliminary analysis
done in connection with this offering, however, we believe that we were likely classified as a PFIC in 2022, and we may be classified
as a PFIC for 2023 and future years. In particular, so long as we do not generate revenue from operations for any taxable year and do
not receive any research and development grants, or even if we receive a research and development grant, if such grant does not constitute
gross income for United States federal income tax purposes, we likely will be classified as a PFIC for such taxable year. Because the
determination of whether we are a PFIC for any taxable year is a factual determination made annually after the end of each taxable year,
there can be no assurance that we will not be considered a PFIC in any taxable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we currently are or become a PFIC during the holding period of a U.S. holder, the U.S. holder would be subject to potentially materially
greater amounts of tax and subject to additional U.S. tax form filing requirements. In addition, a non-corporate U.S. holder will not
be eligible for qualified dividend income treatment on dividends received from us if we are treated as a PFIC for the taxable year in
which the dividends are received or for the preceding taxable year. Specifically, each U.S. Holder who has not elected to mark the shares
to market (as discussed below), would, upon receipt of certain distributions by us and upon disposition of our ordinary shares at a gain:
(1) have such distribution or gain allocated ratably over the U.S. Holder&rsquo;s holding period for the ordinary shares, as the case
may be; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which
we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to
tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral
benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition, when shares of
a PFIC are acquired by reason of death from a decedent that was a U.S. Holder, the tax basis of such shares would not receive a step-up
to fair market value as of the date of the decedent&rsquo;s death, but instead would be equal to the decedent&rsquo;s basis if lower,
unless all gain were recognized by the decedent. Indirect investments in a PFIC may also be subject to these special U.S. federal income
tax rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PFIC rules described above would not apply to a U.S. Holder who makes a QEF election for all taxable years that such U.S. Holder has
held the ordinary shares while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder
who has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder&rsquo;s pro
rata share of our ordinary earnings as ordinary income and such U.S. Holder&rsquo;s pro rata share of our net capital gains as long-term
capital gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only
if we make available certain required information. At this time, we do not expect to calculate our &ldquo;ordinary earnings&rdquo; or
&ldquo;net capital gain&rdquo; under U.S. tax principles or supply U.S. holders with the required &ldquo;PFIC Annual Information Statement.&rdquo;
If we do not provide this information for any reason, it generally will not be possible for a U.S. Holder to make a QEF election if we
are, or if we become, a PFIC. Prospective investors should assume that a QEF election will not be available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the PFIC rules described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder
of our ordinary shares which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the
ordinary shares to market annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close
of the taxable year between the fair market value of the ordinary shares and the U.S. Holder&rsquo;s adjusted tax basis in the ordinary
shares. Losses are allowed only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election
for prior taxable years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders who hold our ordinary shares during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be
a PFIC. U.S. Holders are strongly urged to consult their tax advisors about the PFIC rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Tax
on Net Investment Income</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders who are individuals, estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including
dividends on and gains from the sale or other disposition of our ordinary shares), or in the case of estates and trusts on their net
investment income that is not distributed. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder&rsquo;s total
adjusted income exceeds applicable thresholds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Reporting and Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder may be subject to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of ordinary
shares. In general, backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup
withholding will not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations.
Backup withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder,
provided that the required information is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
federal income tax law requires certain U.S. investors to disclose information relating to investments in securities of a non-U.S. issuer.
Failure to comply with applicable disclosure requirements could result in the imposition of substantial penalties. U.S. holders should
consult their own tax advisors regarding any disclosure obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_112"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into a Controlled Equity Offering<SUP>SM</SUP> Sales Agreement, or the Sales Agreement, with Cantor Fitzgerald &amp; Co.,
or Cantor. Pursuant to this prospectus, we may offer and sell ADSs having an aggregate gross sales price of up to $30,000,000 from time
to time through or to Cantor acting as sales agent or principal. A copy of the Sales Agreement has been filed as an exhibit to our registration
statement on Form F-3 of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
delivery of a placement notice and subject to the terms and conditions of the Sales Agreement, Cantor may sell the ADSs by any method
permitted by law deemed to be an &ldquo;at the market offering&rdquo; as defined in Rule 415(a)(4) promulgated under the Securities Act.
We may instruct Cantor not to sell ADSs if the sales cannot be effected at or above the price designated by us from time to time. We
or Cantor may suspend the offering of ADSs upon notice and subject to other conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay Cantor commissions, in cash, for its service in acting as agent in the sale of the ADSs. Cantor will be entitled to compensation
at a commission rate equal to 3.0% of the sales price per ADS sold under the Sales Agreement. Because there is no minimum offering amount
required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are
not determinable at this time. We have also agreed to reimburse Cantor for certain specified expenses, including the fees and disbursements
of their legal counsel in an amount not to exceed $75,000. Additionally, pursuant to the terms of the Sales Agreement, we agreed
to reimburse Cantor for the fees and costs of its legal counsel reasonably incurred in connection with Cantor&rsquo;s ongoing diligence
arising from the transactions contemplated by the Sales Agreement in an amount not to exceed $25,000 in the aggregate per calendar
half year. We estimate that the total expenses for the offering, excluding compensation and reimbursements payable to Cantor under the
terms of the Sales Agreement, will be approximately $397,515.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement
for sales of ADSs will occur on the second business day following the date on which any sales are made, or on some other date that is
agreed upon by us and Cantor in connection with a particular transaction, in return for payment of the net proceeds to us. Sales of the
ADSs as contemplated in this prospectus will be settled through the facilities of The Depository Trust Company or by such other means
as we and Cantor may agree upon. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
will use its commercially reasonable efforts, consistent with its sales and trading practices, to solicit offers to purchase the ADSs
under the terms and subject to the conditions set forth in the Sales Agreement. In connection with the sale of the ADSs on our behalf,
Cantor will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act and the compensation of Cantor will
be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to Cantor against certain
civil liabilities, including liabilities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of the ADSs pursuant to the Sales Agreement will terminate upon the termination of the Sales Agreement as permitted
therein. We and Cantor may each terminate the Sales Agreement at any time upon ten days&rsquo; prior notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
and its affiliates may in the future provide various investment banking, commercial banking and other financial services for us and our
affiliates, for which services they may in the future receive customary fees. To the extent required by Regulation M, Cantor will not
engage in any market making activities involving the ADSs while the offering is ongoing under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may be made available in electronic format on a website maintained by Cantor, and Cantor may distribute this prospectus electronically.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_113"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters concerning this offering will be passed upon for us by Fenwick &amp; West LLP, New York, New York. Certain legal matters
with respect to the validity of the ordinary shares represented by ADSs offered by this prospectus will be passed upon for us by Giovannelli
e Associati, Studio Legale, Italy. Cantor is being represented in connection with this offering by Duane Morris LLP, New York, New York,
with respect to certain U.S. legal matters, and Chiomenti Studio Legale LLC, New York, New York, with respect to certain Italian legal
matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_114"></A>EXPERTS<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Genenta as of December 31, 2022 and for its fiscal year ended December 31, 2022, included in the Company&rsquo;s
Annual Report on Form 20-F for the year ended December 31, 2022, incorporated by reference herein has been audited by Dannible and
McKee, LLP, independent registered public accounting firm, as set forth in their report thereon. Such financial statements are incorporated
by reference in this prospectus in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
The address of Dannible &amp; McKee, LLP is 221 S. Warren Street #500, Syracuse, New York, United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of Genenta as of December 31, 2021, and for each of its fiscal years in the two-year period
ended December 31, 2021, included in the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2022, incorporated
by reference herein has been audited by Mayer Hoffman McCann P.C., independent registered public accounting firm, as set forth in their
report thereon. Such financial statements are incorporated by reference in this prospectus in reliance upon such report given on the
authority of such firm as experts in accounting and auditing. The address of Mayer Hoffman McCann P.C. is 13500 Evening Creek Drive North
#450, San Diego, California, United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_115"></A>EXPENSES
OF THE OFFERING<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the expenses of this offering payable by us, excluding commissions and reimbursement of expenses, in connection
with this offering. All amounts shown are estimated, except the SEC registration fee and the FINRA filing fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">SEC registration fee</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">11,020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">FINRA filing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,500</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Printing and engraving expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,995</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,000</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Miscellaneous costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">397,515</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_116"></A>ENFORCEMENT
OF CIVIL LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the laws of Italy and our registered office and domicile is located in Milan, Italy. Moreover, a majority of our
directors and executive officers are not residents of the United States, and all or a substantial portion of our assets are located outside
the United States. As a result, it may not be possible for investors to effect service of process within the United States upon us or
upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil
liability provisions of the federal securities laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have been advised by our Italian counsel that the recognition and enforcement of foreign judgements in Italy is regulated either by (i)
treaties or conventions, bilateral or multilateral, between Italy and the foreign country, whose court issued the judgement, or (ii)
Italian Law no. 218 of May 31, 1995 (the &ldquo;International Private Law Act&rdquo;). In this regard, the provisions of the applicable
treaties and conventions, if any, prevail on the provisions of the International Private Law Act. Indeed, Section 2 of the International
Private Law Act states that the provisions of the International Private Law Act are &ldquo;<I>without prejudice to the application of
the international conventions binding on Italy</I>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
said, Italian counsels advise us that there exist no treaties or other conventions in existence between the Republic of Italy and the
United States, or between the Republic of Italy and the U.S. laws, relating to the recognition and enforcement of civil judgments. There
follows that a civil judgment of a court of New York or of a United States federal court applying New York law will be recognized in
Italy under the general provisions of the International Private Law Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
64 of the International Private Law Act provides that a judgment issued in a foreign country is recognized in Italy, without any proceedings
(<I>i.e., </I>without a rehearing on the merits) being necessary, if all of the following conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
the judge who issued the judgment had the power to decide the case pursuant to the principles on jurisdiction provided by Italian law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
the writ of summons (or equivalent pleading) was duly served upon the defendant in compliance with the applicable provisions of the <I>lex
fori </I>(i.e., the application of the rules of the legal system to which the judge belongs);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
the parties entered an appearance, or their default was duly declared in compliance with the applicable provisions of the <I>lex fori</I>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
the judgment to be recognized is a final judgment subject to no further appeal;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
the judgment to be recognized does not contrast with a final judgment issued by an Italian court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
there are no pending proceedings between the same parties and in relation to the same matter, which proceedings were commenced prior
to the commencement of the foreign proceedings; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
the judgment to be recognized does not conflict with Italian public order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the foreign civil judgment must be enforced in Italy, the above-mentioned conditions must be verified by the Italian Court of Appeal
based in the area where the judgment must be executed, as indicated in Article 67 of the International Private Law Act. The subsequent
decision of the competent Court of Appeal constitutes the title to enforce the foreign decision. Whether these requirements are met in
respect of a judgment based upon the civil liability provisions of the United States securities laws, including whether the award of
monetary damages under such laws would constitute a penalty, is an issue for the court making such decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing, investors may be able to enforce in Italy judgments in civil and commercial matters that have been obtained from U.S.
federal or state courts. Nevertheless, we cannot assure you that those judgments will be recognized or enforceable in Italy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_117"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual reports on Form 20-F and other information with the SEC and furnish reports on Form 6-K to the SEC. We are not required to
disclose certain other information that is required from U.S. domestic issuers. Also, as a foreign private issuer, we are exempt from
the rules of the Exchange Act prescribing the furnishing of proxy statements to shareholders and our directors, senior management and
principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC.
Our filings with the SEC are also available to the public through the SEC&rsquo;s website at www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are also exempt from the requirements of Regulation FD (Fair Disclosure) which, generally, are meant to
ensure that select groups of investors are not privy to specific information about an issuer before other investors. We are, however,
still subject to the anti-fraud and anti-manipulation rules of the SEC, such as Rule 10b-5. Since many of the disclosure obligations
required of us as a foreign private issuer are different than those required by other U.S. domestic reporting companies, our shareholders,
potential shareholders and the investing public in general should not expect to receive information about us in the same amount and at
the same time as information is received from, or provided by, other U.S. domestic reporting companies. We are liable for violations
of the rules and regulations of the SEC which do apply to us as a foreign private issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a corporate website at www.genenta.com. Information contained on, or that can be accessed through, our website does not constitute
a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_118"></A>INCORPORATION
OF INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to
you by referring you to another document that we have filed separately with the SEC. You should read the information incorporated by
reference because it is an important part of this prospectus. We incorporate by reference the following information or documents that
we have filed with the SEC:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Reports on Form 6-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223003331/form6-k.htm" STYLE="-sec-extract: exhibit">February
    1, 2023</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223014964/form6-k.htm" STYLE="-sec-extract: exhibit">May 1, 2023</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223016155/form6-k.htm" STYLE="-sec-extract: exhibit">May 10, 2023</A>;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001838716/000149315223013272/form20-f.htm" STYLE="-sec-extract: exhibit">Form 20-F</A> for the year ended December 31, 2022 filed with the SEC on April 21, 2023; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    descriptions of our ordinary shares and ADSs contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315222011671/ex2-4.htm" STYLE="-sec-extract: exhibit">Exhibit 2.4</A> to our Annual Report on Form 20-F for the year ended December
    31, 2022 filed by us with the SEC on April 21, 2023, including any amendment or report filed to update such description and any subsequent
    amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
annual reports on Form 20-F and any amendment thereto and any report on Form 6-K (or portion thereof) that expressly indicates it is
being incorporated by reference in this prospectus, in each case, that we file with or furnish to the SEC prior to the termination or
completion of the offering under this prospectus (including all such reports or documents we may file with or furnish to the SEC on or
after the date on which the registration statement of which this prospectus is a part is first filed with the SEC and prior to the effectiveness
of the registration statement), will also be incorporated by reference into this prospectus and deemed to be part of this prospectus
from the date of the filing or furnishing of such reports and documents. Unless expressly incorporated by reference, nothing in this
prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in any document incorporated by reference herein shall be deemed to be modified or superseded for purposes of this
prospectus to the extent that a statement contained in this prospectus or any prospectus supplement modifies or supersedes such statement.
Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the documents that are incorporated by reference are available at the website maintained by the SEC at http://www.sec.gov. In addition,
copies of all documents incorporated by reference in this prospectus, other than exhibits to those documents unless such exhibits are
specifically incorporated by reference in this prospectus, will be provided at no cost to each person, including any beneficial owner,
to whom a copy of this prospectus is delivered on the written or oral request of that person made to: Genenta Science S.p.A., Via Olgettina
No. 58, 20132, Milan, Italy, Attention: Pierluigi Paracchi.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formf-3_001.jpg" ALT="" ></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Up
to $30,000,000</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>American
Depositary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Representing
Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formf-3_002.jpg" ALT="" ></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>,
2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-right: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II INFORMATION NOT REQUIRED IN PROSPECTUS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
8. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Italian
law requires directors and members of any committee designated by the board of directors to perform their duties with the degree of diligence
required by the nature of their office and according to their specific level of competence. Liability should never arise from business
judgments under the circumstances, even if the decisions made entail significant economic risks, but be attributable only to lack of
diligence by the director in appreciating in advance the risk involved in the transaction to be undertaken, and therefore, the omission
of possible precautions, assessments or the lack of information normally required for a decision of that type, taken under those circumstances
and in that manner. Directors are liable to the company&rsquo;s creditors when their improper management conduct impairs the company&rsquo;s
assets and prevents the company from satisfying creditors&rsquo; claims. If the company cannot repay its creditors, and a court determines
that the directors did not adequately perform their duties relating to the preservation of assets, the court may find directors liable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to provide enhanced liability protection for its directors and to attract and retain highly qualified individuals to act as directors,
our board of directors has agreed to indemnify each current and future member of the board of directors to the maximum extent permitted
by law, save for a limited number of instances, including when (i) officers and directors&rsquo; acts or omissions constituted willful
misconduct or gross negligence, (ii) officers and directors did not act in good faith, for a purpose which they reasonably believed to
be in, or not opposed to, the best interests of the Company and (iii) officers and directors are held liable towards the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9<I>.</I> Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the Exhibit Index on page II-3 for a list of exhibits filed as part of this Registration Statement on Form F-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
10. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
Fee&rdquo; table in the effective registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Provided</I>,
<I>however</I>, that paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant
to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial <I>bona fide</I> offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
To <FONT STYLE="background-color: white">file a post-effective amendment to the registration statement to include any financial statements
required by Item 8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and
information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished, <I>provided</I> that the registrant includes
in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other
information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements.
Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required
by Section 10(a)(3) of the Securities Act or Item 8.A of Form 20-F if such financial statements and information are contained in periodic
reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange
Act of 1934 that are incorporated by reference in the registration statement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 51; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
That, for the purpose of determining liability under the Securities Act to any purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the
date the filed prospectus was deemed part of and included in the registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on
Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of
the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering
described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter,
such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement
to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering
thereof. <I>Provided</I>, <I>however</I>, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such effective date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
the registrant&rsquo;s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
TO EXHIBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
    of Exhibit</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Underwriting Agreement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-2.htm">Controlled
    Equity Offering<SUP>SM</SUP> Sales Agreement, dated May 12, 2023, by and between the Company and Cantor Fitzgerald &amp; Co.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315221027683/ex3-1.htm" STYLE="-sec-extract: exhibit">Deed of Incorporation of Genenta Science S.p.A. (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Registration Statement on Form F-1 (File No. 333-260923))</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315223013272/ex3-2.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of Genenta Science S.p.A. (incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2022)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315221027683/ex4-1.htm" STYLE="-sec-extract: exhibit">Deposit Agreement dated December 17, 2021 between the Company and The Bank of New York Mellon, as depositary (incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Registration Statement on Form F-1 (File No. 333-260923))</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315221027683/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of American Depositary Receipt (included in Exhibit 4.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Form
    of Rights Agreement (including Rights Certificate)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1838716/000149315222011671/ex4-3.htm" STYLE="-sec-extract: exhibit">Underwriter Warrants dated December 17, 2021(incorporated by reference to Exhibit 4.3 to the Company&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2021)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Opinion of <FONT STYLE="background-color: white">Giovanelli and Associates, Italian counsel to the Company</FONT></A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><A HREF="ex23-1.htm">Consent of Dannible &amp; McKee, LLP.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><A HREF="ex23-2.htm">Consent of Mayer Hoffman McCann, P.C.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Consent of Giovanelli and Associates (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#toc2_119">Powers of Attorney (included on the signature page)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex107.htm">Filing Fee Table</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed, if necessary, as an exhibit to a post-effective amendment to this registration statement or as an exhibit to a report filed
    under the Securities Exchange Act of 1934, as amended, and incorporated herein by reference. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Milan, Italy on the 12<SUP>th</SUP> day of May, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENENTA
    SCIENCE S.P.A.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Pierluigi Paracchi</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pierluigi
    Paracchi</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="toc2_119"></A>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
person whose signature appears below hereby constitutes and appoints Pierluigi Paracchi and Richard Slansky and each of them, as his
attorney-in-fact and agent, with full power of substitution and resubstitution for him in any and all capacities, to sign any or all
amendments or post-effective amendments to this registration statement, or any registration statement for the same offering that is to
be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with exhibits thereto
and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorney-in-fact and agent
full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby
ratifying and confirming all that such attorney-in-fact and agent or his substitutes may do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in
the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signatures</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Pierluigi Paracchi</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pierluigi
    Paracchi</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Richard B. Slanksy</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    B. Slansky</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Mark Sirgo</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Director</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Sirgo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Roger Abravenel</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roger
    Abravanel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Guido Guidi</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guido
    Guidi</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony Marucci</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    12, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    Marucci</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE
OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Securities Act of 1933, as amended, the undersigned, Cogency Global Inc., the duly authorized representative in the United States
of Genenta Science S.p.A., has signed this registration statement on May 12, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Cogency Global Inc.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Authorized U.S. Representative</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Colleen A. De Vries</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen
    A. De Vries</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Vice-President on behalf of Cogency Global Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>ex1-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENENTA
SCIENCE S.P.A.</B><BR>
American Depositary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
representing one ordinary share, no par value per share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Controlled
Equity Offering<SUP>SM</SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Sales
Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4in 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
Fitzgerald &amp; Co.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4in 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499
Park Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4in 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5in 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
Science S.p.A., a Republic of Italy joint stock corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), confirms its agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;)
with Cantor Fitzgerald &amp; Co. (the &ldquo;<B><U>Agent</U></B>&rdquo;), as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Sale of Shares</U>. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the
conditions set forth herein, it may sell to or through the Agent, as sales agent or principal, American depositary shares (&ldquo;<B><U>ADSs</U></B>&rdquo;),
each representing one (1) ordinary share with no par value in the capital of the Company (the &ldquo;<B><U>Ordinary Shares</U></B>&rdquo;),
and such ADSs to be offered hereby, the &ldquo;<B><U>Placement ADSs</U></B>&rdquo;; <I>provided</I>, <I>however</I>, that in no event
shall the Company sell through the Agent such number or dollar amount of Placement ADSs that would (a) exceed the number or dollar amount
of Ordinary Shares represented by ADSs registered on the effective Registration Statement (defined below) pursuant to which the
offering is being made, (b) exceed the number of authorized but unissued Ordinary Shares (less Ordinary Shares issuable upon exercise,
conversion or exchange of any outstanding securities of the Company or otherwise reserved from the Company&rsquo;s authorized share capital),
(c) exceed the number or dollar amount of ADSs permitted to be sold under Form F-3 (including General Instruction I.B.5 thereof, if applicable)
or (d) exceed the number or dollar amount of ADSs for which the Company has filed a Prospectus (defined below) (the lesser of (a), (b),
(c) and (d), the &ldquo;<B><U>Maximum Amount</U></B>&rdquo;). Notwithstanding anything to the contrary contained herein, the parties
hereto agree that compliance with the limitations set forth in this <U>Section 1</U> on the amount of Placement ADSs issued and sold
under this Agreement shall be the sole responsibility of the Company and that the Agent shall have no obligation in connection with such
compliance. The offer and sale of Placement ADSs through the Agent will be effected pursuant to the Registration Statement (as defined
below) filed by the Company and which will be declared effective by the Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;
or &ldquo;<B><U>SEC</U></B>&rdquo;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration
Statement to issue ADSs. The Company will deposit pursuant to the Deposit Agreement dated as of December 17, 2021, as amended, among
the Company, The Bank of New York Mellon, as depositary (the &ldquo;<B><U>Depositary</U></B>&rdquo;), and owners and holders of the ADSs
issued thereunder (the &ldquo;<B><U>Deposit Agreement</U></B>&rdquo;), a number of Ordinary Shares equal to the Placement ADSs. Upon
deposit of such Ordinary Shares, the Depositary will issue ADSs representing the Ordinary Shares so deposited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has filed or will file, in accordance with the provisions of the Securities Act of 1933, as amended (the &ldquo;<B><U>Securities
Act</U></B>&rdquo;), and the rules and regulations thereunder (the &ldquo;<B><U>Securities Act Regulations</U></B>&rdquo;), with the
Commission a registration statement on Form F-3, including (i) a base prospectus, relating to certain securities, including the Ordinary
Shares, Ordinary Shares represented by ADSs and rights exercisable for Ordinary Shares and/or Ordinary Shares represented by ADSs, to
be offered from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in
accordance with the provisions of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><U>Exchange Act</U></B>&rdquo;), and
the rules and regulations thereunder and (ii) a prospectus specifically relating to the Placement ADSs to be offered from time to time
pursuant to this Agreement (the &ldquo;<B><U>Placement ADSs Prospectus</U></B>. The Company will furnish to the Agent, for use by the
Agent, copies of the Placement ADSs Prospectus included in such registration statement at the time it becomes effective. Except where
the context otherwise requires, such registration statement(s), including all documents filed as part thereof or incorporated by reference
therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to
Rule 424(b) under the Securities Act Regulations or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities
Act Regulations, and any one or more additional effective registration statements on Form F-3 from time to time that will contain a prospectus
, if applicable (which shall be a Placement ADSs Prospectus), with respect to the Placement ADSs, is herein called the &ldquo;<B><U>Registration
Statement</U></B>.&rdquo; The Placement ADSs Prospectus, including all documents incorporated therein by reference, included in the Registration
Statement, as it may be supplemented, if necessary, by a prospectus supplement specifically related to the Placement ADSs to be offered
from time to time pursuant to this Agreement, in the form in which such prospectus and/or any prospectus supplement have most recently
been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act Regulations, together with the then issued
Issuer Free Writing Prospectus(es) (as defined below), is herein called the &ldquo;<B><U>Prospectus</U></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reference herein to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus shall be deemed to refer to and
include the documents, if any, incorporated by reference therein (the &ldquo;<B><U>Incorporated Documents</U></B>&rdquo;), including,
unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated Documents. Any reference herein
to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement, the
Prospectus or any Issuer Free Writing Prospectus shall be deemed to refer to and include the filing of any document under the Exchange
Act on or after the most-recent effective date of the Registration Statement, or the date of the Prospectus or such Issuer Free Writing
Prospectus, as the case may be, and incorporated therein by reference. For purposes of this Agreement, all references to the Registration
Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission
pursuant to its Electronic Data Gathering Analysis and Retrieval system, or if applicable, the Interactive Data Electronic Application
system when used by the Commission (collectively, &ldquo;<B><U>EDGAR</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Placements</U>.
Each time that the Company wishes to sell Placement ADSs hereunder (each, a &ldquo;<B><U>Placement</U></B>&rdquo;), it will notify the
Agent by email notice (or other method mutually agreed to by the parties) of the number of Placement ADSs to be issued, the time period
during which sales are requested to be made, any limitation on the number of Placement ADSs that may be sold in any one day and any minimum
price below which sales may not be made (a &ldquo;<B><U>Placement Notice</U></B>&rdquo;), the form of which is attached hereto as <U>Schedule
1</U>. The Placement Notice shall originate from any of the individuals from the Company set forth on <U>Schedule 3</U> (with a copy
to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the
Agent set forth on <U>Schedule 3</U>, as such <U>Schedule 3</U> may be amended from time to time. The Placement Notice shall be effective
unless and until (i) the Agent declines to accept the terms contained therein for any reason, in its sole discretion (which declination
must occur within two (2) Business Days (as defined below) of the receipt of the Placement Notice), (ii) the entire amount of the Placement
ADSs thereunder have been sold, (iii) the Company suspends or terminates the Placement Notice or (iv) this Agreement has been terminated
under the provisions of <U>Section 12</U>. The amount of any discount, commission or other compensation to be paid by the Company to
the Agent in connection with the sale of the Placement ADSs shall be calculated in accordance with the terms set forth in <U>Schedule
2</U>. It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with respect
to a Placement or any Placement ADSs unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline
such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event
of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Sale
of Placement ADSs by the Agent</U>. Subject to the provisions of <U>Section 5(a)</U>, the Agent, for the period specified in the Placement
Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and
federal laws, rules and regulations and the rules of the Nasdaq Capital Market (the &ldquo;<B><U>Exchange</U></B>&rdquo;), to sell the
Placement ADSs up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Agent will provide
written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading
Day on which it has made sales of Placement ADSs hereunder setting forth the number of Placement ADSs sold on such day, the compensation
payable by the Company to the Agent pursuant to <U>Section 2</U> with respect to such sales, and the Net Proceeds (as defined below)
payable to the Company, with an itemization of the deductions made by the Agent (as set forth in <U>Section 5(b)</U>) from the gross
proceeds that it receives from such sales. Subject to the terms of the Placement Notice, the Agent may sell Placement ADSs by any method
permitted by law deemed to be an &ldquo;at the market offering&rdquo; as defined in Rule 415(a)(4) of the Securities Act Regulations.
&ldquo;<B><U>Trading Day</U></B>&rdquo; means any day on which ADSs are traded on the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Suspension
of Sales</U>. The Company or the Agent may, upon notice to the other party in writing (including by email correspondence to each of the
individuals of the other party set forth on <U>Schedule 3</U>, if receipt of such correspondence is actually acknowledged by any of the
individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission
or email correspondence to each of the individuals of the other party set forth on <U>Schedule 3</U>), suspend any sale of Placement
ADSs (a &ldquo;<B><U>Suspension</U></B>&rdquo;); <I>provided</I>, <I>however</I>, that such Suspension shall not affect or impair any
party&rsquo;s obligations with respect to any Placement ADSs sold hereunder prior to the receipt of such notice. While a Suspension is
in effect any obligation under <U>Sections 7(l)</U>, <U>7(m)</U>, and <U>7(n)</U> with respect to the delivery of certificates, opinions,
or comfort letters to the Agent, shall be waived. Each of the parties agrees that no such notice under this <U>Section 4</U> shall be
effective against any other party unless it is made to one of the individuals named on <U>Schedule 3</U> hereto, as such Schedule may
be amended from time to time. Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession
of material non-public information, the Company and the Agent agree that (i) no sale of Placement ADSs will take place, (ii) the Company
shall not request the sale of any Placement ADSs, and (iii) the Agent shall not be obligated to sell or offer to sell any Placement ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Sale
and Delivery to the Agent; Settlement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Sale
of Placement ADSs</U><I>. </I>On the basis of the representations and warranties herein contained and subject to the terms and conditions
herein set forth, upon the Agent&rsquo;s acceptance of the terms of a Placement Notice, and unless the sale of the Placement ADSs described
therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Agent, for the period
specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices
and applicable law and regulations to sell such Placement ADSs up to the amount specified, and otherwise in accordance with the terms
of such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in
selling Placement ADSs, (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does
not sell Placement ADSs for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its
normal trading and sales practices and applicable law and regulations to sell such Placement ADSs as required under this Agreement and
(iii) the Agent shall be under no obligation to purchase Placement ADSs on a principal basis pursuant to this Agreement, except as otherwise
agreed by the Agent and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Settlement
of Placement ADSs</U><I>. </I>Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement ADSs will
occur on the second (2nd) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which
such sales are made (each, a &ldquo;<B><U>Settlement Date</U></B>&rdquo;). The Agent shall notify the Company of each sale of Placement
ADSs no later than the opening of the Trading Day immediately following the Trading Day on which it has made sales of Placement ADSs
hereunder. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement ADSs sold (the
&ldquo;<B><U>Net Proceeds</U></B>&rdquo;) will be equal to the aggregate sales price received by the Agent, after deduction for (i) the
Agent&rsquo;s commission, discount or other compensation for such sales payable by the Company pursuant to <U>Section 2</U> hereof, and
(ii) any transaction fees imposed by any Governmental Authority in respect of such sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Delivery of Placement ADSs</U>. On or before each Settlement Date, the Company will, or will cause its transfer agent to, issue and
register in the name of the Depositary the amount of Ordinary Shares to be represented by the Placement ADSs and deliver those Ordinary
Shares to the Depositary&rsquo;s custodian under the Deposit Agreement, and instruct the Depositary to deliver the Placement ADSs issuable
in respect of that deposit by crediting the Agent&rsquo;s or its designee&rsquo;s account (provided the Agent shall have given the Company
written notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit
and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all
cases shall be freely tradable, transferable, registered ADSs in good deliverable form. On each Settlement Date, the Agent will deliver
the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company
agrees that if the Company, its transfer agent (if applicable) or the Depositary, defaults in its obligation to deliver Placement ADSs
on a Settlement Date, through no fault of the Agent, the Company agrees that in addition to and in no way limiting the rights and obligations
set forth in <U>Section 10(a)</U> hereto, it will (i) hold the Agent harmless against any loss, claim, damage, or expense (including
reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or
its transfer agent (if applicable) and (ii) pay to the Agent any commission, discount, or other compensation to which it would otherwise
have been entitled absent such default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Denominations;
Registration</U><I>. </I>The Placement ADSs will be uncertificated and will be registered in the name of the nominee of The Depository
Trust Company (DTC).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Limitations
on Offering Size</U><I>. </I>Under no circumstances shall the Company cause or request the offer or sale of any Placement ADSs if, after
giving effect to the sale of such Placement ADSs, the aggregate gross sales proceeds of Placement ADSs sold pursuant to this Agreement
would exceed the lesser of (A) together with all sales of Placement ADSs under this Agreement, the Maximum Amount and (B) the amount
authorized from time to time to be issued and sold under this Agreement by the Company&rsquo;s board of directors, a duly authorized
committee thereof or a duly authorized executive committee, and notified to the Agent in writing. Under no circumstances shall the Company
cause or request the offer or sale of any Placement ADSs pursuant to this Agreement at a price lower than the minimum price authorized
from time to time by the Company&rsquo;s board of directors, a duly authorized committee thereof or a duly authorized executive committee.
Further, under no circumstances shall the Company cause or permit the aggregate offering amount of Placement ADSs sold pursuant to this
Agreement to exceed the Maximum Amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Representations
and Warranties of the Company</U>. The Company represents and warrants to, and agrees with the Agent that as of the date of this Agreement
and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a different time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company and the transactions contemplated by this Agreement meet the requirements for and comply with the applicable conditions set forth
in Form F-3 (including General Instructions I.A and I.B) under the Securities Act. The Registration Statement has been or will be filed
with the Commission and has been or will be declared effective by the Commission under the Securities Act prior to the issuance of any
Placement Notices by the Company. As of each Applicable Time, the Registration Statement is effective. The Prospectus will name the Agent
as the agent in the section entitled &ldquo;Plan of Distribution.&rdquo; The Company has not received, and has no notice of, any order
of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that
purpose. The Registration Statement and the offer and sale of Placement ADSs as contemplated hereby meet the requirements of Rule 415
under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents
that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement
have been so described or filed. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all
documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered,
or are available through EDGAR, to the Agent and its counsel. The Company has not distributed and, prior to the later to occur of each
Settlement Date and completion of the distribution of the Placement ADSs, will not distribute any offering material in connection with
the offering or sale of the Placement ADSs other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus
to which the Agent has consented, provided that any such consent shall not be unreasonably withheld, conditioned or delayed. The ADSs
are registered pursuant to Section 12(b) of the Exchange Act and are currently listed on the Exchange under the trading symbol &ldquo;GNTA.&rdquo;
The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the ADSs under the Exchange
Act, delisting the ADSs from the Exchange, nor has the Company received any notification that the Commission or the Exchange is contemplating
terminating such registration or listing. To the Company&rsquo;s knowledge, it is in compliance with all applicable listing requirements
of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Registration Statement, when it became or becomes effective, and the Prospectus, and any amendment or supplement thereto, on the date
of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities
Act. At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with
the requirements of the Securities Act. The Registration Statement, when it became or becomes effective, did not, and will not, contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. The Prospectus and any amendment and supplement thereto, on the date thereof and at each Applicable Time (defined
below), did not or will not include an untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in the Prospectus
did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue
statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements
in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall not apply to statements
in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by the Agent
in writing specifically for use in the preparation thereof, it being understood and agreed that the only such information furnished by
the Agent to the Company consists of &ldquo;Agent Information&rdquo; as defined below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Any
Issuer Free Writing Prospectus or any amendment or supplement thereto, and the documents incorporated by reference in the Registration
Statement, the Prospectus or any amendment or supplement thereto, when such documents were or are filed with the Commission under the
Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform
in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) A
registration statement on Form F-6 (File No. 333-261223) covering the registration of the Placement ADSs has been filed with the Commission.
Such registration statement in the form heretofore delivered to the Agent has been declared effective by the Commission in such form.
No other document with respect to such registration statement has heretofore been filed with the Commission. No stop order suspending
the effectiveness of such registration statement has been issued and, to the Company&rsquo;s knowledge, no proceeding for that purpose
has been initiated or threatened by the Commission (the various parts of such registration statement, including all exhibits thereto,
each as amended at the time such part of the registration statement became effective, being hereinafter referred to as the &ldquo;<B><U>ADS
Registration Statement</U></B>&rdquo;). The ADS Registration Statement when it became effective conformed, and any further amendments
thereto will conform, in all material respects to the requirements of the Securities Act and the rules and regulations of the Commission
thereunder, and did not, as of the applicable effective date, contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Company has been duly established and is validly existing as a joint stock company (<I>societ&agrave; per azion&igrave;</I>) in good
standing under the laws of the Republic of Italy with a registered office at Via Olgettina No. 58, 20132 Milan, Italy, Fiscal Code and
number of registration in the Companies Register of Milan No. 08738490963. The Company does not own an interest in any corporation, partnership,
joint venture, limited liability company, trust or other business entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Upon
issuance by the Depositary of Placement ADSs against deposit of the underlying Ordinary Shares in accordance with the provisions of the
Deposit Agreement, such Placement ADSs will be duly and validly issued and persons in whose names the Placement ADSs are registered will
be entitled to the rights specified in the Placement ADSs and in the Deposit Agreement; and upon the sale and delivery to the purchasers
of the Placement ADSs, and payment therefor, pursuant to this Agreement, the purchasers will acquire good, marketable and valid title
to such Placement ADSs, free and clear of all pledges, liens, security interests, charges, claims or encumbrances of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Provided
that (i) the Agent is not resident in Italy for tax purposes and (ii) the Agent is a resident of a jurisdiction for the purposes of a
double tax treaty between Italy and the jurisdiction, is entitled to the benefits of the treaty and does not, and is not deemed to, carry
on business through a permanent establishment in Italy, no stamp, registration, issuance, transfer taxes or other similar taxes, duties,
fees or charges (&ldquo;<B><U>Transfer Taxes</U></B>&rdquo;) are payable by or on behalf of the Agent in connection with (A) the issuance
of the Ordinary Shares underlying the Placement ADSs and the delivery of the Placement ADSs in the manner contemplated by this Agreement,
(B) the deposit with the Depositary of the Ordinary Shares underlying the Placement ADSs against issuance of the Placement ADSs or (C)
the sale and delivery by the Agent of the Placement ADSs as contemplated herein. For the avoidance of doubt, income taxes, withholding
taxes, capital gains taxes and taxes on dividends shall not be considered &ldquo;Transfer Taxes.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) At
the time the Registration Statement was or will be originally declared effective, and at the time the Company&rsquo;s most recent Annual
Report on Form 20-F was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form
F-3 under the Securities Act, including, but not limited to, General Instruction I.B.1 of Form F-3. The aggregate market value of the
outstanding voting and non-voting common equity (as defined in Securities Act Rule 405) of the Company held by persons other than affiliates
of the Company (pursuant to Securities Act Rule 144, those that directly, or indirectly through one or more intermediaries, control,
or are controlled by, or are under common control with, the Company) (the &ldquo;<B><U>Non-Affiliate Shares</U></B>&rdquo;), was greater
than $75.0 million (calculated by multiplying (x) the highest price at which the ADSs of the Company closed on the Exchange within 60
days of the date of this Agreement times (y) the number of Non-Affiliate Shares). The Company is not a shell company (as defined in Rule
405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell
company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.5 of Form F-3) with the Commission
at least 12 calendar months previously reflecting its status as an entity that is not a shell company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Except
as described in the Prospectus, all dividends and other distributions declared and payable on the Ordinary Shares may under current Italian
law and regulations be paid to the Depositary and to the holders of Ordinary Shares or ADSs, as the case may be, in Euros and may be
converted into foreign currency that may be transferred out of Italy in accordance with the Deposit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Neither
the SEC nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any order preventing or suspending the use of
the Prospectus or has instituted or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such
an order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) (i)
At the time of filing of the Registration Statement and (ii) as of the Applicable Time (with such date being used as the determination
date for purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule 405), without taking
account of any determination by the SEC pursuant to Rule 405 that it is not necessary that the Company be considered an Ineligible Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) From
the time of filing of the Registration Statement with the SEC through the date hereof, the Company has been and is an &ldquo;emerging
growth company,&rdquo; as defined in Section 2(a) of the Securities Act (an &ldquo;<B><U>Emerging Growth Company</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) No
Issuer Free Writing Prospectus includes any information that conflicts with the information contained in the Registration Statement.
The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity
with written information furnished to the Company by or on behalf of the Agent specifically for use therein, it being understood and
agreed that the only such information furnished by or on behalf of the Agent consists of Agent Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) This
Agreement has been duly authorized, executed and delivered by the Company. The execution, delivery and performance by the Company of
this Agreement does not violate its Articles of Association (i.e., <I>atto costitutivo</I>), its By-laws (i.e., <I>statuto</I>) or any
law, rule, regulation, judgment, decree or order of any court applicable to it. No consents or approvals and no licenses or orders from,
or any registration or filings with, any Republic of Italy court, government department or other regulatory body (with the exception
of all filing requirements with the Companies Register of Como which, to our knowledge, have been fully complied with other than filings
which are required to and will be made post-closing in connection with the transactions contemplated herein) are required for the due
authorization, execution, delivery or performance by the Company of this Agreement or the consummation of the transactions contemplated
by this Agreement, except such as have been obtained under the Securities Act and such as may be required by FINRA and under state securities,
Blue Sky or foreign laws in connection with the placement and distribution of the Placement ADSs by the Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) The
Company and each of its Subsidiaries (as defined below) have been duly incorporated and are validly existing as a corporation in good
standing under the laws of the jurisdiction in which it is incorporated with full corporate power and authority to own or lease, as the
case may be, and to operate its properties and conduct its business as described in the Prospectus, and is duly qualified to do business
as a foreign corporation and is in good standing under the laws of each jurisdiction which requires such qualification, except in each
case where such failure would not reasonably be expected to have a Material Adverse Effect (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) The
subsidiaries set forth on <U>Schedule 4</U> (collectively, the &ldquo;<B><U>Subsidiaries</U></B>&rdquo;), are the Company&rsquo;s only
significant subsidiaries (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission). No Subsidiary is currently
prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such Subsidiary&rsquo;s
capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from transferring any of such
Subsidiary&rsquo;s property or assets to the Company or any other Subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) There
is no franchise, contract or other document of a character required to be described in the Registration Statement or Prospectus, or to
be filed as an exhibit thereto, which is not described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) The
Company has full legal capacity and power to enter into this Agreement and the Deposit Agreement, and each of this Agreement and the
Deposit Agreement has been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) The
Company is not and, after giving effect to the offering and sale of the Placement ADSs and the application of the proceeds thereof as
described in the Registration Statement and the Prospectus, will not be an &ldquo;investment company&rdquo; as defined in the Investment
Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) No
consent, approval, authorization, filing with or order of any court or governmental agency or body is required in connection with the
transactions contemplated herein or in the Deposit Agreement, except such as have been obtained under the Securities Act and such as
may be required under the listing rules of the Exchange, applicable rules of the Financial Industry Regulatory Authority, Inc. and under
the applicable state and foreign securities laws of any jurisdiction in connection with the placement and distribution of the Placement
ADSs by the Agent in the manner contemplated herein and in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) Neither
the sale of the Placement ADSs nor the consummation of any other of the transactions herein contemplated nor the fulfillment of the terms
hereof or of the Deposit Agreement will conflict with, result in a breach or violation of, or imposition of any lien, charge or encumbrance
upon any property or assets of the Company pursuant to, (i) the constitution of the Company, (ii) the terms of any indenture, contract,
lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which
the Company is a party or bound or to which its property is subject, or (iii) any statute, law, rule, regulation, judgment, order or
decree applicable to the Company of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority
having jurisdiction over the Company or any of its properties, except in the case of clause (ii) and (iii) above, for any such conflict,
breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) No
holders of securities of the Company have rights to the registration of such securities under the Registration Statement or the issuance
of the Placement ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) The
consolidated historical financial statements and schedules of the Company included in the Prospectus and the Registration Statement present
fairly in all material respects the financial condition, results of operations and cash flows of the Company as of the dates and for
the periods indicated, comply as to form in all material respects with the applicable accounting requirements of the Securities Act and
have been prepared in accordance with accounting principles generally accepted in the United States (&ldquo;<B>U.S. GAAP</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) No
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company,
any Subsidiary or its property is pending or, to the knowledge of the Company, threatened that (i) would reasonably be expected to have
a material adverse effect on the performance of this Agreement or the consummation of any of the transactions contemplated hereby or
(ii) could reasonably be expected to have a material adverse effect on the condition (financial or otherwise), prospects, earnings, business
or properties of the Company, whether or not arising from transactions in the ordinary course of business (a &ldquo;<B><U>Material Adverse
Effect</U></B>&rdquo;), except as set forth in or contemplated in the Prospectus (exclusive of any amendment or supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) The
Company leases all such real properties as are reasonably necessary to the conduct of its operations as presently conducted. The Company
does not own any real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) Neither
the Company nor any Subsidiary is in violation or default of (i) any provision of its constitution, (ii) the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument
to which it is a party or bound or to which its property is subject, or (iii) any statute, law, rule, regulation, judgment, order or
decree of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over
the Company, its Subsidiaries or any of its properties, as applicable, except in case of clauses (ii) and (iii), for any such violation
or default as would not reasonably expected, individually or in the aggregate, to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
Dannible &amp; McKee LLP and Mayer Hoffman McCann P.C., who have issued their respective audit reports with respect to the consolidated
financial statements of the Company and its affiliates included in the Prospectus, are, or were at the time of issuance of their respective
audit reports, each an independent public accountant with respect to the Company and its affiliates within the meaning of the Securities
Act and the applicable published rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) The
Company and each of its Subsidiaries has filed all tax returns that are required to be filed or has requested extensions thereof, except
in any case in which the failure so to file would not have a Material Adverse Effect, except as set forth in or contemplated in the Prospectus
(exclusive of any amendment or supplement thereto) and has paid all taxes required to be paid by it and any other assessment, fine or
penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty
that is currently being contested in good faith or that would not have a Material Adverse Effect, except as set forth in or contemplated
in the Prospectus (exclusive of any amendment or supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) With
respect to the Company and its Subsidiaries, except as set forth in or contemplated in the Prospectus (exclusive of any amendment or
supplement thereto): (i) no labor problem, dispute, slowdown, work stoppage or disturbance involving any employees of it exists or, to
the Company&rsquo;s knowledge is threatened or imminent, and it is not aware of any existing or imminent labor problem, dispute, slowdown,
work stoppage or disturbance by the employees of any of its or its principal suppliers, contractors or customers, that could have a Material
Adverse Effect; and (ii) compliance subsists for all its obligations under employment contracts, industrial agreements and awards and
with all codes of conduct and practice relevant to conditions of service and to the relations between it and the employees employed by
it, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The term &ldquo;taxes&rdquo;
mean all net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, withholding,
payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees,
assessments, or charges of any kind whatever imposed by the U.S., the European Union, Italy or any Italian subdivision or local authority,
together with any interest and any penalties, additions to tax, or additional amounts with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) The
Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as the Company and each of its Subsidiaries reasonably believes are prudent and customary in the business in which it
is engaged; all policies of insurance insuring the Company, each Subsidiaries or its respective business, assets, employees, officers
and directors are in full force and effect; each of the Company and its Subsidiaries is in compliance with the terms of such policies
and instruments in all material respects; and there are no material claims by the Company or its Subsidiaries under any such policy or
instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; neither the Company
nor any Subsidiary has been refused any insurance coverage sought or applied for; and neither the Company nor any Subsidiary has reason
to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not reasonably be expected to have a Material
Adverse Effect, except as set forth in or contemplated in the Prospectus (exclusive of any amendment or supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) The
Company and its Subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued by, and have made
all declarations and filings with, all applicable federal, state, local or foreign governmental or other authorities that are necessary
to conduct its businesses (&ldquo;<B><U>Permits</U></B>&rdquo;), except where the failure to possess such Permit would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company or any Subsidiary is in violation
of, or in default under, any of the Permits nor has received any revocation, suspension or modification of any such Permit which, singly
or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse
Effect, except as set forth in or contemplated in the Prospectus (exclusive of any amendment or supplement thereto). Neither the Company
nor any Subsidiary has received any notice that any such Permit will not be renewed in the ordinary course, and, except as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, all Permits are valid and in full force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) The
Company maintains a system of internal accounting controls designed to provide reasonable assurance that (i) transactions are executed
in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only in
accordance with management&rsquo;s general or specific authorization; and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as disclosed in the
Prospectus, the Company&rsquo;s internal controls over financial reporting are effective and the Company is not aware of any material
weakness in its internal controls over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) The
Company maintains &ldquo;disclosure controls and procedures&rdquo; (as such term is defined in Rule 13a-15(e) under the Exchange Act
and the rules and regulations promulgated thereunder); such disclosure controls and procedures have been designed to ensure that information
required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the Commission&rsquo;s rules and forms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh) Each
of the Company and its Subsidiaries is (i) in compliance with any and all applicable foreign, federal, state and local laws and regulations
relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants
(collectively, &ldquo;<B><U>Environmental Laws</U></B>&rdquo;), (ii) has received and is in compliance with all permits, licenses or
other approvals required of them under applicable Environmental Laws to conduct its business and (iii) has not received notice of any
actual or potential liability under any environmental law, except in each case where such non-compliance with Environmental Laws, failure
to receive required permits, licenses or other approvals, or liability would not, individually or in the aggregate, have a Material Adverse
Effect, except as set forth in or contemplated in the Prospectus (exclusive of any amendment or supplement thereto). Except as set forth
in the Prospectus, neither the Company not any Subsidiary has been named as a &ldquo;potentially responsible party&rdquo; under the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) There
is and has been no failure on the part of the Company and any of the Company&rsquo;s directors or officers, in their capacities as such,
to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated in connection thereunder,
that are then in effect and with which the Company is required to comply as of the effectiveness of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj) Neither
the Company nor any Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person
acting on behalf of the Company or any Subsidiary (i) has used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expense relating to political activity; (ii) has made any direct or indirect unlawful payment to any foreign or domestic
government official or employee (including of any government owned or controlled entity, or any person acting in an official capacity
for or on behalf of any of the foregoing) from corporate funds; or (iii) has made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment, or (iv) is aware of or has taken any action, directly or indirectly, that could result in a violation or a
sanction for violation by such persons of the U.S. Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act 2010, OECD Convention
on Combating Bribery of Foreign Public Officials in International Business Transactions, or any other applicable anti-bribery or anti-corruption
law, each as may be amended, or the rules or regulations thereunder (collectively, the &ldquo;<B><U>Anti-Corruption Laws</U></B>&rdquo;);
and each of the Company and its Subsidiaries has instituted and maintains policies and procedures to ensure compliance with the Anti-Corruption
Laws. No part of the proceeds of the offering will be used, directly or indirectly, in violation of the Anti-Corruption Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk) The
operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements and the money laundering statutes of all jurisdictions where the Company or its Subsidiaries conduct business,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by
any governmental agency (collectively, the &ldquo;<B><U>Money Laundering Laws</U></B>&rdquo;) and no action, suit or proceeding by or
before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to
the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll) Neither
the Company nor any of its Subsidiaries (collectively, the &ldquo;<B><U>Entity</U></B>&rdquo;) nor, to the knowledge of the Company,
any director, officer, agent, employee or affiliate of the Entity (i) is, or is controlled or 50% or more owned in the aggregate by or
is acting on behalf of, one or more individuals or entities that are currently the subject of any sanctions administered or enforced
by the United States (including any administered or enforced by the Office of Foreign Assets Control of the U.S. Department of the Treasury,
the U.S. Department of State or the Bureau of Industry and Security of the U.S. Department of Commerce), the United Nations Security
Council, the European Union, a member state of the European Union (including sanctions administered or enforced by His Majesty&rsquo;s
Treasury of the United Kingdom and the Italian Department of the Treasury) or other relevant sanctions authority (collectively, &ldquo;<B><U>Sanctions</U></B>&rdquo;
and such persons, &ldquo;<B><U>Sanctioned Persons</U></B>&rdquo; and each such person, a &ldquo;<B><U>Sanctioned Person</U></B>&rdquo;),
(ii) is located, organized or resident in a country or territory that is, or whose government is, the subject of Sanctions that broadly
prohibit dealings with that country or territory (currently, the Crimea region, Cuba, Iran, North Korea, and Syria) (collectively, &ldquo;<B><U>Sanctioned
Countries</U></B>&rdquo; and each, a &ldquo;<B><U>Sanctioned Country</U></B>&rdquo;) or (iii) will, directly or indirectly, use the proceeds
of this offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other individual
or entity in any manner that would result in a violation of any Sanctions by, or could result in the imposition of Sanctions against,
any individual or entity (including any individual or entity participating in the offering, whether as underwriter, advisor, investor
or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm) The
Entity has not engaged in any dealings or transactions with or for the benefit of a Sanctioned Person, or with or in a Sanctioned Country,
in the preceding three years, nor does the Entity have any plans to engage in dealings or transactions with or for the benefit of a Sanctioned
Person, or with or in a Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn) Except
as would not reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries own, possess, license or
has other rights to use, on reasonable terms, all patents, patent applications, trade and service marks, trade and service mark registrations,
trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property (collectively, the
&ldquo;<B><U>Intellectual Property</U></B>&rdquo;) necessary for the conduct of their respective businesses as now conducted or as proposed
in Prospectus to be conducted. Except as set forth in the Prospectus or as would not reasonably be expected to result in a Material Adverse
Effect, (a) there are no rights of third parties to any such Intellectual Property; (b) to the Company&rsquo;s knowledge, there is no
material infringement by third parties of any such Intellectual Property; (c) there is no pending or, to the knowledge of the Company,
threatened action, suit, proceeding or claim by others challenging rights of the Company and its Subsidiaries in or to any such Intellectual
Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (d) there is no pending or,
to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such
Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (e) there is no
pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or any Subsidiary
infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others, and the Company
is unaware of any other fact which would form a reasonable basis for any such claim; (f) to the Company&rsquo;s knowledge, there is no
prior art of which the Company or any Subsidiary is aware that may render any U.S. patent held by the Company or any Subsidiary invalid
or any U.S. patent application held by the Company or any Subsidiary un-patentable which has not been disclosed to the U.S. Patent and
Trademark Office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) Except
as disclosed in the Registration Statement and the Prospectus, the Company (i) does not have any material lending or other relationship
with any bank or lending affiliate of Cantor Fitzgerald &amp; Co. and (ii) does not intend to use any of the proceeds from the sale of
the Placement ADSs hereunder to repay any outstanding debt owed to any affiliate of Cantor Fitzgerald &amp; Co.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp) Neither
the Company, its Subsidiaries nor any of its properties or assets has any immunity from the jurisdiction of any court or from any legal
process (whether through service or notice, attachment prior to judgment, attachment in aid of execution or otherwise) under the laws
of Italy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq) Each
of the Company and its Subsidiaries are, and at all times have been, in material compliance with all applicable Health Care Laws. For
purposes of this Agreement, &ldquo;<B><U>Health Care Laws</U></B>&rdquo; means: (i) the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
Section 301 et seq.), the Public Health Service Act (42 U.S.C. Section 201 et seq.), and the regulations promulgated thereunder; (ii)
all applicable federal, state, local and foreign health care fraud and abuse laws, including, without limitation, the Anti-Kickback Statute
(42 U.S.C. Section 1320a-7b(b)), the Civil False Claims Act (31 U.S.C. Section 3729 et seq.), the criminal false statements law (42 U.S.C.
Section 1320a-7b(a)), 18 U.S.C. Sections 286 and 287, the health care fraud criminal provisions under the U.S. Health Insurance Portability
and Accountability Act of 1996 (&ldquo;<B>HIPAA</B>&rdquo;) (42 U.S.C. Section 1320d et seq.), the Stark Law (42 U.S.C. Section 1395nn),
the civil monetary penalties law (42 U.S.C. Section 1320a-7a), the exclusion law (42 U.S.C. Section 1320a-7), the Physician Payments
Sunshine Act (42 U.S.C. Section 1320-7h), and applicable laws governing government funded or sponsored healthcare programs; (iii) HIPAA,
as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.); (iv) the Patient
Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010; (v) licensure, quality,
safety and accreditation requirements under applicable federal, state, local or foreign laws or regulatory bodies; (vi) all other local,
state, federal, national, supranational and foreign laws, relating to the clinical drug development activities conducted by the Company
and its Subsidiaries, and (vii) the directives and regulations promulgated pursuant to such statutes and any state or non-U.S. counterpart
thereof. Neither the Company nor any Subsidiary has received any United States Food and Drug Administration (the &ldquo;<B><U>FDA</U></B>&rdquo;)
Form 483, notice of adverse finding, warning letter, untitled letter or notice of any claim, action, suit, proceeding, hearing, enforcement,
investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging
that any product operation or activity is in material violation of any Health Care Laws nor, to the Company&rsquo;s knowledge, is any
such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened. The Company and its
Subsidiaries have filed, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and
supplements or amendments as required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records,
claims, submissions and supplements or amendments were complete and accurate on the date filed or were corrected or supplemented by a
subsequent submission, except as would not cause a Material Adverse Effect. Neither the Company nor its Subsidiaries are a party to any
corporate integrity agreement, monitoring agreement, consent decree, settlement order, or similar agreement with or imposed by any governmental
or regulatory authority. Additionally, neither the Company, its Subsidiaries nor any of its employees, officers, directors or, to the
Company&rsquo;s knowledge, agents, has been excluded, suspended or debarred from participation in any U.S. federal health care program
or human clinical research or, to Company&rsquo;s knowledge, is subject to a governmental inquiry, investigation, proceeding, or other
similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr) The
Company&rsquo;s and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &ldquo;<B><U>IT Systems and Data</U></B>&rdquo;) are adequate for, and operate and
perform as required in connection with the operation of the business of the Company and its Subsidiaries as currently conducted, free
and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants, except as would not reasonably be expected
to result in a Material Adverse Effect. The Company and its Subsidiaries have implemented and maintain commercially reasonable physical,
technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material confidential information
and the integrity, continuous operation, redundancy and security of all IT Systems and Data, including &ldquo;Personal Data,&rdquo; used
in connection with its business. &ldquo;<B>Personal Data</B>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone
number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s license number, passport number,
credit card number, bank information, or customer or account number; (ii) any information which would qualify as &ldquo;personally identifying
information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by the European Union
General Data Protection Regulation (EU 2016/679); (iv) any information which would qualify as &ldquo;protected health information&rdquo;
under HIPAA; and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits
the collection or analysis of any data related to an identified person&rsquo;s health or sexual orientation. There have been no breaches,
violations, outages or unauthorized uses of or accesses to Personal Data, except for those that have been remedied without material cost
or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same.
The Company and its Subsidiaries have been and are presently in material compliance with all applicable laws, directives, or statutes
and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data, including Personal Data and to the protection
of such IT Systems and Data and Personal Data from unauthorized use, access, misappropriation or modification, except as would not reasonably
be expected to result in a Material Adverse Effect. There has been no security breach or other material compromise of or relating to
any of the Company&rsquo;s or its Subsidiaries&rsquo; IT Systems and Data, and neither the Company nor its Subsidiaries have been notified
of, or have any knowledge of, any event or condition that would reasonably be expected to result in, any security breach or other material
compromise to their respective IT Systems and Data, except for any breaches or compromises that would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss) The
Company and its Subsidiaries are, and have at all times been, in material compliance with all applicable data privacy and security laws
and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations regarding
the privacy and security of IT Systems and Data and Personal Data (collectively, the &ldquo;<B><U>Privacy Laws</U></B>&rdquo;), except
as would not, individually or in the aggregate, result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the
Company and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance in all material
respects with its policies and contractual obligations governing the collection, storage, use, disclosure, handling and analysis of Personal
Data. The Company and its Subsidiaries have at all times made all material disclosures to users or customers required by the Privacy
Laws, except as would not, individually or in the aggregate, result in a Material Adverse Effect. The Company further certifies that
neither the Company nor any Subsidiary: (i) has received notice of, any actual or potential liability under or relating to, or actual
or potential violation of, any of the Privacy Laws, and has knowledge of any event or condition that would reasonably be expected to
result in, any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other
corrective action pursuant to any Privacy Laws; or (iii) is a party to any order, decree, or agreement that imposes any obligation or
liability under any Privacy Law, except with respect to subsection (i), (ii) and (iii) as would not, individually or in the aggregate,
result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt) The
preclinical studies and clinical trials that are described in the Registration Statement or the Prospectus (collectively, &ldquo;<B><U>Studies</U></B>&rdquo;)
were conducted by or, to the knowledge of the Company, on behalf of the Company and its Subsidiaries were and, if still ongoing, are
being conducted in all material respects in accordance with the protocols, procedures and controls designed for such Studies and pursuant
to, where applicable, accepted professional scientific standards; the descriptions of the results of such studies contained in the Registration
Statement or the Prospectus are accurate and complete and fairly present the data derived from such Studies, in each case in all material
respects, and the Company has no knowledge of any other Studies the results of which are materially inconsistent with, or otherwise call
into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its Subsidiaries
have made all such filings and obtained all such approvals as may be required by the FDA or any committee thereof, the European Medicines
Agency (&ldquo;<B><U>EMA</U></B>&rdquo;) or any committee thereof, or from any other U.S. or foreign government or drug or medical device
regulatory agency, or health care facility Institutional Review Board (collectively, the &ldquo;<B><U>Regulatory Agencies</U></B>&rdquo;),
except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect; neither the Company
nor its Subsidiaries have received any notice from, or correspondence from, any Regulatory Agency requiring the termination, suspension
or material modification of any Studies conducted by or on behalf of the Company or its Subsidiaries; and the Company and its Subsidiaries
are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu) The
Company and its Subsidiaries have generally enjoyed a satisfactory employer-employee relationship with their respective employees and
are in compliance in all material respects with all collective and individual contracts with or involving their respective employees
and with all European Union laws applicable to Italian companies and Italian national, and local laws and regulations respecting the
employment of their respective employees and employment practices, terms and conditions of employment and wages and hours relating thereto
and, to the knowledge of the Company, there is no dispute with any employee existing or threatened, which dispute would have a Material
Adverse Effect. There are no pending investigations involving the Company, its Subsidiaries, their respective employees or any collective
bargaining organization by any other governmental agency responsible for the enforcement of European Union, Italian national, and local
laws and regulations or collective bargaining agreements. There is no unfair labor practice charge or complaint against the Company,
any Subsidiary or any officer of the Company or any Subsidiary, pending before any regulatory authority, or any strike, picketing, boycott,
dispute, slowdown or stoppage pending or threatened against or involving the Company, any Subsidiary or any officer of the Company or
any Subsidiary, or any predecessor entity, and none has ever occurred. No question concerning representation exists respecting the employees
of the Company or any Subsidiary and no collective bargaining agreement or modification thereof is currently being negotiated by the
Company or any Subsidiary. No grievance or arbitration proceeding is pending under any expired or existing collective bargaining agreements
of the Company or any Subsidiary, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv) All
translations of each agreement, document or other writing provided by the Company for use by the Representatives or for use as exhibits
to the Registration Statement which the Company reasonably believes (i) have been provided by parties whom the Company believes are reliable
in their capacity to fairly and accurately translate such documents, and (ii) fairly and accurately represent the provisions of the original
versions of the documents which they represent. To the extent such translations were provided by others, nothing has come to attention
of officers of the Company familiar with such documents that causes them to believe the translations provided are inaccurate in any material
respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww) The
choice of laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of Italy and will
be honored by the courts of Italy, subject to the restrictions described under the caption &ldquo;Enforcement of Civil Liabilities&rdquo;
in the Registration Statement and the Prospectus. Any final judgment for a fixed or determined sum of money rendered by any U.S. federal
or New York state court located in the State of New York having jurisdiction under its own laws in respect of any suit, action or proceeding
against the Company based upon this Agreement would be recognized by the courts of Italy, without reconsideration or reexamination of
the merits, subject to the restrictions described under the caption &ldquo;Enforcement of Civil Liabilities&rdquo; in the Registration
Statement and the Prospectus, and the applicable bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors
and secured parties in general.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx) Except
as provided by laws or statutes generally applicable to transactions of the type described in this Agreement, neither the Company, its
Subsidiaries nor any of their respective properties, assets or revenues has any right of immunity under Italian, New York or United States
law, from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off
or counterclaim, from the jurisdiction of any Italian, New York or United States federal court, from service of process, attachment upon
or prior judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding
for the giving of any relief or for the enforcement of a judgment, in any such court, with respect to its obligations, liabilities or
any other matter under or arising out of or in connection with this Agreement. To the extent that the Company, its Subsidiaries or any
of their respective properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such
court in which proceedings may at any time be commenced, the Company and its Subsidiaries waive or will waive such right to the extent
permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)
The Company is a &ldquo;foreign private issuer&rdquo; as defined in Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)
The Company is not a party to any agreement with an agent or underwriter for any other &ldquo;at the market&rdquo; or continuous
equity transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)
The Company acknowledges and agrees that the Agent has informed the Company that the Agent may, to the extent permitted under the
Securities Act and the Exchange Act, purchase and sell Ordinary Shares or ADSs for its own account while this Agreement is in
effect, provided, that (i) no such purchase or sales shall take place while a Placement Notice is in effect (except to the extent
the Agent may engage in sales of Placement ADSs purchased or deemed purchased from the Company as a &ldquo;riskless principal&rdquo;
or in a similar capacity) and (ii) the Company shall not be deemed to have authorized or consented to any such purchases or sales by
the Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate signed by an officer of the Company and delivered to the Agent or to counsel for the Agent pursuant to or in connection with
this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agent as to the matters set
forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>Covenants
of the Company</U>. The Company covenants and agrees with the Agent that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Registration
Statement Amendments</U>. After the date of this Agreement and during any period in which a Prospectus relating to any Placement ADSs
is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied
pursuant to Rule 172 under the Securities Act or similar rule), (i) the Company will notify the Agent promptly of the time when any subsequent
amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has
become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment
or supplement to the Registration Statement or Prospectus or for additional information, (ii) the Company will prepare and file with
the Commission, promptly upon the Agent&rsquo;s request, any amendments or supplements to the Registration Statement or Prospectus that,
in the Agent&rsquo;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement ADSs by the
Agent (<I>provided</I>, <I>however</I>, that the failure of the Agent to make such request shall not relieve the Company of any obligation
or liability hereunder, or affect the Agent&rsquo;s right to rely on the representations and warranties made by the Company in this Agreement
and <I>provided</I>, <I>further</I>, that the only remedy the Agent shall have with respect to the failure to make such filing shall
be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the Company will not file any amendment
or supplement to the Registration Statement or Prospectus relating to the Placement ADSs unless a copy thereof has been submitted to
Agent within a reasonable period of time before the filing and the Agent has not objected thereto (<I>provided</I>, <I>however</I>, that
the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the
Agent&rsquo;s right to rely on the representations and warranties made by the Company in this Agreement and <I>provided</I>, <I>further</I>,
that the only remedy the Agent shall have with respect to the failure by the Company to obtain such consent shall be to cease making
sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any document that upon
filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available
via EDGAR; and (iv) the Company will cause each amendment or supplement to the Prospectus relating to the Placement ADSs to be filed
with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document
to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period
prescribed (the determination to file or not file any amendment or supplement with the Commission under this <U>Section 7(a)</U>, based
on the Company&rsquo;s reasonable opinion or reasonable objections, shall be made exclusively by the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Notice
of Commission Stop Orders</U>. The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of
the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of
the suspension of the qualification of the Placement ADSs for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop
order or to obtain its withdrawal if such a stop order should be issued. The Company will advise the Agent promptly after it receives
any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any
Issuer Free Writing Prospectus or for additional information related to the offering of the Placement ADSs or for additional information
related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Delivery
of Prospectus; Subsequent Changes</U>. During any period in which a Prospectus relating to the Placement ADSs is required to be delivered
by the Agent under the Securities Act with respect to the offer and sale of the Placement ADSs, (including in circumstances where such
requirement may be satisfied pursuant to Rule 172 under the Securities Act or similar rule), the Company will comply in all material
respects with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective
due dates (taking into account any extensions available under the Exchange Act) all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under
the Exchange Act. If the Company has omitted any information from the Registration Statement pursuant to Rule 430B under the Securities
Act, it will use its best efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said
Rule 430B and to notify the Agent promptly of all such filings relating to the Placement ADSs if not available on EDGAR. If during such
period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not
misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the
Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement ADSs during such period and the Company
will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement
or omission or effect such compliance; <I>provided, however</I>, that the Company may delay such amendment or supplement if, in the reasonable
judgment of the Company, it is in the best interest of the Company to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Listing
of Placement ADSs</U>. The Company will use its reasonable best efforts to maintain the listing of its ADSs on the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Delivery
of Registration Statement and Prospectus</U>. The Company will furnish to the Agent and its counsel (at the expense of the Company) copies
of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements
to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the
Placement ADSs is required to be delivered under the Securities Act (including all documents filed with the Commission during such period
that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the
Agent may from time to time reasonably request and, at the Agent&rsquo;s request, will also furnish copies of the Prospectus to each
exchange or market on which sales of the Placement ADSs may be made; <I>provided</I>, <I>however</I>, that the Company shall not be required
to furnish any document (other than the Prospectus) to the Agent to the extent such document is available on EDGAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Earning
Statement</U>. The Company will make generally available to its security holders as soon as practicable, but in any event not later than
15 months after the end of the Company&rsquo;s current fiscal quarter, an earning statement covering a 12-month period that satisfies
the provisions of Section 11(a) and Rule 158 of the Securities Act<I>; provided</I> that the Company will be deemed to have furnished
such statement to its security holders to the extent it is available on EDGAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Use
of Proceeds</U>. The Company will use the Net Proceeds as described in the Prospectus in the section entitled &ldquo;Use of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Notice
of Other Sales</U>. Without the prior written consent of the Agent, the Company will not, directly or indirectly, offer to sell, sell,
contract to sell, grant any option to sell or otherwise dispose of any Ordinary Shares or ADSs (other than the Placement ADSs offered
pursuant to this Agreement) or securities convertible into or exchangeable for Ordinary Shares or ADSs, warrants or any rights to purchase
or acquire, Ordinary Shares or ADSs during the period beginning on the fifth (5<SUP>th</SUP>) Trading Day immediately prior to the date
on which any Placement Notice is delivered to the Agent hereunder and ending on the fifth (5<SUP>th</SUP>) Trading Day immediately following
the final Settlement Date with respect to Placement ADSs sold pursuant to such Placement Notice (or, if the Placement Notice has been
terminated or suspended prior to the sale of all Placement ADSs covered by a Placement Notice, the date of such suspension or termination);
and will not directly or indirectly in any other &ldquo;at the market&rdquo; or continuous equity transaction offer to sell, sell, contract
to sell, grant any option to sell or otherwise dispose of any Ordinary Shares or ADSs (other than the Placement ADSs offered pursuant
to this Agreement) or securities convertible into or exchangeable for Ordinary Shares or ADSs, warrants or any rights to purchase or
acquire, Ordinary Shares or ADSs prior to the sixtieth (60<SUP>th</SUP>) day immediately following the termination of this Agreement;
<I>provided</I>, <I>however</I>, that such restrictions will not be required in connection with the Company&rsquo;s issuance or sale
of (i) Ordinary Shares or ADSs, warrants or options to purchase Ordinary Shares or ADSs or Ordinary Shares or ADSs issuable upon the
exercise of options or warrants, pursuant to any employee or director stock option or benefits plan, stock ownership plan or dividend
reinvestment plan (but not Ordinary Shares or ADSs subject to a waiver to exceed plan limits in its dividend reinvestment plan) of the
Company whether now in effect or hereafter implemented or pursuant to any inducement award in accordance with Exchange rules, (ii) Ordinary
Shares or ADSs issuable upon conversion or redemption of securities or the exercise or redemption of warrants, options or other rights
in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agent, (iii) Ordinary
Shares or ADSs or securities convertible into or exchangeable or redeemable for shares of Ordinary Shares or ADSs as consideration for
mergers, acquisitions, other business combinations, joint ventures, collaborations, licensing arrangements or strategic alliances occurring
after the date of this Agreement which are not issued for capital raising purposes, and (iv) <FONT STYLE="background-color: white">for
the avoidance of doubt, non-public discussions or negotiations with respect to any of the foregoing</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Change
of Circumstances</U>. The Company will, at any time during the pendency of a Placement Notice, advise the Agent promptly after it shall
have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any
opinion, certificate, letter or other document required to be provided to the Agent pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Due
Diligence Cooperation</U>. The Company will cooperate with any reasonable due diligence review conducted by the Agent or its representatives
in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents
and senior corporate officers, during regular business hours and at the Company&rsquo;s principal offices, as the Agent may reasonably
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Required
Filings Relating to Placement of Placement ADSs</U>. The Company shall disclose, in its reports on Form 6-K reporting its interim results
for the first six months of its financial year and in its annual report on Form 20-F to be filed by the Company with the Commission from
time to time, the number of the Placement ADSs sold through the Agent under this Agreement, and the net proceeds to the Company from
the sale of the Placement ADSs pursuant to this Agreement during the relevant six-month period or fiscal year, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Representation
Dates; Certificate</U>. (1) On or prior to the date of the first Placement Notice and (2) each time the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
files the Prospectus relating to the Placement ADSs or amends or supplements (other than a prospectus supplement relating solely to an
offering of securities other than the Placement ADSs) the Registration Statement or the Prospectus relating to the Placement ADSs by
means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration
Statement or the Prospectus relating to the Placement ADSs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
files an annual report on Form 20-F under the Exchange Act (including any Form 20-F/A containing amended financial information or a material
amendment to the previously filed Form 20-F);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
furnishes a report on Form 6-K under the Exchange Act containing its unaudited interim financial statements for the first six months
of its financial year, which report shall indicate that it is incorporated by reference into the Registration Statement and Prospectus;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
furnishes a report on Form 6-K under the Exchange Act containing amended financial information under the Exchange Act that is material
to the offering of securities of the Company in the reasonable discretion of the Agent, in which case such report shall indicate that
it is incorporated by reference into the Registration Statement and Prospectus (each date of filing of one or more of the documents referred
to in clauses (i) through (iv) shall be a &ldquo;<B><U>Representation Date</U></B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Company shall furnish the Agent (but in the case of clause (iv) above only if the Agent reasonably determines that the information contained
in such Form 6-K is material) with a certificate dated the Representation Date, in the form and substance satisfactory to the Agent and
its counsel, substantially similar to the form previously provided to the Agent and its counsel, modified, as necessary, to relate to
the Registration Statement and the Prospectus as amended or supplemented. The requirement to provide a certificate under this <U>Section
7(l)</U> shall be waived for any Representation Date occurring at a time a Suspension is in effect or there is no Placement Notice in
effect, which waiver shall continue until the earlier to occur of the date the Company delivers instructions for the sale of Placement
ADSs hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date.
Notwithstanding the foregoing, if the Company subsequently decides to sell Placement ADSs following a Representation Date when a Suspension
was in effect or there was no Placement Notice in effect and did not provide the Agent with a certificate under this <U>Section 7(l)</U>,
then before the Company delivers the instructions for the sale of Placement ADSs or the Agent sells any Placement ADSs pursuant to such
instructions, the Company shall provide the Agent with a certificate in conformity with this <U>Section 7(l)</U> dated as of the date
that the instructions for the sale of Placement ADSs are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Legal
Opinion</U>. (1) Prior to the date of the first Placement Notice and (2) on or prior to each Representation Date with respect to which
the Company is obligated to deliver a certificate pursuant to <U>Section 7(l)</U> for which no waiver is applicable and excluding the
date of this Agreement, the Company shall cause to be furnished to the Agent (i) a written opinion and negative assurance letter of Fenwick
&amp; West LLP (&ldquo;<B><U>Company U.S. Counsel</U></B>&rdquo;), (ii) a written opinion of Giovannelli e Associati Studio Legale (&ldquo;<B><U>Company
Italian Counsel</U></B>&rdquo;) and (iii) a written opinion of D. Young (&ldquo;<B><U>Company Intellectual Property Counsel</U></B>&rdquo;,
and together with Company U.S. Counsel and Company Italian Counsel, &ldquo;<B><U>Company Counsel</U></B>&rdquo;), or other counsel reasonably
satisfactory to the Agent, in each case in form and substance satisfactory to the Agent and its counsel, substantially similar to the
form previously provided to the Agent and its counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus
as then amended or supplemented; <I>provided</I>, <I>however</I>, that in lieu of such opinions and negative assurance letters for subsequent
periodic filings under the Exchange Act, counsel may furnish the Agent with a letter (a &ldquo;<B><U>Reliance Letter</U></B>&rdquo;)
to the effect that the Agent may rely on a prior opinion or negative assurance letter delivered under this <U>Section 7(m)</U> to the
same extent as if it were dated the date of such letter (except that statements in such prior opinion or negative assurance letter shall
be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>Comfort
Letter</U>. (1) Prior to the date of the first Placement Notice and (2) on or prior to each Representation Date with respect to which
the Company is obligated to deliver a certificate pursuant to <U>Section 7(l)</U> for which no waiver is applicable and excluding the
date of this Agreement, the Company shall cause its independent registered public accounting firm to furnish the Agent letters (the &ldquo;<B><U>Comfort
Letters</U></B>&rdquo;), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this <U>Section
7(n)</U>; <I>provided</I>, that if reasonably requested by the Agent, the Company shall cause a Comfort Letter to be furnished to the
Agent within ten (10) Trading Days of the date of occurrence of any material transaction or event requiring the filing of a report on
Form 6-K containing financial information (including the restatement of the Company&rsquo;s financial statements). The Comfort Letter
from the Company&rsquo;s independent registered public accounting firm shall be in a form and substance satisfactory to the Agent, (i)
confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the Public Company
Accounting Oversight Board (&ldquo;<B><U>PCAOB</U></B>&rdquo;), (ii) stating, as of such date, the conclusions and findings of such firm
with respect to the financial information and other matters ordinarily covered by accountants&rsquo; &ldquo;comfort letters&rdquo; to
underwriters in connection with registered public offerings (the first such letter, the &ldquo;<B><U>Initial Comfort Letter</U></B>&rdquo;)
and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it
been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented
to the date of such letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>Company
Tax Opinion</U>. (1) Prior to the date of the first Placement Notice and (2) on or prior to each Representation Date with respect to
which the Company is obligated to deliver a certificate pursuant to <U>Section 7(l)(i)</U> for which no waiver is applicable and excluding
the date of this Agreement, the Company shall cause to be furnished to the Agent a written opinion of Dr. Negonda (&ldquo;<B><U>Company
Tax Counsel</U></B>&rdquo;) or other counsel reasonably satisfactory to the Agent, in each case in form and substance satisfactory to
the Agent and its counsel, substantially similar to the form previously provided to the Agent and its counsel, modified, as necessary,
to relate to the Registration Statement and the Prospectus as then amended or supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <U>Depositary
Opinion</U>. Prior to the date of the first Placement Notice, the Depositary shall have requested and caused Emmet Marvin &amp; Martin,
LLC, counsel for the Depositary, to have furnished to the Agent their opinion dated as of the Closing Date and addressed to the Representatives,
in form and substance reasonably satisfactory to the Agent and its counsel, substantially similar to the form previously provided to
the Agent and its counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <U>Market
Activities; Compliance with Regulation M</U>. The Company will not, directly or indirectly, (i) take any action designed to cause or
result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of Placement ADSs or (ii) sell, bid for, or purchase Ordinary Shares or ADSs in violation
of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement ADSs other than the Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <U>Investment
Company Act</U>. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor any of its Subsidiaries
will be or become, at any time prior to the termination of this Agreement, required to register as an &ldquo;investment company,&rdquo;
as such term is defined in the Investment Company Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <U>No
Offer to Sell</U>. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent
hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such)
will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act),
required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement ADSs hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <U>Blue
Sky and Other Qualifications</U><I>. </I>The Company will use its commercially reasonable efforts, in cooperation with the Agent, to
qualify the Placement ADSs for offering and sale, or to obtain an exemption for the Placement ADSs to be offered and sold, under the
applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Agent may designate and to maintain such
qualifications and exemptions in effect for so long as required for the distribution of the Placement ADSs (but in no event for less
than one year from the date of this Agreement); <I>provided</I>, <I>however</I>, that the Company shall not be obligated to file any
general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which
it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise
so subject. In each jurisdiction in which the Placement ADSs have been so qualified or exempt, the Company will file such statements
and reports as may be required by the laws of such jurisdiction to continue such qualification or exemption, as the case may be, in effect
for so long as required for the distribution of the Placement ADSs (but in no event for less than one year from the date of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <U>Sarbanes-Oxley
Act</U>. The Company and the Subsidiaries will maintain and keep accurate books and records reflecting their assets and maintain internal
accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with GAAP and including those policies and procedures that (i) pertain to
the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of
the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company&rsquo;s
consolidated financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company are being made only in
accordance with management&rsquo;s and the Company&rsquo;s directors&rsquo; authorization, and (iv) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that could have a material
effect on its financial statements. The Company and the Subsidiaries will maintain such controls and other procedures, including, without
limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed
to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms, including,
without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports
that it files or submits under the Exchange Act is accumulated and communicated to the Company&rsquo;s management, including its principal
executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions
regarding required disclosure and to ensure that material information relating to the Company or the Subsidiaries is made known to them
by others within those entities, particularly during the period in which such periodic reports are being prepared.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Secretary&rsquo;s
Certificate; Further Documentation</U>. On or prior to the date of the first Placement Notice, the Company shall deliver to the Agent
a certificate of the Secretary of the Company and attested to by an executive officer of the Company, dated as of such date, certifying
as to (i) the Articles of Association of the Company, (ii) the By-laws of the Company, (iii) the resolutions of the Board of Directors
of the Company authorizing the execution, delivery and performance of this Agreement and the issuance of the Placement ADSs and (iv)
the incumbency of the officers duly authorized to execute this Agreement and the other documents contemplated by this Agreement. Within
five (5) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate pursuant to
Section 7(l) hereof, the Company shall have furnished to the Agent such further information, certificates and documents as the Agent
may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <U>Emerging
Growth Company Status</U>. The Company will promptly notify the Agent if the Company ceases to be an Emerging Growth Company at any time
during the term of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>Payment
of Expenses</U>. The Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement,
including (i) the preparation and filing of the Registration Statement, including any fees required by the Commission, and the printing
or electronic delivery of the Prospectus as originally filed and of each amendment and supplement thereto relating to the Placement ADSs,
in such number as the Agent shall reasonably deem necessary, (ii) the printing and delivery to the Agent of this Agreement and such other
documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement ADSs, (iii) the preparation,
issuance and delivery of the certificates, if any, for the Placement ADSs to the Agent, including any stock or other transfer taxes and
any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement ADSs to the Agent,
(iv) the fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the fees and expenses of the Agent
including but not limited to the fees and expenses of the counsel to the Agent, payable upon the execution of this Agreement, (a) in
an amount not to exceed $75,000 in connection with the execution of this Agreement, (b) in an amount not to exceed $25,000 per calendar
half year thereafter payable in connection with each Representation Date with respect to which the Company is obligated to deliver a
certificate pursuant to <U>Section 7(l)</U> for which no waiver is applicable and excluding the date of this Agreement and (c) in an
amount not to exceed $25,000 for each program &ldquo;refresh&rdquo; (filing of a new registration statement, prospectus or prospectus
supplement relating to the Placement ADSs and/or an amendment of this Agreement) executed pursuant to this Agreement, (vi) the qualification
or exemption of the Placement ADSs under state securities laws in accordance with the provisions of <U>Section 7(r)</U> hereof, including
filing fees, but excluding fees of the Agent&rsquo;s counsel, (vii) the printing and delivery to the Agent of copies of any Permitted
Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto in such number as the Agent shall reasonably
deem necessary, (viii) the preparation, printing and delivery to the Agent of copies of the blue sky survey, (ix) the fees and expenses
payable upon deposit of the Ordinary Shares with Depositary in accordance with the terms of the Deposit Agreement against the issuance
of Placement ADSs evidencing the same, (x) the filing and other fees incident to any review by FINRA of the terms of the sale of the
Placement ADSs including the fees of the Agent&rsquo;s counsel (subject to the cap, set forth in clause (v) above), and (xi) the fees
and expenses incurred in connection with the listing of the Placement ADSs on the Exchange. The Company agrees to pay the fees and expenses
of counsel to the Agent set forth in clause (v) above by wire transfer of immediately available funds directly to such counsel upon presentation
of an invoice containing the requisite payment information prepared by such counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>Conditions
to Agent&rsquo;s Obligations</U>. The obligations of the Agent hereunder with respect to a Placement will be subject to the continuing
accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of
its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to it in its reasonable judgment, and
to the continuing satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Registration
Statement Effective</U>. The Registration Statement shall have become effective and shall be available for the (i) resale of all Placement
ADSs issued to the Agent and not yet sold by the Agent and (ii) sale of all Placement ADSs contemplated to be issued by any Placement
Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>No
Material Notices</U>. None of the following events shall have occurred and be continuing: (i) receipt by the Company of any request for
additional information from the Commission or any other federal or state Governmental Authority during the period of effectiveness of
the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement
or the Prospectus; (ii) the issuance by the Commission or any other federal or state Governmental Authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of
any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement ADSs for
sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that
makes any statement of a material fact made in the Registration Statement or the Prospectus or any document incorporated or deemed to
be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement,
the Prospectus or material documents so that, in the case of the Registration Statement, it will not contain an untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading
and, that in the case of the Prospectus, it will not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>No
Misstatement or Material Omission</U>. The Agent shall not have advised the Company that the Registration Statement or Prospectus, or
any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&rsquo;s reasonable opinion is material, or
omits to state a fact that in the Agent&rsquo;s reasonable opinion is material and is required to be stated therein or is necessary to
make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Material
Changes</U>. Except as contemplated in the Prospectus, or disclosed in the Company&rsquo;s reports filed with the Commission, there shall
not have been any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development
that would reasonably be expected to cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating assigned to any
of the Company&rsquo;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating
organization that it has under surveillance or review its rating of any of the Company&rsquo;s securities (other than asset backed securities),
the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Agent
(without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable
to proceed with the offering of the Placement ADSs on the terms and in the manner contemplated in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Legal
Opinions</U>. The Agent shall have received the opinions and negative assurance letters required to be delivered pursuant to <U>Section
7(m)</U> on or before the date on which such delivery of such opinions is required pursuant to <U>Section 7(m)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Comfort
Letter</U>. The Agent shall have received the Comfort Letter required to be delivered pursuant to <U>Section 7(n)</U> on or before the
date on which such delivery of such Comfort Letter is required pursuant to <U>Section 7(n)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Representation
Certificate</U>. The Agent shall have received the certificate required to be delivered pursuant to <U>Section 7(l)</U> on or before
the date on which delivery of such certificate is required pursuant to <U>Section 7(l)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Company
Tax Opinion</U>. The Agent shall have received the opinion required to be delivered pursuant to <U>Section 7(o)</U> on or before the
date on which such delivery of such opinion is required pursuant to <U>Section 7(o)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Depositary
Opinion</U>. The Agent shall have received the opinion required to be delivered pursuant to <U>Section 7(p)</U> on or before the date
on which such delivery of such opinion is required pursuant to <U>Section 7(p)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>No
Suspension</U>. Trading in the ADSs shall not have been suspended on the Exchange and the ADSs shall not have been delisted from the
Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Other
Materials</U>. On each date on which the Company is required to deliver a certificate pursuant to <U>Section 7(l)</U>, the Company shall
have furnished to the Agent such appropriate further information, opinions, certificates, letters and other documents as the Agent may
reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Securities
Act Filings Made</U>. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance
of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Approval
for Listing</U>. The Placement ADSs shall either have been (i) approved for listing on the Exchange, subject only to notice of issuance,
or (ii) the Company shall have filed an application for listing of the Placement ADSs on the Exchange at, or prior to, the issuance of
any Placement Notice and the Exchange shall have reviewed such application and not provided any objections thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>FINRA</U>.
If applicable, FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable
to the Agent as described in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>No
Termination Event</U>. There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant to <U>Section
12(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>Indemnification
and Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Company
Indemnification</U>. The Company agrees to indemnify and hold harmless the Agent, its affiliates and their respective partners, members,
directors, officers, employees and agents and each person, if any, who controls the Agent or any affiliate within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission
or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading,
or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus
or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount
paid in settlement of any litigation, or any investigation or proceeding by any Governmental Authority, commenced or threatened, or of
any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; <I>provided
</I>that (subject to <U>Section 10(d)</U> below) any such settlement is effected with the written consent of the Company, which consent
shall not unreasonably be delayed or withheld; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) against
any and all expense whatsoever, as incurred (including the reasonable and documented fees and disbursements of counsel), reasonably incurred
in investigating, preparing or defending against any litigation, or any investigation or proceeding by any Governmental Authority, commenced
or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission
(whether or not a party), to the extent that any such expense is not paid under (i) or (ii) above,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided</I>,
<I>however</I>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising
out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with the
Agent Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Agent
Indemnification</U>. Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company who signed
the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the indemnity contained
in <U>Section 10(a)</U>, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions,
made in the Registration Statement (or any amendments thereto), the Prospectus (or any amendment or supplement thereto) or any Issuer
Free Writing Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to the
Agent and furnished to the Company in writing by the Agent expressly for use therein. The Company hereby acknowledges that the only information
that the Agent has furnished to the Company expressly for use in the Registration Statement, the Prospectus or any Issuer Free Writing
Prospectus (or any amendment or supplement thereto) are the statements set forth in the seventh and eighth paragraphs under the caption
&ldquo;Plan of Distribution&rdquo; in the Prospectus (the &ldquo;<B><U>Agent Information</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Procedure</U>.
Any party that proposes to assert the right to be indemnified under this <U>Section 10</U> will, promptly after receipt of notice of
commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under
this <U>Section 10</U>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served,
but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have
to any indemnified party otherwise than under this <U>Section 10</U> and (ii) any liability that it may have to any indemnified party
under the foregoing provision of this <U>Section 10</U> unless, and only to the extent that, such omission results in the forfeiture
of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies
the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects
by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified
party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory
to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense,
the indemnifying party will not be liable to the indemnified party for any other legal expenses except as provided below and except for
the reasonable and documented costs of investigation subsequently incurred by the indemnified party in connection with the defense. The
indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such
counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized
in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may
be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying
party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party
and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf
of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action or counsel
reasonably satisfactory to the indemnified party, in each case, within a reasonable time after receiving notice of the commencement of
the action; in each of which cases the reasonable and documented fees, disbursements and other charges of counsel will be at the expense
of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding
or related proceedings in the same jurisdiction, be liable for the reasonable and documented fees, disbursements and other charges of
more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at any one time for all such indemnified party
or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred.
An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent.
No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry
of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this <U>Section 10</U>
(whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an express and
unconditional release of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all liability
arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Settlement
Without Consent if Failure to Reimburse</U><I>. </I>If an indemnified party shall have requested an indemnifying party to reimburse the
indemnified party for reasonable and documented fees and expenses of counsel for which it is entitled to reimbursement under this <U>Section
10</U>, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by <U>Section 10(a)(ii)
</U>effected without its written consent if (1) such settlement is entered into more than 45 days after receipt by such indemnifying
party of the aforesaid request, (2) such indemnifying party shall have received notice of the terms of such settlement at least 30 days
prior to such settlement being entered into and (3) such indemnifying party shall not have reimbursed such indemnified party in accordance
with such request prior to the date of such settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Contribution</U>.
In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs
of this <U>Section 10</U> is applicable in accordance with its terms but for any reason is held to be unavailable or insufficient from
the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including
any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action,
suit or proceeding or any claim asserted) to which the Company and the Agent may be subject in such proportion as shall be appropriate
to reflect the relative benefits received by the Company on the one hand and the Agent on the other hand. The relative benefits received
by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total net proceeds
from the sale of the Placement ADSs (before deducting expenses) received by the Company bear to the total compensation received by the
Agent from the sale of Placement ADSs on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is
not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only
the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent,
on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action
in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged
omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that
it would not be just and equitable if contributions pursuant to this <U>Section 10(e)</U> were to be determined by pro rata allocation
or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred
to above in this <U>Section 10(e)</U> shall be deemed to include, for the purpose of this <U>Section 10(e)</U>, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent
with <U>Section 10(c)</U> hereof. Notwithstanding the foregoing provisions of this <U>Section 10(e)</U>, the Agent shall not be required
to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation
(within the meaning of <U>Section 11(f)</U> of the Securities Act) will be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. For purposes of this <U>Section 10(e)</U>, any person who controls a party to this Agreement within
the meaning of the Securities Act, any affiliates of the Agent and any officers, directors, partners, employees or agents of the Agent
or any of its affiliates, will have the same rights to contribution as that party, and each director of the Company and each officer
of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to
the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such
party in respect of which a claim for contribution may be made under this <U>Section 10(e)</U>, will notify any such party or parties
from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may
be sought from any other obligation it or they may have under this <U>Section 10(e)</U> except to the extent that the failure to so notify
such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a
settlement entered into pursuant to the last sentence of <U>Section 10(c)</U> hereof, no party will be liable for contribution with respect
to any action or claim settled without its written consent if such consent is required pursuant to <U>Section 10(c)</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>Representations
and Agreements to Survive Delivery</U>. The indemnity and contribution agreements contained in <U>Section 10</U> of this Agreement and
all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective
dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their
respective officers, directors, employees or controlling persons), (ii) delivery and acceptance of the Placement ADSs and payment therefor
or (iii) any termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Agent may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (1) if there has been, since the time
of execution of this Agreement or since the date as of which information is given in the Prospectus, any change, or any development or
event involving a prospective change, in the condition, financial or otherwise, or in the business, properties, earnings, results of
operations or prospects of the Company and its Subsidiaries considered as one enterprise, whether or not arising in the ordinary course
of business, which individually or in the aggregate, in the sole judgment of the Agent is material and adverse and makes it impractical
or inadvisable to market the Placement ADSs or to enforce contracts for the sale of the Placement ADSs, (2) if there has occurred any
material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities
or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international
political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Agent, impracticable
or inadvisable to market the Placement ADSs or to enforce contracts for the sale of the Placement ADSs, (3) if trading in the ADSs has
been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or
minimum prices for trading have been fixed on the Exchange, (4) if any suspension of trading of any securities of the Company on any
exchange or in the over-the-counter market shall have occurred and be continuing, (5) if a major disruption of securities settlements
or clearance services in the United States shall have occurred and be continuing, or (6) if a banking moratorium has been declared by
either U.S. Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that
the provisions of <U>Section 8</U> (Payment of Expenses), <U>Section 10</U> (Indemnification and Contribution), <U>Section 11</U> (Representations
and Agreements to Survive Delivery), <U>Section 17</U> (Governing Law and Time; Waiver of Jury Trial) and <U>Section 18</U> (Consent
to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this
Agreement as provided in this <U>Section 12(a)</U>, the Agent shall provide the required notice as specified in <U>Section 13</U> (Notices).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company shall have the right, by giving ten (10) days&rsquo; notice as hereinafter specified to terminate this Agreement in its sole
discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party
except that the provisions of <U>Section 8</U>, <U>Section 10</U>, <U>Section 11</U>, <U>Section 17</U> and <U>Section 18</U> hereof
shall remain in full force and effect notwithstanding such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Agent shall have the right, by giving ten (10) days&rsquo; notice as hereinafter specified to terminate this Agreement in its sole discretion
at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except
that the provisions of <U>Section 8</U>, <U>Section 10</U>, <U>Section 11</U>, <U>Section 17</U> and <U>Section 18</U> hereof shall remain
in full force and effect notwithstanding such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) This
Agreement shall remain in full force and effect unless terminated pursuant to <U>Sections 12(a)</U>, <U>(b)</U>, or <U>(c)</U> above
or otherwise by mutual agreement of the parties; <I>provided</I>, <I>however</I>, that any such termination by mutual agreement shall
in all cases be deemed to provide that <U>Section 8</U>, <U>Section 10</U>, <U>Section 11</U>, <U>Section 17</U> and <U>Section 18</U>
shall remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Any
termination of this Agreement shall be effective on the date specified in such notice of termination; <I>provided</I>, <I>however</I>,
that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company,
as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement ADSs, such Placement ADSs
shall settle in accordance with the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <U>Notices</U>.
All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement
shall be in writing, unless otherwise specified, and if sent to the Agent, shall be delivered to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
Fitzgerald &amp; Co.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499
Park Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Capital Markets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
(212) 307-3730</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
Fitzgerald &amp; Co.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">499
Park Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
General Counsel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
(212) 829-4708</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duane
Morris LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1540
Broadway</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James T. Seery</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(973) 424-2088</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jtseery@duanemorris.com</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chiomenti
Studio Legale LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
Rockefeller Plaza Suite 3040</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Salvo Arena</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(212) 660-6407</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
salvo.arena@chiomenti.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
if to the Company, shall be delivered to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
Science S.p.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
Olgettina No. 58</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20132
Milan, Italy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Pierluigi Paracchi</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
pierluigi.paracchi@genenta.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fenwick
&amp; West LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">902
Broadway 18th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10010-6035</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Per Chilstrom</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
pchilstrom@fenwick.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Giovannelli
e Associati<BR>
Via dei Bossi, 4 20121<BR>
Milano MI, Italy<BR>
Attention: Gianvittorio Giroletti Angeli and Andrea Bartolucci</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
gianvittorio.giroletti@galaw.it ; andrea.bartolucci@galaw.it</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address
for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile
transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business
Day, on the next succeeding Business Day, (ii) by Electronic Notice, as set forth below, (iii) on the next Business Day after timely
delivery to a nationally-recognized overnight courier or (iv) on the Business Day actually received if deposited in the U.S. mail (certified
or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &ldquo;<B><U>Business Day</U></B>&rdquo;
shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
electronic communication (&ldquo;<B><U>Electronic Notice</U></B>&rdquo;) shall be deemed written notice for purposes of this Section
13 if sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received
at the time the party sending Electronic Notice receives verification of receipt by the receiving party. Any party receiving Electronic
Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (&ldquo;<B><U>Nonelectronic Notic</U>e</B>&rdquo;)
which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors
and the parties referred to in Section 10 hereof. References to any of the parties contained in this Agreement shall be deemed to include
the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party
other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under
this Agreement without the prior written consent of the other party; <I>provided</I>, <I>however</I>, that the Agent may assign its rights
and obligations hereunder to an affiliate thereof without obtaining the Company&rsquo;s consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <U>Adjustments
for Stock Splits</U>. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted
to take into account any stock split, stock dividend or similar event effected with respect to the Placement ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <U>Entire
Agreement; Amendment; Severability; Waiver</U>. This Agreement (including all schedules and exhibits attached hereto and Placement Notices
issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings,
both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof
may be amended except pursuant to a written instrument executed by the Company and the Agent. In the event that any one or more of the
provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by
a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is
valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or
unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder
of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement. No implied waiver
by a party shall arise in the absence of a waiver in writing signed by such party. No failure or delay in exercising any right, power,
or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further
exercise thereof or the exercise of any right, power, or privilege hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <B><U>GOVERNING
LAW AND TIME; WAIVER OF JURY TRIAL</U>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. EACH PARTY HEREBY
IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING
OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18. <B><U>CONSENT
TO JURISDICTION</U>. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE
CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED
HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY
SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE
OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS
BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED)
TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND
SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS
IN ANY MANNER PERMITTED BY LAW.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19. Appointment
of Agent for Service. The Company hereby irrevocably appoints Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, New York
10168 as its agent for service of process in any suit, action or proceeding described in Section 18 and agrees that service of process
in any suit, action or proceeding may be made upon it at the office of such agent. The Company waives, to the fullest extent permitted
by law, any other requirements of or objections to personal jurisdiction with respect thereto. The Company represents and warrants that
such agent has agreed to act as the Company&rsquo;s agent for service of process, and the Company agrees to take any and all action,
including the filing of any and all documents and instruments, that may be necessary to continue such appointment in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20. <U>Counterparts</U>.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile, electronic
mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21. <U>Construction</U>.
The section and exhibit headings herein are for convenience only and shall not affect the construction hereof. References herein to any
law, statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority shall be deemed to refer to such law,
statute, ordinance, code, regulation, rule or other requirement of any Governmental Authority as amended, reenacted, supplemented or
superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22. <U>Permitted
Free Writing Prospectuses</U>. The Company represents, warrants and agrees that, unless it obtains the prior written consent of the Agent,
which consent shall not be unreasonably withheld, conditioned or delayed, and the Agent represents, warrants and agrees that, unless
it obtains the prior written consent of the Company, it has not made and will not make any offer relating to the Placement ADSs that
would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a &ldquo;free writing prospectus,&rdquo; as defined
in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company,
which consent shall not be unreasonably withheld, conditioned or delayed, as the case may be, is hereinafter referred to as a &ldquo;Permitted
Free Writing Prospectus.&rdquo; The Company represents and warrants that it has treated and agrees that it will treat each Permitted
Free Writing Prospectus as an &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433, and has complied and will comply
with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where
required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if
any, listed in <U>Exhibit 21</U> hereto are Permitted Free Writing Prospectuses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23. <U>Absence
of Fiduciary Relationship</U>. The Company acknowledges and agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the
Agent is acting solely as agent in connection with the public offering of the Placement ADSs and in connection with each transaction
contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company
or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand,
and the Agent, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective
of whether or not the Agent has advised or is advising the Company on other matters, and the Agent has no obligation to the Company with
respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) it
is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated
by this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) neither
the Agent nor its affiliates have provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated
by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) it
is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from
those of the Company and the Agent and its affiliates have no obligation to disclose such interests and transactions to the Company by
virtue of any fiduciary, advisory or agency relationship or otherwise; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) it
waives, to the fullest extent permitted by law, any claims it may have against the Agent or its affiliates for breach of fiduciary duty
or alleged breach of fiduciary duty in connection with the sale of Placement ADSs under this Agreement and agrees that the Agent and
its affiliates shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary
duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24. <U>Definitions</U>.
As used in this Agreement, the following terms have the respective meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Applicable
Time</U></B>&rdquo; means (i) each Representation Date, (ii) the time of each sale of any Placement ADSs pursuant to this Agreement and
(iii) each Settlement Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Governmental
Authority</U></B>&rdquo; means (i) any federal, provincial, state, local, municipal, national or international government or governmental
authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court,
tribunal, arbitrator or arbitral body (public or private); (ii) any self-regulatory organization; or (iii) any political subdivision
of any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Issuer
Free Writing Prospectus</U></B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433, relating to the
Placement ADSs that (1) is required to be filed with the Commission by the Company, (2) is a &ldquo;road show&rdquo; that is a &ldquo;written
communication&rdquo; within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt
from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement ADSs or of the offering that does not reflect
the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form
retained in the Company&rsquo;s records pursuant to Rule 433(g) under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Rule
164</U></B>,&rdquo; &ldquo;<B><U>Rule 172</U></B>,&rdquo; &ldquo;<B><U>Rule 405</U></B>,&rdquo; &ldquo;<B><U>Rule 415</U></B>,&rdquo;
&ldquo;<B><U>Rule 424</U></B>,&rdquo; &ldquo;<B><U>Rule 424(b)</U></B>,&rdquo; &ldquo;<B><U>Rule 430B</U></B>,&rdquo; and &ldquo;<B><U>Rule
433</U></B>&rdquo; refer to such rules under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this Agreement to financial statements and schedules and other information that is &ldquo;contained,&rdquo; &ldquo;included&rdquo;
or &ldquo;stated&rdquo; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to
mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration
Statement or the Prospectus, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall
be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing
Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission)
shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to &ldquo;supplements&rdquo;
to the Prospectus shall include, without limitation, any supplements, &ldquo;wrappers&rdquo; or similar materials prepared in connection
with any offering, sale or private placement of any Placement ADSs by the Agent outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B><I>Signature
Page Follows</I></B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below
for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Very
truly yours,</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENENTA
    SCIENCE S.P.A.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Pierluigi Paracchi</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pierluigi
    Paracchi</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">ACCEPTED
as of the date first-above written:</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CANTOR
    FITZGERALD &amp; CO.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><I>/s/
                                            Sage Kelly</I></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sage
    Kelly</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
    Head of Investment Banking</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Sales Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Placement Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
    Science S.p.A.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cantor
    Fitzgerald &amp; Co.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    [&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    Notice</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
    20[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms and subject to the conditions contained in the Sales Agreement between Genenta Science S.p.A., a ., a Republic of Italy
joint stock corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and Cantor Fitzgerald &amp; Co. (&ldquo;<B><U>Agent</U></B>&rdquo;),
dated May 12, 2023, the Company hereby requests that the Agent sell up to [&#9679;] of American depositary shares, each representing one
(1) ordinary share, with no par value per share, of the Company, at a minimum market price of $[&bull;] per share, during the time period
beginning [month, day, time] and ending [month, day, time].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall pay to the Agent in cash, upon each sale of Placement ADSs pursuant to this Agreement, an amount equal to 3.0% of the aggregate
gross proceeds from each sale of Placement ADSs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice
Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>The
Company</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pierluigi
Paracchi (pierluigi.paracchi@genenta.com)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Slansky (richard.slansky@genenta.com)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barbara
Regonini (barbara.regonini@genenta.com)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>The
Agent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sameer
Vasudev (svasudev@cantor.com)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
copies to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFCEO@cantor.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated
by reference to Exhibit 8.1 of the Company&rsquo;s most recently filed Form 20-F, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representation Date Certificate Pursuant to Section 7(l)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, the duly qualified and elected Chief Executive Officer of Genenta Science S.p.A., a Republic of Italy joint stock corporation
(the &ldquo;<U>Company</U>&rdquo;), does hereby certify in such capacity and on behalf of the Company, pursuant to <U>Section 7(l)</U>
of the Sales Agreement, dated May 12, 2023 (the &ldquo;<U>Sales Agreement</U>&rdquo;), between the Company and Cantor Fitzgerald &amp;
Co., that to the best of the knowledge of the undersigned:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The representations and warranties of the Company in <U>Section 6</U> of the Sales Agreement are true and correct on and as of the date
hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties
that speak solely as of a specific date and which were true and correct as of such date; <I>provided</I>, <I>however</I>, that such representations
and warranties also shall be qualified by the disclosure included or incorporated by reference in the Registration Statement and Prospectus;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales
Agreement at or prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used herein without definition shall have the meanings given to such terms in the Sales Agreement. Each of Fenwick &amp; West LLP,
Giovannelli e Associati Studio Legale, D. Young and Dr. Negonda shall be entitled to rely upon the representations and warranties contained
herein for purposes of delivering their respective opinions and, if applicable, negative assurance letters pursuant to Section of the
Sales Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENENTA SCIENCE S.P.A.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pierluigi Paracchi</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
21</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
Free Writing Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1 </B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genenta
Science S.p.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
Olgettina, 58</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20132
- Milan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RE:</B></FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Genenta
  Science S.p.A. &ndash; Registration Statement on Form F-3 </B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have acted as Italian legal advisers to Genenta Science S.p.A., a joint stock company incorporated
                                            under Italian law with its registered office at Via Olgettina 58, 20132, Milan, Italy (the
                                            &ldquo;<B>Company</B>&rdquo;), on certain legal matters of Italian law in connection with
                                            the Company&rsquo;s registration statement on Form F-3 (the &ldquo;<B>Registration Statement</B>&rdquo;)
                                            filed with the United States Securities and Exchange Commission on May 12, 2023 relating
                                            to the registration under the United States Securities Act of 1933, as amended (the &ldquo;<B>Securities
                                            Act of 1933</B>&rdquo;), of possible offerings from time to time by the Company of up to
                                            USD 100,000,000 in aggregate amount of the Company&rsquo;s securities, which may include
                                            any combination of the below:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new
                                            ordinary shares without par value which may be issued by the Company (the &ldquo;<B>Ordinary
                                            Shares</B>&rdquo;) (including Ordinary Shares to be represented by American Depositary Shares
                                            (&ldquo;<B>ADSs</B>&rdquo;), each representing one of the Ordinary Shares); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new
                                            rights to purchase the Company&rsquo;s Ordinary Shares or Ordinary Shares to be represented
                                            by ADSs which may be issued by the Company (the &ldquo;<B>Rights</B>&rdquo; and, together
                                            with the Ordinary Shares, the &ldquo;<B>Securities</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Securities may be sold from time to time by the Company as set forth in the Registration Statement, the base prospectus contained within
the Registration Statement (the &ldquo;<B><I>Base Prospectus</I></B>&rdquo;) and supplements to the Base Prospectus.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Registration Statement contains <FONT STYLE="background-color: white">a sales agreement prospectus (the &ldquo;<B><I>Sales
Agreement Prospectus</I></B>&rdquo;) relating to the offer and sale by the Company through Cantor Fitzgerald &amp; Co., as the sales
agent (the &ldquo;<B><I>Sales Agent</I></B>&rdquo;), from time to time of Ordinary Shares (the &ldquo;<B><I>Placement Shares</I></B>&rdquo;)
represented by ADSs (the &ldquo;<B><I>Placement ADSs</I></B>&rdquo;) having an aggregate maximum offering price of up to </FONT>USD 30,000,000
<FONT STYLE="background-color: white">pursuant to that certain Controlled Equity Offering Sales Agreement, dated as of May 12, 2023,
by and between the Company and the Sales Agent (the &ldquo;<B><I>Sales Agreement</I></B>&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of giving the opinion set forth below, we have examined copies of documents (the
                                            &ldquo;<B>Documents</B>&rdquo;) set out in the schedule A attached hereto (the &ldquo;<B>Schedule
                                            A</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have made no searches or enquiries concerning the Company or any other person or entity,
                                            and we have examined no corporate records of the foresaid, save for those searches, enquiries,
                                            instruments, documents, or corporate records expressly specified as being made or examined
                                            in this opinion. Subject to the foregoing, we have reviewed exclusively those provisions
                                            of the law of the Republic of Italy that we have considered appropriate for the purpose of
                                            this opinion.</FONT></TD></TR></TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            letter, the opinions given in it, and any non-contractual obligations arising out of or in
                                            connection with this letter and/or the opinions given in it, are governed by, and to be construed
                                            in accordance with, Italian law and relate only to Italian law as applied by the Italian
                                            courts, including the laws of the European Union to the extent having the force of law in
                                            Italy, as at today&rsquo;s date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            this legal opinion, Italian legal concepts are expressed in English terms and not in their
                                            original Italian language. The concepts concerned may not be identical to the concepts described
                                            by the same English terms as they exist under the laws of other jurisdictions. This legal
                                            opinion may, therefore, only be relied upon under the express condition that any issues of
                                            interpretation or liability arising hereunder will be governed by Italian law and that any
                                            dispute arising out of or in connection with this legal opinion shall be subject to the exclusive
                                            jurisdiction of the Court of Milan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assumptions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            giving this opinion, we have assumed that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Documents submitted to us as copy or specimen documents are conformed to their originals,
                                            and the originals are genuine, updated and complete;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            signatures stamps and seals on the originals of all Documents submitted to us are genuine;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            statements contained in the Registration Statement, the Base Prospectus and the Sales Agreement
                                            Prospectus and in the Documents were true and accurate when made and remain true and accurate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            warranty by the Company that it is not aware, or has no notice, of any act, matter, thing
                                            or circumstance means that the same does not exist or has not occurred;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            has not been any amendment to the bylaws of the Company (the &ldquo;<B>Bylaws</B>&rdquo;)
                                            referred to and defined in Schedule A under point (i);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            meeting of the Company referred to in Schedule A under point (ii) was duly convened and held
                                            and all formalities required to be fulfilled prior to the convening of such meeting were
                                            fulfilled, and the resolution of the Company referred to in Schedule A under point (ii) was
                                            duly passed and up to the date hereof has not been revoked, superseded, challenged, or amended,
                                            in full or in part, and is still in force;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            such meeting of the Company referred to in Schedule A under point (ii), the shareholders
                                            authorized the Board of Directors, for a five-year period starting from the date of such
                                            meeting, to increase the share capital against payment, in one or more instalments and on
                                            a divisible basis, up to a maximum amount of EUR 300,000,000 (including premium), by issuance
                                            of a maximum number of 30,000,000 new ordinary shares without par value and with regular
                                            dividend entitlement, also without pre-emption right or free of charge, or otherwise for
                                            the five-year period, also in support of third-party grants of participating interests and/or
                                            industrial and intellectual property rights and similar intangible assets (such as patents,
                                            marks and know-how) which can be granted and held by the Board of Directors itself in pursuit
                                            of the corporate object (the &ldquo;<B>Capital Increase Authorization</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            meeting of the Board of Directors of the Company referred to in Schedule A under point (iii)
                                            was duly convened and held and all formalities required to be fulfilled prior to the convening
                                            of such meeting were fulfilled, and the resolution of the Board of Directors of the Company
                                            referred to in Schedule A under point (iii) was duly passed and up to the date hereof has
                                            not been revoked, superseded, challenged, or amended, in full or in part, and is still in
                                            force;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            such meeting of the Board of Directors of the Company referred to in Schedule A under point
                                            (iii), the Board of Directors resolved, in accordance with the Capital Increase Authorization,
                                            to increase the share capital, within the final term of May 31, 2026, up to a maximum
                                            amount equal to the equivalent in euros of USD 30,000,000 (including share
                                            premium), to be determined according to the exchange rate existing on the date of
                                            each transaction carried out pursuant to the Sales Agreement Prospectus, by issuance
                                            of a maximum number of new ordinary shares to be determined according to the ratio between
                                            the maximum amount of the such capital increase and the price at which the new ordinary shares
                                            will be, from time to time, issued, such latter price determined in accordance with methodologies
                                            usual applied for this type of transaction, to the service of the Placement Shares
                                            provided by the Sales Agreement Prospectus (the &ldquo;<B>Capital Increase Resolution</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            offer whatsoever of Ordinary Shares or Rights will take place in the Republic of Italy and/or
                                            in the European Union or, in the event such offer takes place in the Republic of Italy and/or
                                            in the European Union, the same will not be qualified as offer to the public, pursuant to
                                            article 100 of Legislative Decree 58/1998, article 34-ter of the Consob Regulations 11971/99
                                            and article 1, paragraph 4, of Regulation (EU) 2017/1129, as amended from time to time;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.11.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
                                            the purposes of this opinion, the term &ldquo;non-assessable&rdquo; used under paragraph
                                            3.1(a) below means that the owner of the Ordinary Shares cannot be required by the Company
                                            to pay additional amounts for its Ordinary Shares once the subscription price is fully and
                                            duly paid; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.12.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            are no facts, documents, circumstances or matters which may be material to the opinions set
                                            out herein and which have not been disclosed to us by the Company, notwithstanding our reasonable
                                            inquiry.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            express no opinion as to any laws other than the laws of Italy in force at the date hereof
                                            and we have assumed that none of the opinions expressed below will be affected by the laws
                                            of any jurisdiction other than the Republic of Italy. &ldquo;<B>Generally Applicable Law</B>&rdquo;
                                            means the laws of the Republic of Italy (including the rules or regulations promulgated thereunder
                                            or pursuant thereto), that an Italian lawyer exercising customary professional diligence
                                            would reasonably be expected to recognize as being applicable to the Company or the Ordinary
                                            Shares or the Rights. Without limiting the generality of the foregoing definition of Generally
                                            Applicable Law, the term &ldquo;<B>Generally Applicable Law</B>&rdquo; does not include any
                                            law, rule or regulation that is applicable to the Company solely because of the specific
                                            assets or business of the Company or any of its affiliates. In particular, we have made no
                                            independent investigation of the laws of the State of New York as a basis for the opinion
                                            stated herein and do not express or imply any opinion on such laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            and relying upon the foregoing and subject to the assumptions, qualifications and reservations
                                            contained herein and to any matter not disclosed to us, we are of the opinion that,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            respect to the Ordinary Shares, (i) should the Ordinary Shares be duly issued on the basis
                                            of a valid and enforceable resolution of the competent corporate bodies of the Company, duly
                                            taken in compliance with the Capital Increase Authorization and any applicable Italian law;
                                            and (ii) following the resolution taken in line with point (i) above, should the Ordinary
                                            Shares be duly issued in compliance with the Bylaws and any applicable Italian law, and duly
                                            and validly subscribed and fully paid, with no further obligation on the holder of any of
                                            the Ordinary Shares to make any further payment to the Company in respect of such Ordinary
                                            Shares, then the Ordinary Shares will be duly authorized, validly issued, fully paid and
                                            non-assessable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            respect to the Rights, (i) should the Rights be duly issued on the basis of a valid and enforceable
                                            resolution of the competent corporate bodies of the Company, duly taken in compliance with
                                            the Capital Increase Authorization and any applicable Italian law; and (ii) following the
                                            resolution taken in line with point (i) above, should the Rights be duly issued in compliance
                                            with the Bylaws and any applicable Italian law, then the Rights will be duly authorized,
                                            validly issued and will constitute valid and legally binding obligations of the Company in
                                            accordance with their terms; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            respect to the Placement Shares, it is our opinion that, as at today&rsquo;s date, the Placement
                                            Shares, if and when allotted and issued, registered in the name of the recipient in the electronic
                                            books and registers of the relevant intermediaries and delivered as described in the Registration
                                            Statement and the Sales Agreement Prospectus will be duly and validly authorized and issued,
                                            fully paid or credited as fully paid (subject to the receipt of valid consideration by the
                                            Company for the issue thereof in connection with the offering pursuant to the Sales Agreement
                                            as set forth in the Registration Statement and the Sales Agreement Prospectus) and will not
                                            be subject to any call for payment of further capital in connection therewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Qualifications</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are giving no opinion either as to (i) the contents of the Registration Statement, the Base
                                            Prospectus or the Sales Agreement Prospectus (including any documents incorporated by reference
                                            therein), or (ii) bankruptcy, insolvency, liquidation, reorganization moratorium and similar
                                            laws of general applicability relating to or affecting the rights of creditors of the Company
                                            in general.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            should be understood that (i) the opinions expressed above are based upon our examination
                                            of the Documents listed in Schedule A, as applicable, and (ii) we have not been responsible
                                            for investigating or verifying the accuracy of the facts or statements of foreign law, or
                                            that no material facts have been omitted from them and express no opinion with respect thereto.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            Italian court may stay proceedings brought in such court if concurrent proceedings are being
                                            brought elsewhere.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
                                            to Article 2379-<I>ter</I> of the Italian Civil Code, in the event of the lack of call of
                                            the relevant meeting, the absence of the minutes of the relevant meeting, the impossibility
                                            of the subject of the resolutions and/or if the subject of resolutions is not licit, the
                                            resolution adopted by the extraordinary shareholders&rsquo; meeting of the Company held on
                                            May 20, 2021 may be challenged by any individual/entity having a legitimate interest thereto
                                            during the 3 (three) years following the registration of the resolution with the competent
                                            Register of Enterprises.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex5-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reliance</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            opinion is given on the basis that there will be no amendment to or termination or replacement
                                            of the Documents, referred to in Schedule A to this opinion and on the basis of the laws
                                            of Italy in force as at the date of this opinion. This opinion is also given on the basis
                                            that we undertake no responsibility to notify any addressee of this opinion of any change
                                            in the laws of Italy after the date of this opinion. We also disclaim any obligation to advise
                                            you of facts, circumstances, events or developments which hereafter may be brought to our
                                            attention and which may alter, affect or modify the opinion expressed herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            opinion speaks as of its date and is addressed to you solely for your benefit in connection
                                            with the obligations of the Company arising from the offer of the Securities. We consent
                                            to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to
                                            the references to this firm under the caption &ldquo;Legal Matters&rdquo; in the prospectus
                                            which is a part of the Registration Statement. In giving this consent, we do not admit that
                                            we are thereby within the category of persons whose consent is required under Section 7 of
                                            the Securities Act of 1933 or the rules and regulation thereunder. This opinion is not to
                                            be transmitted to anyone else or for any other purpose or quoted or referred to in any public
                                            document or filed with anyone without our express consent, except that it may be disclosed
                                            to your legal counsel, referred to in any list of closing documents in relation to the offering
                                            of the Securities and included in any bible of documents memorializing the offering of the
                                            Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            issue of liability connected with our rendering this opinion shall be solely subject to the
                                            substantive laws of Italy regardless of any reference to the laws of another jurisdiction
                                            pursuant to any applicable rule governing conflicts of laws. Any dispute shall be subject
                                            to the exclusive jurisdiction of the Court of Milan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/
Giovannelli e Associati</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
A </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the Company&rsquo;s currently effective bylaws;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the resolutions passed by the shareholders of the Company on May 20, 2021 pursuant
                                            to which it was resolved, <I>inter alia</I>, to grant the Board of Directors the Capital
                                            Increase Authorization;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            copy of the resolutions passed by the Board of Directors of the Company on May 10, 2023 pursuant
                                            to which it was resolved increase the share capital to the service of  the Sales Agreement Prospectus;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Statement, the Base Prospectus and the Sale Agreement Prospectus; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Sales Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 25%">&nbsp;</TD><TD STYLE="text-align: center; width: 50%">VIA DEI BOSSI, 4 &ndash; 20121 MILANO</TD><TD STYLE="text-align: right; width: 25%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">TEL.: +39 02 9769 7800 &ndash; FAX: +39 02 8718 1445</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">CODICE FISCALE E P.IVA (VAT NO.): 08347040969</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD>&nbsp;</TD><TD STYLE="text-align: center">www.galaw.it</TD><TD>&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="height: 48.75pt; width: 474.75pt"></U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We hereby consent to the incorporation by reference in this Registration Statement on Form F-3 of Genenta Science S.p.A. of our report
dated April 21, 2023, with respect to our audit of the consolidated financial statements of Genenta Science S.p.A. as of December 31, 2022,
and for the year ended December 31, 2022, appearing in the Annual Report on Form 20-F of Genenta Science S.p.A for the year ended December
31, 2022. We also consent to the reference to our firm under the heading &ldquo;Experts&rdquo; in the Prospectus, which is part of this
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 283.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Dannible &amp; McKee, LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dannible
    &amp; McKee, LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Syracuse,
    New York</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in this Registration Statement on Form F-3, and the related prospectus, of our report dated
April 29, 2022, with respect to the consolidated financial statements of Genenta Science, S.p.A. (the &ldquo;Company&rdquo;) as of December
31, 2021, and for each of the two years in the period ended December 31, 2021, which report is included in the Company&rsquo;s Annual
Report on Form 20-F for the year ended December 31, 2022, and to the reference to us under the heading &ldquo;Experts&rdquo; in the prospectus
which is a part of this Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Mayer Hoffman McCann P.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
12, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 107</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Calculation of Fee Filing Tables<BR></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form F-3<BR>
</B>(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Genenta Science S.p.A.<BR>
</B>(Exact name of Registration as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Table 1 &ndash; Newly Registered and Carry Forward
Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    Type</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    Class Title</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    Calculation or&nbsp;Carry Forward Rule</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    Registered</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    Maximum Offering Price Per Unit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Aggregate Offering Price</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    Rate</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    of Registration Fee</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward Form Type</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward File Number</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry
    Forward Initial Effective Date</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
    Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="43" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Newly Registered Securities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
    to be Paid </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
                                            shares, no par value</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                            457(o)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 3%"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                            457(o)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unallocated
    (Universal) Shelf</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
                                            457(o)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A<SUP></SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00011020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees Previously
    Paid</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="43" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry Forward Securities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carry Forward
    Securities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="13" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Offering Amounts</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="12" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fees Previously Paid</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="13" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fee Offsets</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="12" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Fee Due</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    is being registered hereunder an unspecified number of ordinary shares, including those represented by American depositary shares
    (&ldquo;<B><I>ADSs</I></B>&rdquo;), and rights exercisable for ordinary shares and/or ordinary shares represented by ADSs, as may
    be sold from time to time by Genenta Science S.p.A. (the &ldquo;<B><I>Registrant</I></B>&rdquo;).&nbsp;Any securities registered
    hereunder may be sold separately or as units with other securities registered hereunder.&nbsp;There is also being registered hereunder
    an unspecified number of ordinary shares, including those represented by ADSs, as shall be issuable upon the conversion, exchange
    or exercise of any securities that provide for such issuance.&nbsp;In no event will the aggregate offering price of all types of
    securities issued by the Registrant pursuant to this registration statement exceed $100,000,000. Pursuant to Rule&nbsp;416(a) under
    the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;), this registration statement also covers
    any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    proposed maximum offering price per unit and proposed maximum aggregate offering price for each type of security will be determined
    from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and
    is not specific as to each class of security pursuant to Instruction 2(A)(ii)(b) to Item 9 of Form F-3 under the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>formf-3_001.jpg
<TEXT>
begin 644 formf-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !) 4(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+^*G[0-S
M'>SZ3X7E6-(B4FU( ,6;N(^V!_>_*O*= \=ZOH_BRTUV2]N+VZ@?<YN)6?>A
MX=>>Q'I71_'+X?CP7XJ-U:1[-)U(M+"%&%C?.7C_ %R/8^U>=Q_>%?=X3#X9
MX:]-7NM7U/R7,<7C8XQJK)IQ>BV7]>9]VZ'K%MKVD6FHV3^;:W,8DC8>A['W
M'0^XKQSXU?%B[L=0DT#0[AK=XQB[NXS\X8\^6I[8'4]><>M<5\,?BY-X)\.Z
MKILB-/E#)8=Q'*>"#_L_Q?4'UKA))I+J>6:9VEFD8N[L<EF/))KYRC@[5).6
MR/T?"XZ.*IPG'=[B_;+C[5]I\^;[3G=YWF-YF?7=G.??->W_  4^+-W?ZDF@
MZW.;EY ?LEU(?G)'/EL>^1T/7C%>$32+#&TC'"J,FLK3[JZ6^74$GD@FC<20
ME6QY9!R,5UU:*K1Y;'M8C%4,/24:FK?X'WAK&K6^C:7<WUTVRWMT,CL>.G;Z
MDX'XU\PZMXJU'4O$%SK N);6ZF;(:&0H44?=7CL!_6M[Q=\49?'/AS2;=8V@
M^027B] \PXX_V>_X^U<4U?D7$6*FG[&#MR[V?4^;Q&)]I-0@]$>L?#WXR3_:
MXM.\02"6.0A([XC!4]@_J.G/YU[;7S9\*?!?_"6>(1-<)NTZQ(DE!Z.W\*?I
MD^P]Z^DQ7=PW7Q>(PKGBG=7]UO>WG\SUJ$I2@G(6BD)Q7RG\??VZM)^&^L7?
MA_PE91>(M:M6,=S=S2%;.W<=4RO,C ]<8 ]>U?6&Y]6T5^<-G^V]\;KO.HP:
M39W6F@[CY>C2M#CTW@_KFOHC]G_]L_1OC!))HNJVB^'_ !8(G:&W\PO;WA4$
MD1,>0W'W#SP<$T ?2U%?*?[)_P"U=XI^.WCS5-$US3=+LK:UT]KM'LE<.6$B
MK@[F(Q@FOJF1Q'&S,=J@9))P!0 ^BOD/XS?M^:5X7U6?1/ >G+XGU"*0PMJ$
MS,+3S.FV,+\TO/<8&>F:\_'[2O[3+V_]K#P5(-,QO_Y ,NS;]=VZ@#[\HKY#
M^"_[?6E^*M6AT/QYIR>&-0D<0IJ$+-]E,G0+(&^:(Y[G(]<5]<QR!E&#NR,Y
M'2@!]%?)/QN_:V\6?#?X_0^!M,TO2KC2WDLD,UPLAF_?;=W1L<9..*W_ (__
M +;'A[X1ZI<Z!H=K_P )+XE@.R9?,V6MJ_\ ==QRS_[*].Y!H ^EZ*_-S5/V
M[OC%#<)=O9:9IUG(WR1R:7((VYZ;W;)_"OIS]EW]JZW^.WVK1]5LH])\4V<7
MGM#"Q,-U%D R1YY!!(RISC(.: /H>BFE@%SVKYX_:"_;,\-?!B^GT33X/^$C
M\3QK^\M8Y-D%J2,@3/S\W^R!GUQ0!]$T5\ VG[4O[1OC*%M3T#P9G3#\RFUT
M266,K_O,V6^HK>\!_P#!035='UO^R/B=X7;3]IVR7EA"\4L/N\#\D?[IS[&@
M#[@HK.T'7M/\2Z39ZGI5Y%J&GWD0F@NH&W)(AZ$&OGS]KS]I/Q'\ ;OPW%H-
MAI]Z-4CN&E^W*YVF,IC;M(_O&@#Z4HKYV\<?M@Z#\,_AKX7U768_[0\5ZUI-
MOJ":)8'&WS$#%G8_ZN/)."<DXX%?-VN?MZ_%G5"]]I>D:=I6E@Y5EL)9U ]Y
M&./QXH _1JD/2OC[]FS]N"X^(GBFT\*>-;*ULM1OCY=CJ5CE8I9>T;H2=I;L
M0<$\8KVW]H[XE>(/A3\,YM?\,Z8NKZHMW! +62*24;';#-M3GB@#X2_:<D=?
MVO=5&]@/[2T_@'C[D5?J#W-?CO\ $3X@:YXW^*ESXKUC34L-=EN()GL5B=%5
MHPH0;6^;G:/?FOJOX>_MD?%;Q1\0/#VBZEX*MK33]0OX;:XG6PN5,<;L 6#$
MX&!W-,#[>HKG?'WCO1OAKX5O?$7B"[-GI5FH,LJQL[9) 50J@DDD@#ZU\?:]
M^WMXN\::O+IOPP\#2W@!PLUW$]S.1V)CCX3/H6-(#[CHKX"U7]I[]I'P+#_:
M7B/P<L.FJ<NUUHTD<8'NZM\OXU[W^SG^USHGQTN#HUW:_P!@^*8XS)]C,F^*
MY4?>:%N^.ZGD#UYH ^@J*2B@#E?B!X+@\=>%KO2Y<"5AOMY3_P LY0#M;Z=C
M[$U\8W5G<:7?3V=W$T-U;R-%+&PP58'!%?>VWWKYM_:0T/3;/Q587T$@74;J
M(_:8%'4+PKGW/3\*]W*\4Z4G0EM+\&?(Y]@(UH1Q$?BCH_-?\ \F@3:G(]ZF
M3^E,3[M7M%M;>]UBSMKR<VMI+,B33@9\M"0"?RKTZDHTXN4M$;Y<HTXI=$6-
M6\ ZK+X#3Q,$QIHN/+:/!WE.@D_W=W'ZU@Z99F^N$B7A>K$=AWK[;DT/3VT(
MZ288SIAM_LYAXV^7MQ_+O7R>FBVVBWM[;VMP;J 3,L<Y&"Z X4_E7@3S!PHS
M?VNA>:WIU%6OOH2!!&H51A5& !3[>WEO+J*W@1I9Y7$<<:]68G %(WW2:]%^
M!-EI]]XFOIII5;4+*-3# 1T#9#/]1T_&ORNI@YYAB/9=-V_+JSEP=-U9I'K?
M@GPK%X0\/V]@F#+_ *R>0?QR'[Q^G8>P%=%28]Z6OOJ5.-&"IP5DMCZU))61
MXI^UU\4KGX5?!35KW3Y3!JVH2)IME*O!C>0$LX]U17(]P*^4/V(?V==.^*&L
M7OBWQ-;"^T'2IA#;6<O*75SC<2_]Y4!!QW)&<XQ7K/\ P4DBN&^'OA*10WV5
M-6=9#VWF%MGZ!J[']@66VD_9ZLU@V^;'J5T)P.N_>",_\!*UJ,^B[>UAM+=(
M((8X8$7:L4:A54>@ X KY;_:Z_9FT[Q!X;O?'GA*U71O%VCH;Z1K$>4+N-/F
M8G& )% +!AR<8.>,?5-<I\6/^26^,/\ L#W?_HEZ /A7_@G*WF?&+Q W7=HK
M'\YDKV_]OGXN7G@7X=V7AG2[EK;4/$;O'-+&<,EH@'F 'MO+*N?0M7AO_!-_
M_DKFN?\ 8#/_ *.CK5_X*20R_P#"PO"$K@_9VTN54]"PF^;]"M,#TG]A3]G_
M $K1/!-E\0-6L8[O7-5W/8-,F19VP)"E >C/C.[KC '?/USM_P YK\Z?AM\(
MOVA_$G@+0=3\+^,&M_#US:(]C"NL-&(XL8"[=ORXZ8[5TO\ PH;]J;_H=9?_
M  >M_P#$T@/0OVX/V>]+\4^!-0\=:78QVWB+2$\Z[:%-OVVV_C#@=64?,&ZX
M!!K4_8+^+%UX^^%]SH6IW#7.H^&Y5MEED;+/;."8LGN5VLN?117D.H?L[?M.
M:M8W%E>^+C=6=PC1302ZVQ21",%2-O((KTW]C7]G/QG\#_$WB6\\3+8QVFH6
MD,,*V=SYI+J[$DC QP: /G+]N"[FL/VFM5NK=VBN(;:RDBDC^\K"($$>^:^G
M_P!EO]E72? OA^R\5>*["/6/&NH+]K=KQ1*MEO\ F"J#QYG.6<\Y.!P.?F']
MMS_DZ#4/^N6G_P#H"U^F5E_QZ0_[B_R%,#-\5>$])\9Z#=Z+K-A#?Z9=1F*6
M"5 1@C&1Z$=B.0:_,CX!0W'PS_:UT/2%E8M::W-I#OW>,EX^?J-IK]4*_,+3
MUV_MX+_V.C?^C#2 ^ZOVE/BI)\'_ (/ZYKUJP&ID+9V&X9'VB0[5/_ 1EO\
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MR#W!'((!JOX.\"^'_A]H<.E>'=*M=(T^$ ".V0+G'=CU8^Y)->9?M2?M!Q_
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M_O"BOEKPS^WEX.F\-Z5)K#"+5VM(FO$A<;%G*#S OMNSBB@#ZGHHHH ****
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M=%M;>:XN7)QDE5(C0=2[< "NE_:._P"2*^*?^O1_Y&OF+_@FC_J/$_U7^0H
D^Q+;P'X8DMXFE\*Z-!*R O%]BA;8<<KD+SCUHKHU^Z** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>formf-3_002.jpg
<TEXT>
begin 644 formf-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  T 1@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^^IB"=Q$>
MU4PS?=(P<]6('!QTSW[X _,'_@HE_P %5OV;_P#@G7X=MD^(%_<>-_B]XBL9
M+KP3\'/"LB2^(]72-BJ:AK-P=]MX;T,$.1J&HC=.8F2TMYWY6]_P5._X*!>'
MO^">O[,&M_$X1:?K?Q5\57!\'_![PA<R8_MOQ?>H<ZC=0J&9](\.VGF:OJC#
M:KI"MN)0\RBO\V;XI?%+XD?&OQ_XE^*GQ:\6ZMX]^(?C'4;G4_$'B36[ZYO9
MI)YYGN8K&P2YEE73](TTSRVEAIUKMMH;5 L>"68_N?A!X0/CJ4LZSOVN$X:P
M$W3M056E7S.MAZD8SI4)4H3JK!4:DHR:4+U4G&+4%.:_$_%;Q7CP9&&4Y/&G
MBL\Q%)XB3JS4J>7T9I_O)VTE.2YE"FI.5-VE*+T/UI_:<_X+X_\ !0O]HC5=
M0A\,>/=,_9Q\"SO)%8>$OA):R0^(!;!Y45M3\;:C<7NK7EXT01+I]--E:"42
M-:1>4P"_EYXM_:+_ &@_'FIV^M>,OCC\5?%FK6&/LFI:_P",]5O[^T4S"X"V
MMQ+(\MLJSJDJA'RI0!L' /1_LN?LK?&S]L;XO:/\%?@-X4E\4>+-1 N]4U">
M3[+X8\%:(A87'B/Q;JTF^+3M-B$?E01E_M=[<E8+."8DLO\ 1(O_  :N_&<>
M%A>+^UIX$7Q?_90N1H2_#W5!H?\ ;CVOFC3GU8:J;A[$W96W;41 [B,FY%N,
M&.OZ>Q.;>$OAI6PV25)Y%DF)E"+5\O\ KF)E2J13C/&5:-/$5;RBV^;$./LV
MY*24F[?S?A\L\3?$6E7S:DLUS>E"4ZBG4KJE@Z:YO@PU+GA*=3FM[-13=HWB
MN57?X>?##_@IE_P4 ^$.J6^K>!?VM/BVDMKY(73/%>N'QCX?F2T4I!%<:+K\
M=S:RPHC,J!54/&Q1C'\K5_43_P $M_\ @X*@_:&\<^%OV=/VR]%\,^!?B=XH
MEAT?P+\6?"\=UIW@7QGKC2)%9:'X@TR]NKV7PUXCU!/FBO([DZ)>SY@2.R::
M**OY ?VF?V;?BQ^R/\:/&'P&^->AIH?CWP=/;"9[&3[9HNO:;?6XN-.U_0-1
MPB7VEZA#+$4?F2W=I+:9$DB*UX69;NW*7>G75Q9ZAILT&HZ7?6KR0W>GZI9.
M)["_M)XV1X;JWN8TDBFC99%'RA^CUU<4>&W!''V3O$X/+LNC7S#!JME>>992
MA@ZD:U2$YTL74K4&_K$:\G3I<DXN\6HR44I-9\-<>\8\$9U3P^)QN9/#X3%K
M#YCD^.G*48M3A3J+WW>T4Y-6UBDEI8_V!T()8-MSL&TKD' (4\],!L@@GL,X
M%9VK:G8Z-8WNK:K=06&EZ98W.HZG?74@BMK*QT^*6ZNKNXF9@L<5M;1333,1
MM*)S@+E?B#_@F1^T!J/[3?["O[.'QEUJ2:XU_P 1> [73?$5S.9#/>:YX:O+
MKPSJ=]-),0TLMW<Z4UW-*>7EGD;+8R?R^_X.)_V\9OV>/V;[#]FOX=ZZEC\7
MOVCXIK'5'L;R6/5?#'PHMIY(]?U9%MI8;BWE\0W4!\/6,SND$L9U"%P5<U_!
M>4\&YIG/&,.#*49O&_VO5P.)KKVB5/"X*K5^M8F;IJ34*=.C.2A*WM.>$-7)
M<W]J9IQ9@<JX4J<65G!X599''8>DYQBY5Z\+0HPOJY.<TKQ33Y)-:6/P=_;*
M_P""\_[;/C#]I;XJW_[,_P :Y/AS\"M*\1W7AGX?:!:>&-!U+[=I'A^>>Q;Q
M-/<:I:3W;7&O7<)O$VR+!]AEA"1[0"WS$W_!<'_@J;D#_AJ;4EWD(,>"/"!)
M+>N=.  .,$YX+9.!DC\I8HHX(EC3"6]O$J(2 I0QA8_FX R\A2- H =F.WY5
MX<2><.<?>!)/ !"YVD#[QRJY.>&R1M(K_0K ^'/ ^!R[#X1<-9%56$P]"A.M
M6RJEB*\ITZ5*$JTI)2K35:;]IS5(\SE*5[-2M_">.\0^,<3C<1BX\19K"G6Q
M%6HJ:Q%:E",9S=2-*'LTXM4H2C#>^BY5RV;_ - 7_@W\_;C^-G[9WP+^-O\
MPT+X]'Q$^(OPT^)=E!'KDUCINEW7_",^(+"[O-)M#IFF00Q11P26%Y'%<2+(
MT_F?-S'D_P! $BJ>&RS'8",9#G=P#D <C()Z!22,8S7\.O\ P:Y_%%?#W[3O
M[0WPCEN'BM_B/\,/#?BFRA>:*.)]0\&:QJ-J1Y;XDGN#:ZV67RB66-&#\'C^
MXFZG2VM;B[G95CMK:6XEDD=8UCAAB>64F1_DC"HC?.V$7@M\H-?PWXQ9#0X?
M\1,ZP6"H8?#87$/ 8K!4<)0]C"$<5A(I4XT&HKD@[MTUUFX[L_L_PHSVKGG
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M%5">(R_@?)Y0CEF2TJ5/%TZ,N>-2M^[E3H:27,J$)0:ES/FG4G%I<EW^J/\
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M"Q>7%O-9WJ2*&ANH'!\@G'S_ ($9;DO#V7<2X98/'X;C7 36!XCRW$.C.O\
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M9I]2AM[F1G$@+>E_\'5?C*<_&G]DKP-<-##IMAX ^('BJW,MVP:?4;O5M+L
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M_P#! /\ X)::EJ$U\/V>&TWS=L?V32?&GBRQL8@D;J##;)J;+&<D.2#]]5.
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$K;G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "_!8 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHHK$W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^#
M_P#@XG_Y1_6W_90--_\ 1-U7WA7PA_P<3_\ */ZV_P"R@:;_ .B;JOH>%/\
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MO_P4'\=:C9WGFZ=X;N4\/Z: V0JVB^7-CZW'GM^-?LC\)/VU-(\0?\$SK/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *^$/^#B?_E'];?\ 90--_P#1-U7W?7PA_P '
M$_\ RC^MO^R@:;_Z)NJ^AX4_Y*3"_P"-'S'&?_)*XS_KW(_"ZBBBOZ?/Y&.A
M^$GPS\0?&;XH>'_A+X4N+6+4_$FKV^FV$M](R0I--($4NRJQ"Y(R0I..QK[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK_HV_P 9_P#@?:?_ !5+_4[BG2V%:^<?_DA_Z]<'ZWQB?RE_\B=[\!/V@?\
M@H3\"?@WX<^#]G_P3RU+4HO#VF)9I?2ZV(VG"Y^8J$(7KTR:]S_9D_:-_:Q^
M*_Q"F\-?&[]D&Y\":0FF23QZS-JWGAYU= L.W8.H9CG/\-?)_P#Q$Q?L]?\
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M*$@.H7:PZ$;6'4@>]U^:7_$3%^SU_P!&W^,__ ^T_P#BJ/\ B)B_9Z_Z-O\
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M5MXS"+AI%D4@,6!![@5SO_$3%^SU_P!&W^,__ ^T_P#BJ/\ B)B_9Z_Z-O\
M&?\ X'VG_P 54PX-XIC?_97KYQ_^2'/CO@^=O]L6GE+_ .1/;%_;9_X*(E@#
M_P $V;X#/)_X2'_[76+_ ,%"_AQ^T=JW[3OPC^/GP=^!NH>*O^$1M/M=[96L
MJHBS"97$+.>5SSR :\M_XB8OV>O^C;_&?_@?:?\ Q5'_ !$Q?L]?]&W^,_\
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M !5'^I7%'_0,_OC_ )A_K]PA_P!!<?NE_P#(GZ645^:?_$3%^SQ_T;AXT_\
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M^:?_ !$Q?L\?]&X>-/\ P.M/_BJ/^(F+]GC_ *-P\:?^!UI_\51_J5Q1_P!
MS^^/^8?Z_<(?]!<?NE_\B?I917YI_P#$3%^SQ_T;AXT_\#K3_P"*H_XB8OV>
M/^C</&G_ ('6G_Q5'^I7%'_0,_OC_F'^OW"'_07'[I?_ ")^EE%?FG_Q$Q?L
M\?\ 1N'C3_P.M/\ XJC_ (B8OV>/^C</&G_@=:?_ !5'^I7%'_0,_OC_ )A_
MK]PA_P!!<?NE_P#(GZ645^:?_$3%^SQ_T;AXT_\  ZT_^*H_XB8OV>/^C</&
MG_@=:?\ Q5'^I7%'_0,_OC_F'^OW"'_07'[I?_(GZ645^:?_ !$Q?L\?]&X>
M-/\ P.M/_BJ/^(F+]GC_ *-P\:?^!UI_\51_J5Q1_P! S^^/^8?Z_<(?]!<?
MNE_\B?I917YI_P#$3%^SQ_T;AXT_\#K3_P"*H_XB8OV>/^C</&G_ ('6G_Q5
M'^I7%'_0,_OC_F'^OW"'_07'[I?_ ")^EE%?FG_Q$Q?L\?\ 1N'C3_P.M/\
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M/&G_ ('6G_Q5'^I7%'_0,_OC_F'^OW"'_07'[I?_ ")^EE%?FG_Q$Q?L\?\
M1N'C3_P.M/\ XJC_ (B8OV>/^C</&G_@=:?_ !5'^I7%'_0,_OC_ )A_K]PA
M_P!!<?NE_P#(GZ645^:?_$3%^SQ_T;AXT_\  ZT_^*H_XB8OV>/^C</&G_@=
M:?\ Q5'^I7%'_0,_OC_F'^OW"'_07'[I?_(GZ645^:?_ !$Q?L\?]&X>-/\
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M.KP?Q+1I2J3PS48IMN\=EOU-*/'/"F(JQI4\5%RDTDK2U;T70^^:***^:/K
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MN!)M0G1?E@C:5(E9CVR[HH]S6O#\8OBY;PI;V_Q3\1QQHH5$37+@!0.   _
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M)WA33)?#>F^ K:XO]+MO$LS16Z&WNBK0KY8PTQ4J^""@ (+&G_:&:6NZ\_\
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M\.6GB:7P5/X@\+RZ1X@EDL[I8YDA:"9WB#1L'D0[@I!&>*/[0S3_ )_3_P#
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M_P"C.?AM_P"$?:?_ !%>ST4?VGF7_/\ G_X%+_,/[(RK_H'A_P" 1_R/&/\
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MI8_L\^*IM9\<7[VWA?P?'L^T7*@%A<22G"0PE!OWM_"0<$'-']H9K:_MI_\
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M '>'_@,?\CQC_AW-^P1_T9S\-O\ PC[3_P"(H_X=S?L$?]&<_#;_ ,(^T_\
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MY!*<X'?IGHOVPKCXLVG[,GC*X^!L=TWBE=';^RQ8KNG^^OFF(=3((O,*8YW
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M689FU?V\[?XI?YDO*\J3M]7A?_#'_(]'_P"'<W[!'_1G/PV_\(^T_P#B*/\
MAW-^P1_T9S\-O_"/M/\ XBN,B_X*)Z[9^'[3XN^*OV4_%VD_#&^FC\GQQ/=0
M.T=O(P6.ZELU_>1PME3OR>&!&<BNG^+/[9NJ>#/C,GP'^%WP+U?QSK\_A>WU
MZU73-2AMX'M))9(V=I).$"[%QUW&10/6E_:&:_\ /Z?_ ($_\Q_V9D__ #XA
M_P" +_(N?\.YOV"/^C.?AM_X1]I_\11_P[F_8(_Z,Y^&W_A'VG_Q%>8?#7]H
MO0/@Q\5/CYXZ^)DMZCGQ-HD&D^'(I//N[F\ETY2ME;Q@G?(SG&%XX+'@$U]/
M^ ]=\0^)_"%AX@\4^$)=!O[RW$L^CSW2S26I/(1V0;2V,9 R >,G%*68YG'_
M )?S_P# G_F..5Y3+_F'A_X!'_(\N/\ P3H_8'4%F_8Z^&P ZD^$+3_XBC_A
MW/\ L$?]&<_#;_PC[3_XBO-O^"I7_#2MS\"_%MSX.\2Z=X=\#Z3HD5QJ-U;.
M[ZEJ\S3*AMEQ@00C*EFSN;[O0FO:OC9\+/&GQI^#EG\/O!_Q,NO"HOI+3^V-
M2L4)N9;$ &:")PP,3N,#S.<#/!S3_M',K)^WGK_>E_F+^R\JNU]7A_X#'_(Y
MY?\ @G3^P,XRO['7PV(]O"%I_P#$4'_@G3^P,I"M^QW\-@3T!\(6G/\ XY7B
MO[.\GP:\+?MR:=\./V,O'&J77ARST+4%^)NF7FMW-U:+/'A+=XOM3,QG\[AC
M'E0N>G-=5\0OV*?AZ?#7C7XY_M<_%[6;S6/M-Y?6/B'3_$5W8P>'[,9-O%;0
MI(J;D&/O*VYCQR>6\PS%/6O/_P "E_F)97E;6F'A_P" Q_R/0/\ AW/^P0.O
M['/PV_\ "/M/_B*%_P""='[ SKN3]CKX;$'H1X0M/_B*\*T_Q7\9?CI\)OV<
MOV>?BIXIUC3I_B)#>7OC&^MKAK:]O]-L;=YHHVD7#*9T\HN1ACGD\G/<> /
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MB@ HHHH **** "BBB@ KYX_:/\ WGC#]MKX(7UYX+EU31;*U\0#5)I=-,]K
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M5?ACX*OPRZ7HO@N[NU\5:A&W$DSHNS[)&1E4!/F$@GC@;'[4'[0OC#X@>&O
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M,E]KMS'/JES).\C2LD8C0#<3L55& BX498XRQ)F4^;<J,7$\<_;6\-^(M?\
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M(2=B5 N+HC!,A&%/W0,#'TGXZ_9[T?\ :3N-,^*T?QF^*GA*.]T>#RM'T+Q
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M- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\\^.7QV\%ZM^UG\0/#/Q1_;2\5_#?0_"\>EZ?HVG>&+UQ]IN'MO.N971(I"
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M,%Y\ _V=/%_Q=TRWCEO-%T>26PCE&4:X8B.+<.Z[W4GV!KYX\>>#_CU^R/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C 30# 2(  A$! Q$!_\0
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M-68Y]0TS2[9(-'-Q*=V^.!HXECYXZD#GVJG<WOC"Z1DM-&L+3<,;[JZ\S'_
M5']:!&CIGBG0]88)8ZG;RR'I'NVM^1YK2N;F"SMWN+F5(H8QEG<X 'UKS2P^
M$C/??:]6U,%C)YACM$V<YSP3T_ 5VWB7P]'XBT"32VG>'.UDD'.&7IGU%,"C
M#XYL=0E>/2+*_P!3*'#/;PX0?\"8@5:_M[45P9/#6H!?57B8_D&K!\-6/B;P
MA9-IK:7;ZC9ARZ2VTX1QGKD-C-6?$-]XFU/2FMM'TB^LKLNI$S31J  >1]Z@
M#I-0UFPTBQ%YJ-PMK$?^>AYSZ8'4_2LBV\8KJ2"32M%U.\A)P)O+6-&^A8C-
M8&H>!=6\2>%M/35+TIK-KORTC;U<,>A([XQR*V-(N_$NDZ?#8WV@+<B!!&LU
MG<)A@!@?*V,&@#3M]:OI+B.*?P_?P!SCS-T;JON<-P*NW>J065Q'#(LK._38
MF>^*XWQ/)XQUDVHT.RO-.$9;S6>>-=^<8Z$].:F\0:;XQN-0TQ]*NVCMXX8Q
M= 3!=S@_-]>*0'<T444 %%%% !1110 4444 %%%% !1110 4444 %%9/B.34
MTTH_V0K&Z,B\J 2%'S'@\<@;?^!5BIJ/BR*]FSIRR122-)&''"(  $R._!.3
MUS0!V%%<G<WWBE&C4V\80R\O#;EBJCU&[G/([8X-2V.H^)[F[$=QIMO;)N"N
MQRP3U(.1NSV],B@#IZ*YN:[U^ZU,6T, MK7[1M>4Q9*QJ<Y!)P=P'I\N:K7=
M]X@ANY)K>RN9W224>3PL7EC.PCC+$\$X.<\4 =;17*OJGBF.U$PTR&1AP8U4
M@MD$[NO&..,$DYI)-6\3QVA)TF-I<*0R*2#D=-N<Y&#GTR* .KHKE]1NM=>"
M#9;W"2-:K)MM@!F<GE6)S@ ?GZTDNI^)8R=NG1N0-RH(SRO/5MV PP#C'.>,
M4 =317-VNLZQ=ZO]G%AY4"NN\O$0=ASR6S@'&TXP?O5!)>>*1!.\-LF6=_+6
M2/<R@Y(Z, 0/E&._- '07\=S)' +5]K+/&S\XR@;YA^59-O9:[!-;![KS86G
M:2;=)\T8RV%!_B4@KQVQ56'4_%,OF;M,AC"YQN4Y)&!CJ.N<Y'H:;<:KXG65
MK>/3E)5) 9Q"=I/S;& W>PX]Z )TL-;^P(B2RQW MG65GN-_F2$?*5_NX/.>
M*G?3M3G%JBW,MNJI()6\PD[CC:1\W/?J<>U5;?4/$QD2)[! Q.'9XSM )'SY
MW=LGY>O'6HCJOB:29('TYHH]N)9DCY4Y&67D]B>.>E %Q[#5VAU)!/+YDK$6
M\HEQM7*].>#C/:B2SUW%Q&TYD11"L3I)L:0!R7)]&VX'O[58O]1U./5;""RL
M6DMI2IGE=#A5)Y[\$#GFJL^J>(DN;A4TI/L\;827!8L-V"0H//!! ]C0 Z>Q
MUAG4Q22+;^>&\DS9<)L((+9&<M@XSQ27ECKH>\EM+DD2NBI"\F B87+*>QSN
MR.]0-?\ B8K#(UDJ('Q($CR2N!\V-W^T3M'/R]:CM]2\6",))IL;EU=O,8;=
MI(RJXSVY'UQ[F@#=M+*:'5+N:221H&V>2IE9@./FX)]:R9-/\1213Q"\*"8M
M,'$GS1,"=L:_[)^7Z<^M59-4\5I(#'IP8!?+*M&<*^3SG.6'RKR,#YCZ5<U7
M4M?2]^RV.G$Q^5AI@N0'(ZJ<XP#ZCL: )_LVK^;J$F6WRK_H_P"]^5"54>O&
M#GM3(+'78[BV$EV7BM7\L'?S<(0<N_\ M#CCU!/>J$>J>*('CB;37F))+NZ<
M8P<<@X'(_458?4_$L)G4Z='*\0)CV1D+.,>N[Y<'ZYXZ4 -BT[Q MBZ-/)YA
M6(',W)8-ER#GN/<?2K4MCJS:A!+',ZVR)&'C$IW9#$MCD@\8SG/'0TUM1U]=
M+MG^PH;N4OD+&Q Q]T$9!7/<YXI$F\0I!:YC5IYI7:4LGRPINPJX!YPO/7DT
M ='17'SZKXJ!A*Z:,I_K46,X.0 &!R<]2=HZ;>M UWQ,\3M'I2.\;>4ZB-@
M?ERX.?FY+?*!VZT =A17+G4_$J)&\FGQ;6^5PD98I@#Y\;OFR2?E_6H;+4/%
MC.D$]A$O #S.A[X.X '' R,9Z@<T ==17+C5==@M-]U;@7,URD44<=N6V)LW
M.V W/.>XQ1_:7B<)$7TZ$2/SL5"P&" 06W<?Q$'Z"@#J**XR'4_%L%O*DVGI
M+)&  _EGYF)!R #C')&.V!DU8.K>)&=_^)60B.,$1G[N.>-WS'G.!Z<&@#JZ
M*Y9]4\31PB7^S8W&XH$6,[B,<.1NX'*_+SW]*/M/B2XTEY3#Y%T[QJ$" [%
MRY )ZGIUH ZFBN86[\4&./%M;J<#.Z,L1U_VA_=_\>'O5S1=0U>ZN9DU*R\A
M !L*H0,XYR2?_K>] &W1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) /X# 2(  A$! Q$!_\0
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M #@D]:N^./$EUX:T!KK3K1;N_)+10-G#(BF20G'HBM^)4=ZJ^)O#NL^(=-T
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M3*[U,Q_<@PM+P=OS?=QVZYJ@OBJ[71;O6)]+C%A:7-S%.8KDO(L<,KQO(%*
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)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
